assay_description,canonical_smiles,document_chembl_id,relation,standard_relation,standard_type,standard_units,standard_value,type,units,value,SMILES,year
Residual activity of CDK8/Cyclin C at 1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,81.0,Residual activity,%,81.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Residual activity of CDK8/Cyclin C at 10 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,75.0,Residual activity,%,75.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Residual activity of CDK8/Cyclin C at 0.1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,87.0,Residual activity,%,87.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Residual activity of CDK8/Cyclin C at 1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,79.0,Residual activity,%,79.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Residual activity of CDK8/Cyclin C at 10 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,88.0,Residual activity,%,88.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Residual activity of CDK8/Cyclin C at 0.1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,CHEMBL1152560,=,=,Residual activity,%,94.0,Residual activity,%,94.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,2009.0
Residual activity of CDK8/Cyclin C at 1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,CHEMBL1152560,=,=,Residual activity,%,95.0,Residual activity,%,95.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,2009.0
Residual activity of CDK8/Cyclin C at 10 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,CHEMBL1152560,=,=,Residual activity,%,82.0,Residual activity,%,82.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,2009.0
Residual activity of CDK8/Cyclin C at 0.1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,79.0,Residual activity,%,79.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Inhibition of CDK8/cyclin C (unknown origin) at 10 uM relative to control,CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1,CHEMBL2401733,=,=,Inhibition,%,7.0,INH,%,7.0,CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1,2013.0
Binding affinity to CDK8/CycC (unknown origin) assessed as residence time,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCCN2CCN(C(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)CC2)cc1,CHEMBL3400049,=,=,TIME,hr,27.1,Time,min,1626.0,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCCN2CCN(C(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)CC2)cc1,2015.0
Binding affinity to CDK8/CycC (unknown origin) assessed as residence time,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCCN2CCOCC2)cc1,CHEMBL3400049,<,<,TIME,hr,0.02333,Time,min,1.4,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCCN2CCOCC2)cc1,2015.0
Inhibition of CDKB/cyclinC (unknown origin) at 1 uM by FRET method,N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1,CHEMBL3627690,=,=,Inhibition,%,11.6,INH,%,11.6,N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1,2015.0
Inhibition of CDK8/cyclinC (unknown origin) at 1 uM,Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1,CHEMBL3745631,=,=,Inhibition,%,1.0,INH,%,1.0,Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1,2016.0
Inhibition of CDK8/cyclinC (unknown origin) at 100 nM,CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,CHEMBL3758169,=,=,Inhibition,%,7.9,INH,%,7.9,CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,2016.0
Inhibition of CDK8/cyclinC (unknown origin) at 100 nM,CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21,CHEMBL3758169,=,=,Inhibition,%,11.7,INH,%,11.7,CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(N)=O)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,110.0,IC50,uM,0.11,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(N)=O)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)NC5CC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,8.0,IC50,uM,0.008,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)NC5CC5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,7.0,IC50,uM,0.007,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC(O)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,4.0,IC50,uM,0.004,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC(O)C5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,COC1CN(C(=O)c2ccc3[nH]nc(Cc4ccc(-c5cnn(C)c5)cc4)c3c2)C1,CHEMBL3774357,=,=,IC50,nM,6.0,IC50,uM,0.006,COC1CN(C(=O)c2ccc3[nH]nc(Cc4ccc(-c5cnn(C)c5)cc4)c3c2)C1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCCC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,4.0,IC50,uM,0.004,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCCC5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCC(F)(F)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,5.0,IC50,uM,0.005,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCC(F)(F)C5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,4.0,IC50,uM,0.004,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCNCC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,7.0,IC50,uM,0.007,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCNCC5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCCCC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,6.0,IC50,uM,0.006,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCCCC5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CC[C@H](O)C5)cc34)ccc21,CHEMBL3774357,=,=,IC50,nM,4.0,IC50,uM,0.004,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CC[C@H](O)C5)cc34)ccc21,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CCC(F)(F)C5)cc34)ccc21,CHEMBL3774357,=,=,IC50,nM,2.0,IC50,uM,0.002,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CCC(F)(F)C5)cc34)ccc21,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CC(O)C5)cc34)ccc21,CHEMBL3774357,=,=,IC50,nM,4.0,IC50,uM,0.004,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CC(O)C5)cc34)ccc21,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,COC1CN(C(=O)c2ccc3[nH]nc(Cc4ccc5c(cnn5C)c4)c3c2)C1,CHEMBL3774357,=,=,IC50,nM,7.0,IC50,uM,0.007,COC1CN(C(=O)c2ccc3[nH]nc(Cc4ccc5c(cnn5C)c4)c3c2)C1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,CNC(=O)c1ccc2[nH]nc(CC(C)C)c2c1,CHEMBL3774357,=,=,IC50,nM,840.0,IC50,uM,0.84,CNC(=O)c1ccc2[nH]nc(CC(C)C)c2c1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc(OC)c(OC)c3)c2c1,CHEMBL3774357,=,=,IC50,nM,2500.0,IC50,uM,2.5,CNC(=O)c1ccc2[nH]nc(Cc3ccc(OC)c(OC)c3)c2c1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,CNC(=O)c1ccc2[nH]nc(Cc3cccc(C)c3)c2c1,CHEMBL3774357,=,=,IC50,nM,170.0,IC50,uM,0.17,CNC(=O)c1ccc2[nH]nc(Cc3cccc(C)c3)c2c1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc4cnn(C)c4c3)c2c1,CHEMBL3774357,=,=,IC50,nM,280.0,IC50,uM,0.28,CNC(=O)c1ccc2[nH]nc(Cc3ccc4cnn(C)c4c3)c2c1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,CHEMBL3774357,=,=,IC50,nM,10.0,IC50,uM,0.01,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,2016.0
Binding affinity to CDK8/Cyclin C (unknown origin) by reporter displacement assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,CHEMBL3774357,=,=,IC50,nM,53.0,IC50,nM,53.0,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,2016.0
Binding affinity to CDK8/Cyclin C (unknown origin) assessed as residence time by reporter displacement assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,CHEMBL3774357,<,<,TIME,hr,0.02333,Time,min,1.4,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3774357,=,=,IC50,nM,15.0,IC50,uM,0.015,CNC(=O)c1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc(-c4cnn(CC(C)(C)O)c4)cc3)c2c1,CHEMBL3774357,=,=,IC50,nM,16.0,IC50,uM,0.016,CNC(=O)c1ccc2[nH]nc(Cc3ccc(-c4cnn(CC(C)(C)O)c4)cc3)c2c1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cnc(-c2ccc3[nH]nc(Cc4ccc(-c5cnn(C)c5)cc4)c3c2)c1,CHEMBL3774357,=,=,IC50,nM,78.0,IC50,uM,0.078,Cn1cnc(-c2ccc3[nH]nc(Cc4ccc(-c5cnn(C)c5)cc4)c3c2)c1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(-c5nccn5C)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,32.0,IC50,uM,0.032,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(-c5nccn5C)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(-c5cc(N)ccn5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,270.0,IC50,uM,0.27,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(-c5cc(N)ccn5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,CC(=O)Nc1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3774357,=,=,IC50,nM,29.0,IC50,uM,0.029,CC(=O)Nc1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(NS(C)(=O)=O)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,73.0,IC50,uM,0.073,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(NS(C)(=O)=O)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(N5CCCC5=O)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,36.0,IC50,uM,0.036,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(N5CCCC5=O)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,CC(=O)NCCNc1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3774357,=,=,IC50,nM,680.0,IC50,uM,0.68,CC(=O)NCCNc1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(N5CCOCC5)cc34)cc2)cn1,CHEMBL3774357,>,>,IC50,nM,30000.0,IC50,uM,30.0,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(N5CCOCC5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(S(=O)(=O)NC5CC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,180.0,IC50,uM,0.18,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(S(=O)(=O)NC5CC5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@H](O)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,3.0,IC50,uM,0.003,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@H](O)C5)cc34)cc2)cn1,2016.0
Displacement of dye-labeled ATP competitive probe from recombinant human CDK8/Cyclin C incubated for 20 mins by Alexa647 probe-based FRET assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,2.0,IC50,uM,0.002,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,2016.0
Binding affinity to CDK8/Cyclin C (unknown origin) by reporter displacement assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,6.0,IC50,nM,6.0,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,2016.0
Binding affinity to CDK8/Cyclin C (unknown origin) assessed as residence time by reporter displacement assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,TIME,hr,1.0,Time,min,60.0,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,2016.0
Binding affinity to human CDK8 (1 to 464 amino acid residues)/Cyclin C (1 to 283 amino acid residues) assessed as residence time by reporter displacement assay,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL3797072,=,=,TIME,hr,0.8833,Time,min,53.0,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,2016.0
Binding affinity to human CDK8 (1 to 464 amino acid residues)/Cyclin C (1 to 283 amino acid residues) by reporter displacement assay,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL3797072,=,=,IC50,nM,4.9,IC50,nM,4.9,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(N)c2s1,CHEMBL3804775,=,=,IC50,nM,1.5,IC50,nM,1.5,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(N)c2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,Cc1ncc(Oc2ccc(Cl)cc2)c2cc(C(N)=O)sc12,CHEMBL3804775,=,=,IC50,nM,8.0,IC50,nM,8.0,Cc1ncc(Oc2ccc(Cl)cc2)c2cc(C(N)=O)sc12,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(Cl)c2s1,CHEMBL3804775,=,=,IC50,nM,11.0,IC50,nM,11.0,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(Cl)c2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(F)c2s1,CHEMBL3804775,=,=,IC50,nM,16.0,IC50,nM,16.0,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(F)c2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,CC(=O)Nc1ccc(Oc2cncc3sc(C(N)=O)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,29.0,IC50,nM,29.0,CC(=O)Nc1ccc(Oc2cncc3sc(C(N)=O)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,NC(=O)c1ccc(Oc2cncc3sc(C(N)=O)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,21.0,IC50,nM,21.0,NC(=O)c1ccc(Oc2cncc3sc(C(N)=O)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,N#Cc1ccc(Oc2cncc3sc(C(N)=O)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,5.1,IC50,nM,5.1,N#Cc1ccc(Oc2cncc3sc(C(N)=O)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,NC(=O)c1cc2c(Oc3ccc(OC(F)(F)F)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,12.0,IC50,nM,12.0,NC(=O)c1cc2c(Oc3ccc(OC(F)(F)F)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,COc1ccc(Oc2cncc3sc(C(N)=O)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,25.0,IC50,nM,25.0,COc1ccc(Oc2cncc3sc(C(N)=O)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,Cc1ccc(Oc2cncc3sc(C(N)=O)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,6.0,IC50,nM,6.0,Cc1ccc(Oc2cncc3sc(C(N)=O)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,CNC(=O)c1cc2c(Oc3ccc(I)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,5.3,IC50,nM,5.3,CNC(=O)c1cc2c(Oc3ccc(I)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,O=C(c1cc2c(Oc3ccc(Cl)cc3)cncc2s1)C1CC1,CHEMBL3804775,=,=,IC50,nM,59.0,IC50,nM,59.0,O=C(c1cc2c(Oc3ccc(Cl)cc3)cncc2s1)C1CC1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,CCC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,29.0,IC50,nM,29.0,CCC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,CC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,32.0,IC50,nM,32.0,CC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,CC(C)NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,100.0,IC50,nM,100.0,CC(C)NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,O=C(NC1CC1)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,24.0,IC50,nM,24.0,O=C(NC1CC1)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,CCNC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,16.0,IC50,nM,16.0,CCNC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,CN(C)C(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,75.0,IC50,nM,75.0,CN(C)C(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,CNC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,8.2,IC50,nM,8.2,CNC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,6.2,IC50,nM,6.2,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,COC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,62.0,IC50,nM,62.0,COC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,O=C(O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,=,=,IC50,nM,2.8,IC50,nM,2.8,O=C(O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,NC(=O)c1ccc(Oc2cncc3sc(-c4nnn[nH]4)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,4.4,IC50,nM,4.4,NC(=O)c1ccc(Oc2cncc3sc(-c4nnn[nH]4)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,CC(=O)Nc1ccc(Oc2cncc3sc(-c4nnn[nH]4)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,2.0,IC50,nM,2.0,CC(=O)Nc1ccc(Oc2cncc3sc(-c4nnn[nH]4)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,N#Cc1ccc(Oc2cncc3sc(-c4nnn[nH]4)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,1.0,IC50,nM,1.0,N#Cc1ccc(Oc2cncc3sc(-c4nnn[nH]4)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,FC(F)(F)Oc1ccc(Oc2cncc3sc(-c4nnn[nH]4)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,1.1,IC50,nM,1.1,FC(F)(F)Oc1ccc(Oc2cncc3sc(-c4nnn[nH]4)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,Cc1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,1.6,IC50,nM,1.6,Cc1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,Clc1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,1.1,IC50,nM,1.1,Clc1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,Fc1ccc(Oc2cncc3sc(-c4nnn[nH]4)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,5.5,IC50,nM,5.5,Fc1ccc(Oc2cncc3sc(-c4nnn[nH]4)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,c1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,8.3,IC50,nM,8.3,c1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,NC(=O)c1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1,CHEMBL3804775,=,=,IC50,nM,3.0,IC50,nM,3.0,NC(=O)c1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system by fluorescence polarization assay,Ic1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1,CHEMBL3804775,=,=,IC50,nM,0.7,IC50,nM,0.7,Ic1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 0.1 uM by fluorescence polarization assay relative to control,Ic1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1,CHEMBL3804775,>,>,Inhibition,%,80.0,INH,%,80.0,Ic1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 0.1 uM by fluorescence polarization assay relative to control,NC(=O)c1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1,CHEMBL3804775,>,>,Inhibition,%,80.0,INH,%,80.0,NC(=O)c1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM by fluorescence polarization assay relative to control,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,CHEMBL3804775,>,>,Inhibition,%,80.0,INH,%,80.0,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1,2016.0
Inhibition of full length human recombinant His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM by fluorescence polarization assay relative to control,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(N)c2s1,CHEMBL3804775,>,>,Inhibition,%,80.0,INH,%,80.0,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(N)c2s1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,CNC(=O)c1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2n1,CHEMBL3826875,=,=,IC50,nM,3.6,IC50,nM,3.6,CNC(=O)c1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2n1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,CNC(=O)c1ccc2cncc(-c3ccc4c(cnn4C)c3)c2n1,CHEMBL3826875,=,=,IC50,nM,5.4,IC50,nM,5.4,CNC(=O)c1ccc2cncc(-c3ccc4c(cnn4C)c3)c2n1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,CNC(=O)c1ccc2cncc(-c3ccc4cnn(C)c4c3)c2n1,CHEMBL3826875,=,=,IC50,nM,6.9,IC50,nM,6.9,CNC(=O)c1ccc2cncc(-c3ccc4cnn(C)c4c3)c2n1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4C)c2n1,CHEMBL3826875,=,=,IC50,nM,0.9,IC50,nM,0.9,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4C)c2n1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4)c2n1,CHEMBL3826875,=,=,IC50,nM,5.3,IC50,nM,5.3,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4)c2n1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(N)=O)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,1.5,IC50,nM,1.5,Cn1cc(-c2ccc(-c3cncc4ccc(C(N)=O)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)O)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,4.7,IC50,nM,4.7,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)O)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(C#N)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,390.0,IC50,nM,390.0,Cn1cc(-c2ccc(-c3cncc4ccc(C#N)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,3.6,IC50,nM,3.6,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCC5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,COC1CN(C(=O)c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,CHEMBL3826875,=,=,IC50,nM,5.2,IC50,nM,5.2,COC1CN(C(=O)c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CC(F)(F)C5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,26.0,IC50,nM,26.0,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CC(F)(F)C5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,3.5,IC50,nM,3.5,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCCC5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCOCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,13.0,IC50,nM,13.0,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCOCC5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCNCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,25.0,IC50,nM,25.0,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCNCC5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,CC(=O)Nc1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2n1,CHEMBL3826875,=,=,IC50,nM,1.8,IC50,nM,1.8,CC(=O)Nc1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2n1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCCC5=O)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,2.4,IC50,nM,2.4,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCCC5=O)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCNC5=O)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,1.0,IC50,nM,1.0,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCNC5=O)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,COC1CN(c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,CHEMBL3826875,=,=,IC50,nM,816.0,IC50,nM,816.0,COC1CN(c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCOCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,1195.0,IC50,nM,1195.0,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCOCC5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ccnn5C)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,470.0,IC50,nM,470.0,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ccnn5C)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ccn(C)n5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,1230.0,IC50,nM,1230.0,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ccn(C)n5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ncco5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,16.0,IC50,nM,16.0,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ncco5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5nccn5C)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,0.71,IC50,nM,0.71,Cn1cc(-c2ccc(-c3cncc4ccc(-c5nccn5C)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,CNC(=O)c1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3826875,=,=,IC50,nM,4.5,IC50,nM,4.5,CNC(=O)c1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)NC5CC5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,2.1,IC50,nM,2.1,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)NC5CC5)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,COC1CN(C(=O)c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,CHEMBL3826875,=,=,IC50,nM,11.0,IC50,nM,11.0,COC1CN(C(=O)c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,6.2,IC50,nM,6.2,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,CC(=O)Nc1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3826875,=,=,IC50,nM,4.9,IC50,nM,4.9,CC(=O)Nc1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ncco5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,34.0,IC50,nM,34.0,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ncco5)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5nccn5C)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,5.6,IC50,nM,5.6,Cn1cc(-c2ccc(-c3cncc4ccc(-c5nccn5C)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCOC5=O)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,4.6,IC50,nM,4.6,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCOC5=O)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCCS5(=O)=O)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,6.7,IC50,nM,6.7,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCCS5(=O)=O)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cncc4ccc(S(N)(=O)=O)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,5.6,IC50,nM,5.6,Cn1cc(-c2ccc(-c3cncc4ccc(S(N)(=O)=O)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCNCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,100.0,IC50,nM,100.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCNCC5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCOCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,52.0,IC50,nM,52.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCOCC5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,CHEMBL3826875,=,=,IC50,nM,1.1,IC50,nM,1.1,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,21.0,IC50,nM,21.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCC5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,COC1(C)CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,CHEMBL3826875,=,=,IC50,nM,12.0,IC50,nM,12.0,COC1(C)CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(F)(F)C5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,17.0,IC50,nM,17.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(F)(F)C5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(C)(F)C5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,37.0,IC50,nM,37.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(C)(F)C5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,28.0,IC50,nM,28.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCCC5)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(-c5nccn5C)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,160.0,IC50,nM,160.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(-c5nccn5C)nc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCC5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,36.0,IC50,nM,36.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCC5)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,CHEMBL3826875,=,=,IC50,nM,12.0,IC50,nM,12.0,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,COC1(C)CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,CHEMBL3826875,=,=,IC50,nM,44.0,IC50,nM,44.0,COC1(C)CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,12.0,IC50,nM,12.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(C)(F)C5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,33.0,IC50,nM,33.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(C)(F)C5)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,CC(=O)Nc1ccc2c(N)ncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3826875,=,=,IC50,nM,29.0,IC50,nM,29.0,CC(=O)Nc1ccc2c(N)ncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)NC5CC5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,9.1,IC50,nM,9.1,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)NC5CC5)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(N5CCOC5=O)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,20.0,IC50,nM,20.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(N5CCOC5=O)cc34)cc2)cn1,2016.0
Competitive binding affinity to full length His-tagged human recombinant CDK8/cyclin C expressed in baculovirus after 20 mins in presence of Alexa647 tracer by FRET assay,CNC(=O)c1ccc2c(N)ncc(-c3ccc4c(c3)CS(=O)(=O)N4)c2n1,CHEMBL3826875,,,Inhibition,%,,INH,,,CNC(=O)c1ccc2c(N)ncc(-c3ccc4c(c3)CS(=O)(=O)N4)c2n1,2016.0
Binding affinity to human CDK8 (1 to 464 residues)/cyclin C (1 to 283 residues) by reporter probe displacement assay,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,CHEMBL3826875,=,=,IC50,nM,5.1,IC50,nM,5.1,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,2016.0
Binding affinity to human CDK8 (1 to 464 residues)/cyclin C (1 to 283 residues) by reporter probe displacement assay,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,CHEMBL3826875,=,=,IC50,nM,32.7,IC50,nM,32.7,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,2016.0
Binding affinity to human CDK8 (1 to 464 residues)/cyclin C (1 to 283 residues) assessed as probe residence time by reporter probe displacement assay,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,CHEMBL3826875,=,=,TIME,hr,0.25,Time,min,15.0,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,2016.0
Binding affinity to human CDK8 (1 to 464 residues)/cyclin C (1 to 283 residues) assessed as probe residence time by reporter probe displacement assay,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,CHEMBL3826875,=,=,TIME,hr,0.3833,Time,min,23.0,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,CCOc1ccccc1CNC(=O)c1nn2c(C)ncc2s1,CHEMBL3853318,=,=,IC50,nM,129.0,IC50,nM,129.0,CCOc1ccccc1CNC(=O)c1nn2c(C)ncc2s1,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,CCOc1ccccc1C(C)NC(=O)c1nn2c(C)ncc2s1,CHEMBL3853318,=,=,IC50,nM,781.0,IC50,nM,781.0,CCOc1ccccc1C(C)NC(=O)c1nn2c(C)ncc2s1,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1ncc2sc(C(=O)N3CCCC3c3ccccc3)nn12,CHEMBL3853318,=,=,IC50,nM,77.0,IC50,nM,77.0,Cc1ncc2sc(C(=O)N3CCCC3c3ccccc3)nn12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1ncc2sc(C(=O)N3CCCC3c3ccc(F)cc3)nn12,CHEMBL3853318,=,=,IC50,nM,60.0,IC50,nM,60.0,Cc1ncc2sc(C(=O)N3CCCC3c3ccc(F)cc3)nn12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1ncc2sc(C(=O)N3CCCC3c3ccc(Cl)cc3)nn12,CHEMBL3853318,=,=,IC50,nM,17.0,IC50,nM,17.0,Cc1ncc2sc(C(=O)N3CCCC3c3ccc(Cl)cc3)nn12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1ncc2sc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)nn12,CHEMBL3853318,=,=,IC50,nM,3.8,IC50,nM,3.8,Cc1ncc2sc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)nn12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1ncc2sc(C(=O)N3CCC[C@@H]3c3ccc(Cl)cc3)nn12,CHEMBL3853318,=,=,IC50,nM,110.0,IC50,nM,110.0,Cc1ncc2sc(C(=O)N3CCC[C@@H]3c3ccc(Cl)cc3)nn12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,O=C(c1ccc2[nH]ncc2c1)N1CCC[C@H]1c1ccc(Cl)cc1,CHEMBL3853318,=,=,IC50,nM,32.0,IC50,nM,32.0,O=C(c1ccc2[nH]ncc2c1)N1CCC[C@H]1c1ccc(Cl)cc1,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,1.4,IC50,nM,1.4,Cc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1nnc2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cn12,CHEMBL3853318,=,=,IC50,nM,3990.0,IC50,nM,3990.0,Cc1nnc2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cn12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1ncc2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cn12,CHEMBL3853318,=,=,IC50,nM,9.0,IC50,nM,9.0,Cc1ncc2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cn12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,4.9,IC50,nM,4.9,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Br)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,3.1,IC50,nM,3.1,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Br)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(F)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,32.0,IC50,nM,32.0,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(F)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Nc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(F)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,49.0,IC50,nM,49.0,Nc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(F)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Nc1n[nH]c2ccc(C(=O)N3CCCC[C@H]3c3ccc(F)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,45.0,IC50,nM,45.0,Nc1n[nH]c2ccc(C(=O)N3CCCC[C@H]3c3ccc(F)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Nc1n[nH]c2ccc(C(=O)N3CC[C@@H](c4ccc(Cl)cc4)C3)cc12,CHEMBL3853318,=,=,IC50,nM,24.0,IC50,nM,24.0,Nc1n[nH]c2ccc(C(=O)N3CC[C@@H](c4ccc(Cl)cc4)C3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,CNc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,5.4,IC50,nM,5.4,CNc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,1.7,IC50,nM,1.7,Cc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1n[nH]c2ccc(C(=O)N3CCN(C)CC3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,15.0,IC50,nM,15.0,Cc1n[nH]c2ccc(C(=O)N3CCN(C)CC3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1n[nH]c2ccc(C(=O)N3CCOCC3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,8.5,IC50,nM,8.5,Cc1n[nH]c2ccc(C(=O)N3CCOCC3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1n[nH]c2cnc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,11.0,IC50,nM,11.0,Cc1n[nH]c2cnc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)nc12,CHEMBL3853318,=,=,IC50,nM,1.3,IC50,nM,1.3,Cc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)nc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,2.6,IC50,nM,2.6,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay relative to control,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,Inhibition,%,100.0,INH,%,100.0,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay relative to control,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Br)cc3)cc12,CHEMBL3853318,=,=,Inhibition,%,98.0,INH,%,98.0,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Br)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay relative to control,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(F)cc3)cc12,CHEMBL3853318,=,=,Inhibition,%,93.0,INH,%,93.0,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(F)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay relative to control,Nc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(F)cc3)cc12,CHEMBL3853318,=,=,Inhibition,%,94.0,INH,%,94.0,Nc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(F)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay relative to control,Nc1n[nH]c2ccc(C(=O)N3CCCC[C@H]3c3ccc(F)cc3)cc12,CHEMBL3853318,=,=,Inhibition,%,95.0,INH,%,95.0,Nc1n[nH]c2ccc(C(=O)N3CCCC[C@H]3c3ccc(F)cc3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay relative to control,Nc1n[nH]c2ccc(C(=O)N3CC[C@@H](c4ccc(Cl)cc4)C3)cc12,CHEMBL3853318,=,=,Inhibition,%,96.0,INH,%,96.0,Nc1n[nH]c2ccc(C(=O)N3CC[C@@H](c4ccc(Cl)cc4)C3)cc12,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/cyclin C expressed in Baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition and incubated in dark for 60 mins by FRET-based Lanthascreen assay relative to control,CNc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,Inhibition,%,99.0,INH,%,99.0,CNc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Binding affinity to human CDK8 (1 to 464 residues)/cyclin C (1 to 283 residues) by reporter displacement assay,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,INH,nM,4.0,INH,nM,4.0,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Binding affinity to human CDK8 (1 to 464 residues)/cyclin C (1 to 283 residues) assessed as residence time by reporter displacement assay,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,TIME,hr,0.3,Time,min,18.0,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-CHKStide as substrate after 60 mins in presence of 33P-ATP by microbeta scintillation counting analysis,CC(C)c1c2cc(-c3ccnc(N[C@H]4CC[C@H](NC5CCOCC5)CC4)n3)ccc2nn1C,CHEMBL3856187,=,=,IC50,nM,16.0,IC50,nM,16.0,CC(C)c1c2cc(-c3ccnc(N[C@H]4CC[C@H](NC5CCOCC5)CC4)n3)ccc2nn1C,2016.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1noc2ncnc(N3CCC(C(=O)NCCCN4CCOCC4)CC3)c12,CHEMBL4004862,=,=,Inhibition,%,1.0,INH,%,1.0,Cc1noc2ncnc(N3CCC(C(=O)NCCCN4CCOCC4)CC3)c12,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCCc1c(C(=O)Nc2ccc(NC(C)=O)cc2)nnn1-c1ccc2noc(-c3ccccc3)c2c1,CHEMBL4004862,=,=,Inhibition,%,27.0,INH,%,27.0,CCCc1c(C(=O)Nc2ccc(NC(C)=O)cc2)nnn1-c1ccc2noc(-c3ccccc3)c2c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4004862,=,=,Inhibition,%,99.0,INH,%,99.0,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1ccc(Cl)cc1N1CCN(C(=O)c2noc3ncnc(N4CCCC4)c23)CC1,CHEMBL4004862,=,=,Inhibition,%,4.0,INH,%,4.0,Cc1ccc(Cl)cc1N1CCN(C(=O)c2noc3ncnc(N4CCCC4)c23)CC1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Fc1ccc(-c2noc3ncnc(N4CCN(c5ccccn5)CC4)c23)cc1,CHEMBL4004862,=,=,Inhibition,%,19.0,INH,%,19.0,Fc1ccc(-c2noc3ncnc(N4CCN(c5ccccn5)CC4)c23)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1ccc(Cl)cc1N1CCN(c2ncnc3sc(C(=O)O)c(C)c23)CC1,CHEMBL4004862,=,=,Inhibition,%,75.0,INH,%,75.0,Cc1ccc(Cl)cc1N1CCN(c2ncnc3sc(C(=O)O)c(C)c23)CC1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Fc1ccc(N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1,CHEMBL4004862,=,=,Inhibition,%,81.0,INH,%,81.0,Fc1ccc(N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1ccc(-n2ncc(C(C)(C)C)c2NC(=O)CN(C)C(=O)Nc2ccccc2C)c(C)c1,CHEMBL4004862,=,=,Inhibition,%,13.0,INH,%,13.0,Cc1ccc(-n2ncc(C(C)(C)C)c2NC(=O)CN(C)C(=O)Nc2ccccc2C)c(C)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCc1ccc(-n2c(SCc3ccccc3C)nc3[nH]ncc3c2=O)cc1,CHEMBL4004862,=,=,Inhibition,%,10.0,INH,%,10.0,CCc1ccc(-n2c(SCc3ccccc3C)nc3[nH]ncc3c2=O)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1ccc(NC(=O)CCc2nc3ccncc3[nH]2)cc1F,CHEMBL4004862,=,=,Inhibition,%,7.0,INH,%,7.0,Cc1ccc(NC(=O)CCc2nc3ccncc3[nH]2)cc1F,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(Cc1ccc(NC(=O)N2CCSc3ncccc32)cc1)NCc1cccc(Cl)c1,CHEMBL4004862,=,=,Inhibition,%,14.0,INH,%,14.0,O=C(Cc1ccc(NC(=O)N2CCSc3ncccc32)cc1)NCc1cccc(Cl)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1cccc(N2CCN(c3ncnc4onc(C)c34)CC2)c1C,CHEMBL4004862,=,=,Inhibition,%,28.0,INH,%,28.0,Cc1cccc(N2CCN(c3ncnc4onc(C)c34)CC2)c1C,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CN1C(=O)c2ccccc2C(C(=O)Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)C1c1cccs1,CHEMBL4004862,=,=,Inhibition,%,-6.0,INH,%,-6.0,CN1C(=O)c2ccccc2C(C(=O)Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)C1c1cccs1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,COc1ccc(-n2nc(C(=O)NCC(=O)N3CCC(Cc4ccccc4)CC3)c3ccccc3c2=O)cc1,CHEMBL4004862,=,=,Inhibition,%,0.0,INH,%,0.0,COc1ccc(-n2nc(C(=O)NCC(=O)N3CCC(Cc4ccccc4)CC3)c3ccccc3c2=O)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CC(=O)c1cccc(NC(=O)c2nnn(-c3ccc4noc(-c5ccccc5)c4c3)c2C)c1,CHEMBL4004862,=,=,Inhibition,%,80.0,INH,%,80.0,CC(=O)c1cccc(NC(=O)c2nnn(-c3ccc4noc(-c5ccccc5)c4c3)c2C)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(Nc1c(C(=O)c2ccccc2)oc2ccccc12)c1cc(-c2ccc3c(c2)OCCO3)on1,CHEMBL4004862,=,=,Inhibition,%,18.0,INH,%,18.0,O=C(Nc1c(C(=O)c2ccccc2)oc2ccccc12)c1cc(-c2ccc3c(c2)OCCO3)on1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1c(C(=O)Nc2ccc3ccc(=O)oc3c2)nnn1-c1ccc2noc(-c3ccccc3)c2c1,CHEMBL4004862,=,=,Inhibition,%,52.0,INH,%,52.0,Cc1c(C(=O)Nc2ccc3ccc(=O)oc3c2)nnn1-c1ccc2noc(-c3ccccc3)c2c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CC(=O)N1CCC2(CC1)CC(=O)c1ccc(OCC(=O)Nc3cccc(C(F)(F)F)c3)cc1O2,CHEMBL4004862,=,=,Inhibition,%,95.0,INH,%,95.0,CC(=O)N1CCC2(CC1)CC(=O)c1ccc(OCC(=O)Nc3cccc(C(F)(F)F)c3)cc1O2,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCc1ccc(NC(=O)c2c(O)c3ccccc3n(CC)c2=O)cc1,CHEMBL4004862,=,=,Inhibition,%,46.0,INH,%,46.0,CCc1ccc(NC(=O)c2c(O)c3ccccc3n(CC)c2=O)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1ccc2sc(NNC(=O)c3ccc(S(=O)(=O)CN4CCc5ccccc5C4)cc3)nc2c1C,CHEMBL4004862,=,=,Inhibition,%,6.0,INH,%,6.0,Cc1ccc2sc(NNC(=O)c3ccc(S(=O)(=O)CN4CCc5ccccc5C4)cc3)nc2c1C,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(NC1C2CS(=O)(=O)CC2NN1c1ccc(F)cc1)c1ccc(C(=O)c2ccccc2)cc1,CHEMBL4004862,=,=,Inhibition,%,0.0,INH,%,0.0,O=C(NC1C2CS(=O)(=O)CC2NN1c1ccc(F)cc1)c1ccc(C(=O)c2ccccc2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCOC(=O)c1c(C)oc2ncnc(NCCc3ccc(OCC)cc3)c12,CHEMBL4004862,=,=,Inhibition,%,9.0,INH,%,9.0,CCOC(=O)c1c(C)oc2ncnc(NCCc3ccc(OCC)cc3)c12,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCOC(=O)Cc1ccc(NC(=O)Nc2cc3c(cc2N2CCCC2)n(CC)c(=O)n3CC)cc1,CHEMBL4004862,=,=,Inhibition,%,11.0,INH,%,11.0,CCOC(=O)Cc1ccc(NC(=O)Nc2cc3c(cc2N2CCCC2)n(CC)c(=O)n3CC)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(OCc1cc(=O)n2nc(C3CC3)sc2n1)c1ccc(NC(=O)c2cccc3ccccc23)cc1,CHEMBL4004862,=,=,Inhibition,%,0.0,INH,%,0.0,O=C(OCc1cc(=O)n2nc(C3CC3)sc2n1)c1ccc(NC(=O)c2cccc3ccccc23)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1nc(Nc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cc(N2CCCCC2)n1,CHEMBL4004862,=,=,Inhibition,%,97.0,INH,%,97.0,Cc1nc(Nc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cc(N2CCCCC2)n1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1oc2ccccc2c1C(=O)CSc1nc(O)c2c(n1)NCN2,CHEMBL4004862,=,=,Inhibition,%,14.0,INH,%,14.0,Cc1oc2ccccc2c1C(=O)CSc1nc(O)c2c(n1)NCN2,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1cc(C)c2c(n1)SCCN2C(=O)Nc1ccc(C(=O)NCc2cccc(Cl)c2)cc1,CHEMBL4004862,=,=,Inhibition,%,0.0,INH,%,0.0,Cc1cc(C)c2c(n1)SCCN2C(=O)Nc1ccc(C(=O)NCc2cccc(Cl)c2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCn1c(=O)c(=O)n(CC(=O)NCc2ccccc2)c2ccccc21,CHEMBL4004862,=,=,Inhibition,%,-2.0,INH,%,-2.0,CCn1c(=O)c(=O)n(CC(=O)NCc2ccccc2)c2ccccc21,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CN(C)c1ccc(CNC(=O)C2CCN(c3ccc4nncn4n3)CC2)cc1,CHEMBL4004862,=,=,Inhibition,%,0.0,INH,%,0.0,CN(C)c1ccc(CNC(=O)C2CCN(c3ccc4nncn4n3)CC2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CC(=O)c1ccc(NC(=O)COc2cc(-c3ccccc3)nc3ccc(F)cc23)cc1,CHEMBL4004862,=,=,Inhibition,%,10.0,INH,%,10.0,CC(=O)c1ccc(NC(=O)COc2cc(-c3ccccc3)nc3ccc(F)cc23)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,COc1cccc(NC(=O)CSc2nc3ccc(NC(=O)Nc4cc(C)cc(C)c4)cc3s2)c1,CHEMBL4004862,=,=,Inhibition,%,20.0,INH,%,20.0,COc1cccc(NC(=O)CSc2nc3ccc(NC(=O)Nc4cc(C)cc(C)c4)cc3s2)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCC(=O)Nc1nc2cc(NC(=O)c3cc(-c4ccccc4)nc4c(C)cccc34)ccc2s1,CHEMBL4004862,=,=,Inhibition,%,0.0,INH,%,0.0,CCC(=O)Nc1nc2cc(NC(=O)c3cc(-c4ccccc4)nc4c(C)cccc34)ccc2s1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1ccc(-c2nccc(Nc3cccc(C(=O)NCc4ccc(C(C)C)cc4)c3)n2)cc1,CHEMBL4004862,=,=,Inhibition,%,2.0,INH,%,2.0,Cc1ccc(-c2nccc(Nc3cccc(C(=O)NCc4ccc(C(C)C)cc4)c3)n2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCOc1ccc(NC(=O)N2CCCC(c3cccc(C(=O)Nc4cccc(Cl)c4)c3)C2)cc1,CHEMBL4004862,=,=,Inhibition,%,5.0,INH,%,5.0,CCOc1ccc(NC(=O)N2CCCC(c3cccc(C(=O)Nc4cccc(Cl)c4)c3)C2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(Nc1ccc(Cl)cc1)N1CCCC(c2cccc(C(=O)N3CCC4(CC3)OCCO4)c2)C1,CHEMBL4004862,=,=,Inhibition,%,-3.0,INH,%,-3.0,O=C(Nc1ccc(Cl)cc1)N1CCCC(c2cccc(C(=O)N3CCC4(CC3)OCCO4)c2)C1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCOC(=O)Cc1ccc(NC(=O)NC(C(=O)N2CCc3ccccc32)c2ccccc2)cc1,CHEMBL4004862,=,=,Inhibition,%,16.0,INH,%,16.0,CCOC(=O)Cc1ccc(NC(=O)NC(C(=O)N2CCc3ccccc32)c2ccccc2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(NC1CCCc2ccccc21)C1CCN(C2=CN3C(C=C2)NNC3c2ccc(Cl)cc2)CC1,CHEMBL4004862,=,=,Inhibition,%,-2.0,INH,%,-2.0,O=C(NC1CCCc2ccccc21)C1CCN(C2=CN3C(C=C2)NNC3c2ccc(Cl)cc2)CC1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(Nc1ccc2c(c1)OCCO2)c1cccc(Nc2cc(-c3ccc(F)cc3)ncn2)c1,CHEMBL4004862,=,=,Inhibition,%,4.0,INH,%,4.0,O=C(Nc1ccc2c(c1)OCCO2)c1cccc(Nc2cc(-c3ccc(F)cc3)ncn2)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,NNc1cc(N2CCN(c3ccccc3F)CC2)ncn1,CHEMBL4004862,=,=,Inhibition,%,3.0,INH,%,3.0,NNc1cc(N2CCN(c3ccccc3F)CC2)ncn1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1ccc(N2Cc3c(ncnc3N3CCCC(C(=O)NCc4cccc(C(F)(F)F)c4)C3)N2)cc1,CHEMBL4004862,=,=,Inhibition,%,-7.0,INH,%,-7.0,Cc1ccc(N2Cc3c(ncnc3N3CCCC(C(=O)NCc4cccc(C(F)(F)F)c4)C3)N2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(NCC1CCN(c2nsc(Cc3ccc(F)cc3)n2)CC1)Nc1ccc(Cl)c(Cl)c1,CHEMBL4004862,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(NCC1CCN(c2nsc(Cc3ccc(F)cc3)n2)CC1)Nc1ccc(Cl)c(Cl)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C1Nc2ccc(F)cc2/C1=N\Nc1ccc(C(=O)N2CCCC2COc2ccc(F)cc2)cc1,CHEMBL4004862,=,=,Inhibition,%,3.0,INH,%,3.0,O=C1Nc2ccc(F)cc2/C1=N\Nc1ccc(C(=O)N2CCCC2COc2ccc(F)cc2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCCn1c(=O)oc2cc(NC(=O)Nc3cccc(C)c3)ccc21,CHEMBL4004862,=,=,Inhibition,%,18.0,INH,%,18.0,CCCn1c(=O)oc2cc(NC(=O)Nc3cccc(C)c3)ccc21,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,COc1ccc(CC(=O)N2CCN(c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)CC2)cc1,CHEMBL4004862,=,=,Inhibition,%,99.0,INH,%,99.0,COc1ccc(CC(=O)N2CCN(c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)CC2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCNc1c(NC(=O)NCc2ccc(C)cc2)c(=O)oc2ccccc12,CHEMBL4004862,=,=,Inhibition,%,-3.0,INH,%,-3.0,CCNc1c(NC(=O)NCc2ccc(C)cc2)c(=O)oc2ccccc12,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CC(=O)c1ccc(NC(=O)COc2cc(C(F)(F)F)c3c(C)nn(-c4ccc(C)cc4)c3n2)cc1,CHEMBL4004862,=,=,Inhibition,%,-6.0,INH,%,-6.0,CC(=O)c1ccc(NC(=O)COc2cc(C(F)(F)F)c3c(C)nn(-c4ccc(C)cc4)c3n2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCc1ccc(-n2nc(C)c3c(C(F)(F)F)cc(OCC(=O)Nc4ccc5c(c4)OCO5)nc32)cc1,CHEMBL4004862,=,=,Inhibition,%,-14.0,INH,%,-14.0,CCc1ccc(-n2nc(C)c3c(C(F)(F)F)cc(OCC(=O)Nc4ccc5c(c4)OCO5)nc32)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1ccc(-c2nc(C)cc(OCC(=O)Nc3ccc(C#N)cc3)n2)cc1,CHEMBL4004862,=,=,Inhibition,%,-4.0,INH,%,-4.0,Cc1ccc(-c2nc(C)cc(OCC(=O)Nc3ccc(C#N)cc3)n2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,COc1ccc(CNC(=O)Cn2cnc3c(C(N)=O)nsc3c2=O)cc1,CHEMBL4004862,=,=,Inhibition,%,4.0,INH,%,4.0,COc1ccc(CNC(=O)Cn2cnc3c(C(N)=O)nsc3c2=O)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,COc1ccc(OC)c(NC(=O)Nc2ccc(Cn3cnc(-c4nc(-c5ccc(F)cc5)no4)c3)cc2)c1,CHEMBL4004862,=,=,Inhibition,%,1.0,INH,%,1.0,COc1ccc(OC)c(NC(=O)Nc2ccc(Cn3cnc(-c4nc(-c5ccc(F)cc5)no4)c3)cc2)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(Nc1cccc2ccccc12)c1cccc(C2CSC(S(=O)(=O)N3CCOCC3)C2)c1,CHEMBL4004862,=,=,Inhibition,%,-1.0,INH,%,-1.0,O=C(Nc1cccc2ccccc12)c1cccc(C2CSC(S(=O)(=O)N3CCOCC3)C2)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,COc1cc(NC(=O)N2CCN(c3cc(-c4ccc(C)cc4)ncn3)CC2)cc(OC)c1,CHEMBL4004862,=,=,Inhibition,%,-6.0,INH,%,-6.0,COc1cc(NC(=O)N2CCN(c3cc(-c4ccc(C)cc4)ncn3)CC2)cc(OC)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(Cc1ccccc1F)Nc1ccc2ncnc(N3CCCC3)c2c1,CHEMBL4004862,=,=,Inhibition,%,14.0,INH,%,14.0,O=C(Cc1ccccc1F)Nc1ccc2ncnc(N3CCCC3)c2c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CNc1nccc(N2CCC(CC(=O)NCc3nc4ccccc4n3C)CC2)n1,CHEMBL4004862,=,=,Inhibition,%,24.0,INH,%,24.0,CNc1nccc(N2CCC(CC(=O)NCc3nc4ccccc4n3C)CC2)n1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CSc1cccc(NC(=O)NC2CCN(c3ccc(F)cc3)C2=O)c1,CHEMBL4004862,=,=,Inhibition,%,2.0,INH,%,2.0,CSc1cccc(NC(=O)NC2CCN(c3ccc(F)cc3)C2=O)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(Nc1ccco1)NC1CCN(c2ncnc3c2CCC3)C1,CHEMBL4004862,=,=,Inhibition,%,15.0,INH,%,15.0,O=C(Nc1ccco1)NC1CCN(c2ncnc3c2CCC3)C1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,COc1ccc(CNC(=O)C2CCCN(c3cnc4nccnc4c3)C2)cc1,CHEMBL4004862,=,=,Inhibition,%,3.0,INH,%,3.0,COc1ccc(CNC(=O)C2CCCN(c3cnc4nccnc4c3)C2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 0.5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4004862,=,=,Inhibition,%,100.0,INH,%,100.0,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 0.5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CC(=O)N1CCC2(CC1)CC(=O)c1ccc(OCC(=O)Nc3cccc(C(F)(F)F)c3)cc1O2,CHEMBL4004862,=,=,Inhibition,%,69.0,INH,%,69.0,CC(=O)N1CCC2(CC1)CC(=O)c1ccc(OCC(=O)Nc3cccc(C(F)(F)F)c3)cc1O2,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 0.5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1nc(Nc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cc(N2CCCCC2)n1,CHEMBL4004862,=,=,Inhibition,%,61.0,INH,%,61.0,Cc1nc(Nc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cc(N2CCCCC2)n1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 0.5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(NCC1CCN(c2nsc(Cc3ccc(F)cc3)n2)CC1)Nc1ccc(Cl)c(Cl)c1,CHEMBL4004862,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(NCC1CCN(c2nsc(Cc3ccc(F)cc3)n2)CC1)Nc1ccc(Cl)c(Cl)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 0.5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,COc1ccc(CC(=O)N2CCN(c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)CC2)cc1,CHEMBL4004862,=,=,Inhibition,%,95.0,INH,%,95.0,COc1ccc(CC(=O)N2CCN(c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)CC2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCc1nnc(NS(=O)(=O)c2ccc(NC(=O)Nc3ccc(Cl)c(Cl)c3)cc2)s1,CHEMBL4004862,=,=,Inhibition,%,59.0,INH,%,59.0,CCc1nnc(NS(=O)(=O)c2ccc(NC(=O)Nc3ccc(Cl)c(Cl)c3)cc2)s1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(Nc1cccc(C(F)(F)F)c1)Nc1nnc(SCc2nc3ccccc3[nH]c2=O)s1,CHEMBL4004862,=,=,Inhibition,%,100.0,INH,%,100.0,O=C(Nc1cccc(C(F)(F)F)c1)Nc1nnc(SCc2nc3ccccc3[nH]c2=O)s1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1cc2nc(CSc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cc(=O)n2o1,CHEMBL4004862,=,=,Inhibition,%,59.0,INH,%,59.0,Cc1cc2nc(CSc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cc(=O)n2o1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,COc1ccc(C(=O)N2CCCN(c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cn3)CC2)cc1,CHEMBL4004862,=,=,Inhibition,%,82.0,INH,%,82.0,COc1ccc(C(=O)N2CCCN(c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cn3)CC2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1ccc(Nc2cc(Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)nc(C)n2)cc1,CHEMBL4004862,=,=,Inhibition,%,5.0,INH,%,5.0,Cc1ccc(Nc2cc(Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)nc(C)n2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CC(=O)Nc1ccc(NC(=O)Cc2csc(NC(=O)Nc3cccc(Cl)c3)n2)cc1,CHEMBL4004862,=,=,Inhibition,%,13.0,INH,%,13.0,CC(=O)Nc1ccc(NC(=O)Cc2csc(NC(=O)Nc3cccc(Cl)c3)n2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,C=CCNC(=O)C1CCN(C(=O)Nc2ccc(NC(=O)Nc3cccc(F)c3)cc2)CC1,CHEMBL4004862,=,=,Inhibition,%,8.0,INH,%,8.0,C=CCNC(=O)C1CCN(C(=O)Nc2ccc(NC(=O)Nc3cccc(F)c3)cc2)CC1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(Nc1cccc(Cl)c1)Nc1nnc(CC(=O)N2CCCC2)s1,CHEMBL4004862,=,=,Inhibition,%,85.0,INH,%,85.0,O=C(Nc1cccc(Cl)c1)Nc1nnc(CC(=O)N2CCCC2)s1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1nc(Nc2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)cc(N2CCCCC2)n1,CHEMBL4004862,=,=,Inhibition,%,14.0,INH,%,14.0,Cc1nc(Nc2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)cc(N2CCCCC2)n1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CCNC(=O)c1cn(-c2ccc(SCC(=O)Nc3cccc(C(F)(F)F)c3)nn2)cn1,CHEMBL4004862,=,=,Inhibition,%,16.0,INH,%,16.0,CCNC(=O)c1cn(-c2ccc(SCC(=O)Nc3cccc(C(F)(F)F)c3)nn2)cn1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,O=C(CSc1ccc(N2CCCC(C(=O)NC3CC3)C2)nn1)Nc1cccc(C(F)(F)F)c1,CHEMBL4004862,=,=,Inhibition,%,5.0,INH,%,5.0,O=C(CSc1ccc(N2CCCC(C(=O)NC3CC3)C2)nn1)Nc1cccc(C(F)(F)F)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,COc1ccc(C(=O)NCc2nnc(SCC(=O)Nc3cccc(C(F)(F)F)c3)o2)cc1OC,CHEMBL4004862,=,=,Inhibition,%,4.0,INH,%,4.0,COc1ccc(C(=O)NCc2nnc(SCC(=O)Nc3cccc(C(F)(F)F)c3)o2)cc1OC,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,NC(=O)C1CC(=O)N(c2ccc(OCC(=O)Nc3cccc(C(F)(F)F)c3)cc2)C1,CHEMBL4004862,=,=,Inhibition,%,12.0,INH,%,12.0,NC(=O)C1CC(=O)N(c2ccc(OCC(=O)Nc3cccc(C(F)(F)F)c3)cc2)C1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 1 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,C=CCNC(=O)C1CC(=O)N(c2ccc(OCC(=O)Nc3cccc(C(F)(F)F)c3)cc2)C1,CHEMBL4004862,=,=,Inhibition,%,3.0,INH,%,3.0,C=CCNC(=O)C1CC(=O)N(c2ccc(OCC(=O)Nc3cccc(C(F)(F)F)c3)cc2)C1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 2.5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CC(=O)Nc1ccc(NC(=O)c2nnn(-c3ccc4noc(-c5ccc(Cl)cc5)c4c3)c2C)cc1,CHEMBL4004862,=,=,Inhibition,%,4.0,INH,%,4.0,CC(=O)Nc1ccc(NC(=O)c2nnn(-c3ccc4noc(-c5ccc(Cl)cc5)c4c3)c2C)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 2.5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1c(C(=O)Nc2ccc(-n3cnnn3)cc2)nnn1-c1ccc2noc(-c3ccccc3)c2c1,CHEMBL4004862,=,=,Inhibition,%,-2.0,INH,%,-2.0,Cc1c(C(=O)Nc2ccc(-n3cnnn3)cc2)nnn1-c1ccc2noc(-c3ccccc3)c2c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 2.5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CC(=O)Nc1ccc(NC(=O)c2ccc3noc(-c4ccc(Cl)cc4)c3c2)cc1,CHEMBL4004862,=,=,Inhibition,%,43.0,INH,%,43.0,CC(=O)Nc1ccc(NC(=O)c2ccc3noc(-c4ccc(Cl)cc4)c3c2)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 2.5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,Cc1c(C(=O)Nc2cccc(C(F)(F)F)c2)nnn1-c1ccc2noc(-c3ccc(Cl)cc3)c2c1,CHEMBL4004862,=,=,Inhibition,%,19.0,INH,%,19.0,Cc1c(C(=O)Nc2cccc(C(F)(F)F)c2)nnn1-c1ccc2noc(-c3ccc(Cl)cc3)c2c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system at 2.5 uM preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay relative to control,CC(=O)Nc1ccc(NC(=O)c2nnn(-c3ccc4noc(-c5ccccc5)c4c3)c2C)cc1,CHEMBL4004862,=,=,Inhibition,%,59.0,INH,%,59.0,CC(=O)Nc1ccc(NC(=O)c2nnn(-c3ccc4noc(-c5ccccc5)c4c3)c2C)cc1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4004862,=,=,IC50,nM,6.0,IC50,nM,6.0,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay,O=C(Nc1cccc(C(F)(F)F)c1)Nc1nnc(SCc2nc3ccccc3[nH]c2=O)s1,CHEMBL4004862,=,=,IC50,nM,9.0,IC50,nM,9.0,O=C(Nc1cccc(C(F)(F)F)c1)Nc1nnc(SCc2nc3ccccc3[nH]c2=O)s1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay,O=C(Nc1cccc(Cl)c1)Nc1nnc(CC(=O)N2CCCC2)s1,CHEMBL4004862,=,=,IC50,nM,183.0,IC50,nM,183.0,O=C(Nc1cccc(Cl)c1)Nc1nnc(CC(=O)N2CCCC2)s1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay,CC(=O)c1cccc(NC(=O)c2nnn(-c3ccc4noc(-c5ccccc5)c4c3)c2C)c1,CHEMBL4004862,=,=,IC50,nM,93.0,IC50,nM,93.0,CC(=O)c1cccc(NC(=O)c2nnn(-c3ccc4noc(-c5ccccc5)c4c3)c2C)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay,O=C(NCC1CCN(c2nsc(Cc3ccc(F)cc3)n2)CC1)Nc1ccc(Cl)c(Cl)c1,CHEMBL4004862,=,=,IC50,nM,6.5,IC50,nM,6.5,O=C(NCC1CCN(c2nsc(Cc3ccc(F)cc3)n2)CC1)Nc1ccc(Cl)c(Cl)c1,2017.0
Inhibition of Alexa647 tracer binding to full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system preincubated for 20 mins followed by tracer addition measured after 60 mins by TR-FRET based Lanthascreen assay,COc1ccc(CC(=O)N2CCN(c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)CC2)cc1,CHEMBL4004862,=,=,IC50,nM,36.0,IC50,nM,36.0,COc1ccc(CC(=O)N2CCN(c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)CC2)cc1,2017.0
Inhibition of full length N-terminal GST/His6-tagged human CDK8 (M1 to Y463 residues)/N-terminal His6-tagged Cyc C (M1 to S283 residues) expressed in Sf9 insect cells at 1 uM using RBER-IRStide as substrate by filter binding assay relative to control,CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1,CHEMBL4017467,=,=,Inhibition,%,0.0,INH,%,0.0,CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1,2017.0
Inhibition of full length N-terminal GST/His6-tagged human CDK8 (M1 to Y463 residues)/N-terminal His6-tagged Cyc C (M1 to S283 residues) expressed in Sf9 insect cells at 1 uM using RBER-IRStide as substrate by filter binding assay relative to control,Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CCN(S(=O)(=O)C2CC2)C4)cn1,CHEMBL4017467,,,Inhibition,%,,INH,,,Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CCN(S(=O)(=O)C2CC2)C4)cn1,2017.0
Inhibition of full length N-terminal GST/His6-tagged human CDK8 (M1 to Y463 residues)/N-terminal His6-tagged Cyc C (M1 to S283 residues) expressed in Sf9 insect cells at 1 uM using RBER-IRStide as substrate by filter binding assay relative to control,CS(=O)(=O)N1CCc2c(nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn23)C1,CHEMBL4017467,,,Inhibition,%,,INH,,,CS(=O)(=O)N1CCc2c(nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn23)C1,2017.0
Inhibition of full length N-terminal GST/His6-tagged human CDK8 (M1 to Y463 residues)/N-terminal His6-tagged Cyc C (M1 to S283 residues) expressed in Sf9 insect cells at 1 uM using RBER-IRStide as substrate by filter binding assay relative to control,Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CN(c2ccc(F)cc2)CC4)cn1,CHEMBL4017467,=,=,Inhibition,%,3.0,INH,%,3.0,Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CN(c2ccc(F)cc2)CC4)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cnsc1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,IC50,nM,27.0,IC50,nM,27.0,O=C(/C=C/c1cnccc1-c1cnsc1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cncs1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,IC50,nM,41.0,IC50,nM,41.0,O=C(/C=C/c1cnccc1-c1cncs1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,COc1ncc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,CHEMBL4020708,=,=,IC50,nM,8.1,IC50,nM,8.1,COc1ncc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,COc1ccc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,CHEMBL4020708,=,=,IC50,nM,28.0,IC50,nM,28.0,COc1ccc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,NC(=O)c1ccc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,CHEMBL4020708,=,=,IC50,nM,8.3,IC50,nM,8.3,NC(=O)c1ccc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4020708,=,=,IC50,nM,6.5,IC50,nM,6.5,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cn[nH]c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,IC50,nM,0.54,IC50,nM,0.54,O=C(/C=C/c1cnccc1-c1cn[nH]c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1ccc2[nH]cnc2c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,IC50,nM,1.5,IC50,nM,1.5,O=C(/C=C/c1cnccc1-c1ccc2[nH]cnc2c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cnc2cc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)ccc21,CHEMBL4020708,=,=,IC50,nM,4800.0,IC50,nM,4800.0,Cn1cnc2cc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)ccc21,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cnc2ccc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)cc21,CHEMBL4020708,=,=,IC50,nM,2.5,IC50,nM,2.5,Cn1cnc2ccc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)cc21,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,IC50,nM,6.4,IC50,nM,6.4,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cnn(C(F)F)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,IC50,nM,6.4,IC50,nM,6.4,O=C(/C=C/c1cnccc1-c1cnn(C(F)F)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cnn(CC(F)(F)F)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,IC50,nM,28.0,IC50,nM,28.0,O=C(/C=C/c1cnccc1-c1cnn(CC(F)(F)F)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cnn(Cc2ccccc2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,IC50,nM,4.5,IC50,nM,4.5,O=C(/C=C/c1cnccc1-c1cnn(Cc2ccccc2)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccncc2CCC(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4020708,=,=,IC50,nM,41.0,IC50,nM,41.0,Cn1cc(-c2ccncc2CCC(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(CCc1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,IC50,nM,29.0,IC50,nM,29.0,O=C(CCc1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2cc(N)ncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4020708,=,=,IC50,nM,990.0,IC50,nM,990.0,Cn1cc(-c2cc(N)ncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccnc(O)c2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4020708,>,>,IC50,nM,10000.0,IC50,nM,10000.0,Cn1cc(-c2ccnc(O)c2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4020708,=,=,IC50,nM,5.2,IC50,nM,5.2,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,IC50,nM,6.5,IC50,nM,6.5,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccncc2/C=C/C(N)=O)cn1,CHEMBL4020708,>,>,IC50,nM,10000.0,IC50,nM,10000.0,Cn1cc(-c2ccncc2/C=C/C(N)=O)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccccc2)cn1,CHEMBL4020708,=,=,IC50,nM,51.0,IC50,nM,51.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccccc2)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,CC1COCCN1Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,CHEMBL4020708,=,=,IC50,nM,20.0,IC50,nM,20.0,CC1COCCN1Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,CC1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2)CCO1,CHEMBL4020708,=,=,IC50,nM,6.7,IC50,nM,6.7,CC1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2)CCO1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3C4CCC3COC4)cc2)cn1,CHEMBL4020708,=,=,IC50,nM,6.3,IC50,nM,6.3,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3C4CCC3COC4)cc2)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC4CC3CO4)cc2)cn1,CHEMBL4020708,=,=,IC50,nM,16.0,IC50,nM,16.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC4CC3CO4)cc2)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3CC2CO3)cc1,CHEMBL4020708,=,=,IC50,nM,9.6,IC50,nM,9.6,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3CC2CO3)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3CC(C2)O3)cc1,CHEMBL4020708,=,=,IC50,nM,6.7,IC50,nM,6.7,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3CC(C2)O3)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCC(F)(F)C3)cc2)cn1,CHEMBL4020708,=,=,IC50,nM,6.2,IC50,nM,6.2,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCC(F)(F)C3)cc2)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC(F)(F)C3)cc2)cn1,CHEMBL4020708,=,=,IC50,nM,11.0,IC50,nM,11.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC(F)(F)C3)cc2)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,CHEMBL4020708,=,=,IC50,nM,2.5,IC50,nM,2.5,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCN(CC(F)(F)F)C3)cn1,CHEMBL4020708,=,=,IC50,nM,4.5,IC50,nM,4.5,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCN(CC(F)(F)F)C3)cn1,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CCN(CC(F)(F)F)C2,CHEMBL4020708,=,=,IC50,nM,7.1,IC50,nM,7.1,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CCN(CC(F)(F)F)C2,2017.0
Inhibition of kinase tracer 236 binding to full length N terminal GST-tagged human CDK8 (1 to 464 end residues) /CycC ( 1 to 283 end residues) expressed in baculovirus expression system after 60 min by TR-FRET assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)(F)F)CC3)cn1,CHEMBL4020708,=,=,IC50,nM,3.2,IC50,nM,3.2,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)(F)F)CC3)cn1,2017.0
Inhibition of full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate measured after 30 mins by TR-FRET based LANCE assay,OC[C@H](Nc1cncc(-c2ccc3[nH]ncc3c2)c1)c1ccccc1,CHEMBL4028808,=,=,IC50,nM,0.4,IC50,nM,0.4,OC[C@H](Nc1cncc(-c2ccc3[nH]ncc3c2)c1)c1ccccc1,2017.0
Inhibition of full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate measured after 30 mins by TR-FRET based LANCE assay,OC[C@H](Nc1cncc(-c2ccc(O)c(Cl)c2)n1)c1ccccc1,CHEMBL4028808,=,=,IC50,nM,0.2,IC50,nM,0.2,OC[C@H](Nc1cncc(-c2ccc(O)c(Cl)c2)n1)c1ccccc1,2017.0
Inhibition of full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate measured after 30 mins by TR-FRET based LANCE assay,NC(=O)c1[nH]cc(-c2ccncc2)c1Cl,CHEMBL4028808,=,=,IC50,nM,7.0,IC50,nM,7.0,NC(=O)c1[nH]cc(-c2ccncc2)c1Cl,2017.0
Inhibition of full length N-terminal GST/His6-tagged human CDK8 (M1 to Y463 residues)/N-terminal His6-tagged Cyc C (M1 to S283 residues) expressed in Sf9 insect cells at 1 uM using RBER-IRStide as substrate by filter binding assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4028808,=,=,IC50,nM,24.0,IC50,nM,24.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2017.0
Inhibition of full length recombinant human His-tagged CDK8/Cyclin C expressed in baculovirus expression system by LanthaScreen assay,c1cc2cc(c1)-c1cnc3ccc(nn13)NCCCCCO2,CHEMBL4028808,=,=,IC50,nM,31.0,IC50,nM,31.0,c1cc2cc(c1)-c1cnc3ccc(nn13)NCCCCCO2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(=O)N(C)C)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,68.0,IC50,nM,68.0,CSc1sc(C(=O)N(C)C)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CNC(=O)c1sc(SC)c2c1CCc1cnsc1-2,CHEMBL4028808,=,=,IC50,nM,9.3,IC50,nM,9.3,CNC(=O)c1sc(SC)c2c1CCc1cnsc1-2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C#N)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,23.0,IC50,nM,23.0,CSc1sc(C#N)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(=O)O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,9.5,IC50,nM,9.5,CSc1sc(C(=O)O)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(N)=O)c2c1-c1snnc1CC2,CHEMBL4028808,=,=,IC50,nM,60.0,IC50,nM,60.0,CSc1sc(C(N)=O)c2c1-c1snnc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) at 1 uM after 60 mins by TR-FRET assay relative to control,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,Inhibition,%,105.0,INH,%,105.0,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(=O)Nc2ccccc2)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,540.0,IC50,nM,540.0,CSc1sc(C(=O)Nc2ccccc2)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,0.65,IC50,nM,0.65,CSc1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(N)=O)c2c1-c1oncc1CC2,CHEMBL4028808,=,=,IC50,nM,45.0,IC50,nM,45.0,CSc1sc(C(N)=O)c2c1-c1oncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(N)=O)c2c1-c1[nH]ncc1CC2,CHEMBL4028808,=,=,IC50,nM,1700.0,IC50,nM,1700.0,CSc1sc(C(N)=O)c2c1-c1[nH]ncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(N)=O)c2c1-c1c(cnn1C)CC2,CHEMBL4028808,=,=,IC50,nM,18.0,IC50,nM,18.0,CSc1sc(C(N)=O)c2c1-c1c(cnn1C)CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) at 1 uM after 60 mins by TR-FRET assay relative to control,CSc1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,Inhibition,%,99.0,INH,%,99.0,CSc1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(N)=O)c2c1-c1nn(C)cc1CC2,CHEMBL4028808,>,>,IC50,nM,10000.0,IC50,nM,10000.0,CSc1sc(C(N)=O)c2c1-c1nn(C)cc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(=O)Nc2ccccn2)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,180.0,IC50,nM,180.0,CSc1sc(C(=O)Nc2ccccn2)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)c(C)n1,CHEMBL4028808,=,=,IC50,nM,1.4,IC50,nM,1.4,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)c(C)n1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CCOCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,IC50,nM,1.1,IC50,nM,1.1,CCOCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,IC50,nM,0.46,IC50,nM,0.46,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CC(C)(O)CNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,IC50,nM,2.4,IC50,nM,2.4,CC(C)(O)CNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CN(C)C(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,IC50,nM,23.0,IC50,nM,23.0,CN(C)C(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,IC50,nM,1.9,IC50,nM,1.9,CNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,NC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,IC50,nM,0.93,IC50,nM,0.93,NC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CC(=O)Nc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,IC50,nM,0.57,IC50,nM,0.57,CC(=O)Nc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CNc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,IC50,nM,0.59,IC50,nM,0.59,CNc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,NC(=O)c1sc(Oc2ccc(N)nc2)c2c1CCc1cnsc1-2,CHEMBL4028808,=,=,IC50,nM,0.6,IC50,nM,0.6,NC(=O)c1sc(Oc2ccc(N)nc2)c2c1CCc1cnsc1-2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,Cc1c(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)ccc[n+]1[O-],CHEMBL4028808,=,=,IC50,nM,4.4,IC50,nM,4.4,Cc1c(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)ccc[n+]1[O-],2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,Cc1ccncc1Oc1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,4.7,IC50,nM,4.7,Cc1ccncc1Oc1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,Cc1cncc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)c1,CHEMBL4028808,=,=,IC50,nM,5.1,IC50,nM,5.1,Cc1cncc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)c1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,Cc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,IC50,nM,0.99,IC50,nM,0.99,Cc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,Cc1ncccc1Oc1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,0.47,IC50,nM,0.47,Cc1ncccc1Oc1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,NC(=O)c1sc(Oc2cccnc2)c2c1CCc1cnsc1-2,CHEMBL4028808,=,=,IC50,nM,1.5,IC50,nM,1.5,NC(=O)c1sc(Oc2cccnc2)c2c1CCc1cnsc1-2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,NC(=O)c1sc(Oc2ccccn2)c2c1CCc1cnsc1-2,CHEMBL4028808,=,=,IC50,nM,11.0,IC50,nM,11.0,NC(=O)c1sc(Oc2ccccn2)c2c1CCc1cnsc1-2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,NC(=O)c1sc(Oc2ccccc2)c2c1CCc1cnsc1-2,CHEMBL4028808,=,=,IC50,nM,0.34,IC50,nM,0.34,NC(=O)c1sc(Oc2ccccc2)c2c1CCc1cnsc1-2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,COc1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,2.3,IC50,nM,2.3,COc1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CS(=O)(=O)c1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,63.0,IC50,nM,63.0,CS(=O)(=O)c1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,C[S+]([O-])c1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,88.0,IC50,nM,88.0,C[S+]([O-])c1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(=O)Nc2ccsn2)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,66.0,IC50,nM,66.0,CSc1sc(C(=O)Nc2ccsn2)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(=O)Nc2ccn(C)n2)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,22.0,IC50,nM,22.0,CSc1sc(C(=O)Nc2ccn(C)n2)c2c1-c1sncc1CC2,2017.0
Inhibition of kinase tracer-236 binding to GST-tagged CDK8/CyclinC (unknown origin) after 60 mins by TR-FRET assay,CSc1sc(C(=O)Nc2ccon2)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,IC50,nM,12.0,IC50,nM,12.0,CSc1sc(C(=O)Nc2ccon2)c2c1-c1sncc1CC2,2017.0
Inhibition of full length recombinant human His-tagged CDK8/Cyclin C expressed in Baculovirus expression system by Z'Lyte assay,CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1,CHEMBL4028866,=,=,IC50,nM,48.0,IC50,nM,48.0,CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,CCc1cnccc1-c1c[nH]c(C#N)c1,CHEMBL4043169,=,=,IC50,nM,4630.0,IC50,uM,4.63,CCc1cnccc1-c1c[nH]c(C#N)c1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,N#Cc1cc(-c2ccncc2)c[nH]1,CHEMBL4043169,=,=,IC50,nM,280.0,IC50,uM,0.28,N#Cc1cc(-c2ccncc2)c[nH]1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,NC(=O)c1cc(-c2ccncc2)c[nH]1,CHEMBL4043169,=,=,IC50,nM,170.0,IC50,uM,0.17,NC(=O)c1cc(-c2ccncc2)c[nH]1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,CNC(=O)c1cc(-c2ccncc2)c[nH]1,CHEMBL4043169,=,=,IC50,nM,410.0,IC50,uM,0.41,CNC(=O)c1cc(-c2ccncc2)c[nH]1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,Cc1[nH]c(C(N)=O)cc1-c1ccncc1,CHEMBL4043169,=,=,IC50,nM,240.0,IC50,uM,0.24,Cc1[nH]c(C(N)=O)cc1-c1ccncc1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,NC(=O)c1cc(-c2ccncc2)c(Cl)[nH]1,CHEMBL4043169,=,=,IC50,nM,160.0,IC50,uM,0.16,NC(=O)c1cc(-c2ccncc2)c(Cl)[nH]1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,NC(=O)c1cc(-c2ccncc2Cl)c[nH]1,CHEMBL4043169,=,=,IC50,nM,19.0,IC50,uM,0.019,NC(=O)c1cc(-c2ccncc2Cl)c[nH]1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,Cc1cnccc1-c1c[nH]c(C(N)=O)c1,CHEMBL4043169,=,=,IC50,nM,87.0,IC50,uM,0.087,Cc1cnccc1-c1c[nH]c(C(N)=O)c1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,NC(=O)c1cc(-c2ccncc2Br)c[nH]1,CHEMBL4043169,=,=,IC50,nM,37.0,IC50,uM,0.037,NC(=O)c1cc(-c2ccncc2Br)c[nH]1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,Cc1cc(-c2c[nH]c(C(N)=O)c2)ccn1,CHEMBL4043169,=,=,IC50,nM,480.0,IC50,uM,0.48,Cc1cc(-c2c[nH]c(C(N)=O)c2)ccn1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,NC(=O)c1cc(-c2ccnc(Cl)c2)c[nH]1,CHEMBL4043169,=,=,IC50,nM,350.0,IC50,uM,0.35,NC(=O)c1cc(-c2ccnc(Cl)c2)c[nH]1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,Cn1cc(-c2ccncc2)cc1C(N)=O,CHEMBL4043169,=,=,IC50,nM,4950.0,IC50,uM,4.95,Cn1cc(-c2ccncc2)cc1C(N)=O,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,NC(=O)c1cc(-c2ccncc2)cn1Cc1ccccc1,CHEMBL4043169,=,=,IC50,nM,170.0,IC50,uM,0.17,NC(=O)c1cc(-c2ccncc2)cn1Cc1ccccc1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,Cc1c(-c2ccncc2)c[nH]c1C(N)=O,CHEMBL4043169,=,=,IC50,nM,8.0,IC50,uM,0.008,Cc1c(-c2ccncc2)c[nH]c1C(N)=O,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,CCc1c(-c2ccncc2)c[nH]c1C(N)=O,CHEMBL4043169,=,=,IC50,nM,13.0,IC50,uM,0.013,CCc1c(-c2ccncc2)c[nH]c1C(N)=O,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,NC(=O)c1[nH]cc(-c2ccncc2)c1C(F)(F)F,CHEMBL4043169,=,=,IC50,nM,3.0,IC50,uM,0.003,NC(=O)c1[nH]cc(-c2ccncc2)c1C(F)(F)F,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,NC(=O)c1[nH]cc(-c2ccncc2)c1Cl,CHEMBL4043169,=,=,IC50,nM,5.0,IC50,uM,0.005,NC(=O)c1[nH]cc(-c2ccncc2)c1Cl,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,Cc1cc(-c2c[nH]c(C(N)=O)c2C)ccn1,CHEMBL4043169,=,=,IC50,nM,19.0,IC50,uM,0.019,Cc1cc(-c2c[nH]c(C(N)=O)c2C)ccn1,2017.0
Inhibition of recombinant full length His-tagged human CDK8/Cyclin C expressed in baculovirus expression system using Ulight-GS peptide as substrate after 30 mins in presence of ATP by TR-FRET assay,Cc1cnccc1-c1c[nH]c(C(N)=O)c1C,CHEMBL4043169,=,=,IC50,nM,10.0,IC50,uM,0.01,Cc1cnccc1-c1c[nH]c(C(N)=O)c1C,2017.0
Inhibition of recombinant full length His-tagged human CDK8/CyclinC expressed in baculovirus expression system at 1 uM by FRET assay relative to control,CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@H]1[C@@H]2CN(C3COC3)C[C@@H]21,CHEMBL4118097,=,=,Inhibition,%,9.9,INH,%,9.9,CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@H]1[C@@H]2CN(C3COC3)C[C@@H]21,2017.0
Inhibition of recombinant full length His-tagged human CDK8/CyclinC expressed in baculovirus expression system at 1 uM by FRET assay relative to control,Nc1ncc(-c2cc([C@H]3[C@@H]4CN(C5COC5)C[C@@H]43)n(CC3CC3)n2)cc1C(F)(F)F,CHEMBL4118097,=,=,Inhibition,%,2.4,INH,%,2.4,Nc1ncc(-c2cc([C@H]3[C@@H]4CN(C5COC5)C[C@@H]43)n(CC3CC3)n2)cc1C(F)(F)F,2017.0
Inhibition of GST-tagged human CDK8/CycC (04 to 109 residues) using kinase tracer 236 probe incubated for 60 mins by TR-FRET assay,Cn1cc(-c2ccc(S(=O)(=O)N3CCC(Nc4ccc(C#N)cn4)CC3)cc2)cn1,CHEMBL4145674,>,>,IC50,nM,10000.0,IC50,uM,10.0,Cn1cc(-c2ccc(S(=O)(=O)N3CCC(Nc4ccc(C#N)cn4)CC3)cc2)cn1,2018.0
Inhibition of GST-tagged human CDK8/CycC (04 to 109 residues) using kinase tracer 236 probe incubated for 60 mins by TR-FRET assay,Cn1cc(-c2ccc(N(C(=O)NCc3ccccc3)[C@H]3CC[C@H](Nc4ccc(C#N)cn4)CC3)cc2)ccc1=O,CHEMBL4145674,>,>,IC50,nM,10000.0,IC50,uM,10.0,Cn1cc(-c2ccc(N(C(=O)NCc3ccccc3)[C@H]3CC[C@H](Nc4ccc(C#N)cn4)CC3)cc2)ccc1=O,2018.0
Inhibition of GST-tagged human CDK8/CycC (04 to 109 residues) using kinase tracer 236 probe incubated for 60 mins by TR-FRET assay,Cn1cc(-c2ccc(N(C(=O)NCc3ccccc3)[C@H]3CC[C@@H](Nc4ccc(C#N)cn4)CC3)cc2)cn1,CHEMBL4145674,>,>,IC50,nM,10000.0,IC50,uM,10.0,Cn1cc(-c2ccc(N(C(=O)NCc3ccccc3)[C@H]3CC[C@@H](Nc4ccc(C#N)cn4)CC3)cc2)cn1,2018.0
Inhibition of GST-tagged human CDK8/CycC (04 to 109 residues) using kinase tracer 236 probe incubated for 60 mins by TR-FRET assay,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4145674,=,=,IC50,nM,15.0,IC50,uM,0.015,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2018.0
Inhibition of recombinant human N-terminal GST/HIS6-tagged CDK8 (M1 to Y463 residues)/human N-terminal His6-tagged Cyclin C (M1 to S283 residues) expressed in Sf9 insect cells at 1 uM using RBER-IRStide as substrate by fliter binding assay relative to control,CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1,CHEMBL4177600,<,<,Inhibition,%,25.0,INH,%,25.0,CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1,2017.0
Inhibition of recombinant human N-terminal GST/HIS6-tagged CDK8 (M1 to Y463 residues)/human N-terminal His6-tagged Cyclin C (M1 to S283 residues) expressed in Sf9 insect cells at 1 uM using RBER-IRStide as substrate by fliter binding assay relative to control,CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1,CHEMBL4177600,<,<,Inhibition,%,25.0,INH,%,25.0,CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1,2017.0
Inhibition of recombinant human N-terminal GST/HIS6-tagged CDK8 (M1 to Y463 residues)/human N-terminal His6-tagged Cyclin C (M1 to S283 residues) expressed in Sf9 insect cells at 1 uM using RBER-IRStide as substrate by fliter binding assay relative to control,CS(=O)(=O)N1CCN(Cc2cn3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1,CHEMBL4177600,<,<,Inhibition,%,25.0,INH,%,25.0,CS(=O)(=O)N1CCN(Cc2cn3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1,2017.0
Inhibition of recombinant human N-terminal GST/HIS6-tagged CDK8 (M1 to Y463 residues)/human N-terminal His6-tagged Cyclin C (M1 to S283 residues) expressed in Sf9 insect cells at 1 uM using RBER-IRStide as substrate by fliter binding assay relative to control,CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1,CHEMBL4177600,<,<,Inhibition,%,25.0,INH,%,25.0,CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1,2017.0
Inhibition of CDK8/CCNC (unknown origin) using RBER-IRStide as substrate in presence of [gamma33P]ATP by radiometric method,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,CHEMBL4219051,=,=,IC50,nM,5.0,IC50,nM,5.0,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,2018.0
Inhibition of CDK8/Cyclin-C (unknown origin) in presence of [gamma33P]ATP by radiometric method,Cc1c(Br)c(Br)c2c3c1nc(N1CCNCC1)n3CCC2,CHEMBL4219051,=,=,IC50,nM,4.0,IC50,nM,4.0,Cc1c(Br)c(Br)c2c3c1nc(N1CCNCC1)n3CCC2,2018.0
Inhibition of CDK8/CCNC (unknown origin) using RBER-IRStide as substrate in presence of [gamma33P]ATP by radiometric method,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,CHEMBL4219051,=,=,IC50,nM,280.0,IC50,nM,280.0,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,2018.0
Inhibition of CDK8/Cyclin-C (unknown origin) in presence of [gamma33P]ATP by radiometric method,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4219051,=,=,IC50,nM,24.0,IC50,nM,24.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2018.0
Inhibition of recombinant full length human His-tagged CDK8/Cyclin-C expressed in baculovirus expression system at 0.1 uM by LanthaScreen assay relative to control,CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2,CHEMBL4251601,=,=,Inhibition,%,43.0,INH,%,43.0,CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2,2018.0
Inhibition of recombinant full length human His-tagged CDK8/Cyclin-C expressed in baculovirus expression system at 1 uM by LanthaScreen assay relative to control,CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2,CHEMBL4251601,=,=,Inhibition,%,85.0,INH,%,85.0,CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2,2018.0
Inhibition of recombinant full length His-tagged human CDK8/CyclinC expressed in baculovirus expression system,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,CHEMBL4261600,>,>,IC50,nM,10000.0,IC50,uM,10.0,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,2018.0
Inhibition of recombinant human full length His-tagged CDK8/cyclin C expressed in baculovirus expression system in presence of 5 uM ATP,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,CHEMBL4265877,=,=,IC50,nM,43.0,IC50,uM,0.043,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,2018.0
Inhibition of recombinant human full length His-tagged CDK8/cyclin C expressed in baculovirus expression system in presence of 5 uM ATP,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1,CHEMBL4265877,=,=,IC50,nM,111.0,IC50,uM,0.111,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1,2018.0
Binding affinity to recombinant human full length N-terminal GST-tagged CDK8 co-expressed with N-terminal GST-tagged CyclinC expressed in baculovirus expression system using RNA polymerase peptide as substrate incubated for 1 hr by TR-FRET assay,CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4321812,=,=,Kd,nM,299.0,Kd,nM,299.0,CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2019.0
Binding affinity to recombinant human full length N-terminal GST-tagged CDK8 co-expressed with N-terminal GST-tagged CyclinC expressed in baculovirus expression system using RNA polymerase peptide as substrate incubated for 1 hr by TR-FRET assay,CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4321812,=,=,Kd,nM,148.0,Kd,nM,148.0,CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2019.0
Inhibition of human recombinant CDK8/cyclinC expressed in Baculovirus system,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1,CHEMBL4321825,>,>,IC50,nM,10000.0,IC50,uM,10.0,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1,2019.0
Inhibition of human recombinant CDK8/cyclinC expressed in Baculovirus system,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,CHEMBL4321825,=,=,IC50,nM,68.0,IC50,uM,0.068,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full-length human His-tagged CDK8/CyclinC expressed in baculovirus expression system by Lanthascreen Eu kinase binding assay,Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl,CHEMBL4321874,=,=,IC50,nM,351.0,IC50,nM,351.0,Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl,2020.0
Inhibition of kinase tracer 236 binding to recombinant full-length human His-tagged CDK8/CyclinC expressed in baculovirus expression system at 1000 nM by Lanthascreen Eu kinase binding assay relative to control,Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl,CHEMBL4321874,=,=,Inhibition,%,87.0,INH,%,87.0,Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl,2020.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay,COc1ccc(CNc2ncnc3scc(-c4ccccc4)c23)cc1,CHEMBL4330136,=,=,IC50,nM,2900.0,IC50,uM,2.9,COc1ccc(CNc2ncnc3scc(-c4ccccc4)c23)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay,COc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCCC2)cc1,CHEMBL4330136,=,=,IC50,nM,1300.0,IC50,uM,1.3,COc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCCC2)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4330136,=,=,Inhibition,%,100.0,INH,%,100.0,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL4330136,=,=,Inhibition,%,99.6,INH,%,99.6,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Cc1nnc(-c2cc3ccccc3n2CC(=O)Nc2cccc(C(F)(F)F)c2)o1,CHEMBL4330136,=,=,Inhibition,%,15.6,INH,%,15.6,Cc1nnc(-c2cc3ccccc3n2CC(=O)Nc2cccc(C(F)(F)F)c2)o1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Cc1ccc(N(C)C(=O)c2c(-c3ccccc3)nnc3ccccc23)cc1C,CHEMBL4330136,=,=,Inhibition,%,16.0,INH,%,16.0,Cc1ccc(N(C)C(=O)c2c(-c3ccccc3)nnc3ccccc23)cc1C,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,CCOCCCNC(=O)c1ccc(-n2c(-c3ccccc3)nc3cccnc32)cc1,CHEMBL4330136,=,=,Inhibition,%,26.1,INH,%,26.1,CCOCCCNC(=O)c1ccc(-n2c(-c3ccccc3)nc3cccnc32)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,O=C(NCc1cccnc1)c1ccc(-n2c(-c3ccccc3)nc3cccnc32)cc1,CHEMBL4330136,=,=,Inhibition,%,38.9,INH,%,38.9,O=C(NCc1cccnc1)c1ccc(-n2c(-c3ccccc3)nc3cccnc32)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,COc1cc(-c2nc3cnccn3c2Nc2cccc(Cl)c2)ccc1O,CHEMBL4330136,=,=,Inhibition,%,41.0,INH,%,41.0,COc1cc(-c2nc3cnccn3c2Nc2cccc(Cl)c2)ccc1O,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Oc1cccc(-c2nc3cnccn3c2Nc2ccccc2)c1,CHEMBL4330136,=,=,Inhibition,%,42.6,INH,%,42.6,Oc1cccc(-c2nc3cnccn3c2Nc2ccccc2)c1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,CCc1ccccc1NC(=O)Cn1c(C)cc(=O)n2nc(-c3ccc(Cl)cc3)nc12,CHEMBL4330136,=,=,Inhibition,%,35.3,INH,%,35.3,CCc1ccccc1NC(=O)Cn1c(C)cc(=O)n2nc(-c3ccc(Cl)cc3)nc12,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,COc1ccc(Cl)cc1NC(=O)Cn1c(C)cc(=O)n2nc(-c3ccccc3)nc12,CHEMBL4330136,=,=,Inhibition,%,15.8,INH,%,15.8,COc1ccc(Cl)cc1NC(=O)Cn1c(C)cc(=O)n2nc(-c3ccccc3)nc12,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,COc1ccc(C(=O)N(Cc2ccccc2)c2nc3[nH]c(C)cc(=O)n3n2)cc1,CHEMBL4330136,=,=,Inhibition,%,14.4,INH,%,14.4,COc1ccc(C(=O)N(Cc2ccccc2)c2nc3[nH]c(C)cc(=O)n3n2)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Cc1cc(OCc2nc(C)c(C(=O)Nc3ccc4c(c3)OCO4)s2)ccc1Cl,CHEMBL4330136,=,=,Inhibition,%,49.5,INH,%,49.5,Cc1cc(OCc2nc(C)c(C(=O)Nc3ccc4c(c3)OCO4)s2)ccc1Cl,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,COc1ccc(NC(=O)c2sc(COc3ccc(Cl)c(C)c3)nc2C)cc1,CHEMBL4330136,=,=,Inhibition,%,-7.6,INH,%,-7.6,COc1ccc(NC(=O)c2sc(COc3ccc(Cl)c(C)c3)nc2C)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Cc1ccc(C)c(OCc2nc(C)c(C(=O)Nc3cccc(F)c3)s2)c1,CHEMBL4330136,=,=,Inhibition,%,12.1,INH,%,12.1,Cc1ccc(C)c(OCc2nc(C)c(C(=O)Nc3cccc(F)c3)s2)c1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Cc1ccc(C)c(OCc2nc(C)c(C(=O)Nc3cccc(Cl)c3)s2)c1,CHEMBL4330136,=,=,Inhibition,%,17.1,INH,%,17.1,Cc1ccc(C)c(OCc2nc(C)c(C(=O)Nc3cccc(Cl)c3)s2)c1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Cc1ccc(C)c(OCc2nc(C)c(C(=O)Nc3ccc(OC(C)C)cc3)s2)c1,CHEMBL4330136,=,=,Inhibition,%,31.9,INH,%,31.9,Cc1ccc(C)c(OCc2nc(C)c(C(=O)Nc3ccc(OC(C)C)cc3)s2)c1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1,CHEMBL4330136,=,=,Inhibition,%,50.8,INH,%,50.8,c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,COc1ccc(CNc2ncnc3scc(-c4ccccc4)c23)cc1,CHEMBL4330136,=,=,Inhibition,%,88.8,INH,%,88.8,COc1ccc(CNc2ncnc3scc(-c4ccccc4)c23)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Cc1ccc(NC(=O)c2cc(-c3ccc4c(c3)CC(C)O4)on2)cc1Cl,CHEMBL4330136,=,=,Inhibition,%,13.6,INH,%,13.6,Cc1ccc(NC(=O)c2cc(-c3ccc4c(c3)CC(C)O4)on2)cc1Cl,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Cc1ccc(C)c(N2CC(c3nc4ccccc4n3CCN3CCOCC3)CC2=O)c1,CHEMBL4330136,=,=,Inhibition,%,14.5,INH,%,14.5,Cc1ccc(C)c(N2CC(c3nc4ccccc4n3CCN3CCOCC3)CC2=O)c1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,Cc1cccc(N2CC(c3nc4ccccc4n3CCN3CCOCC3)CC2=O)c1C,CHEMBL4330136,=,=,Inhibition,%,15.4,INH,%,15.4,Cc1cccc(N2CC(c3nc4ccccc4n3CCN3CCOCC3)CC2=O)c1C,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,CCOc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCC2)cc1,CHEMBL4330136,=,=,Inhibition,%,50.0,INH,%,50.0,CCOc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCC2)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,CCOc1ccc(C(=O)c2cnc3ccc(Cl)cc3c2N2CCCC2)cc1,CHEMBL4330136,=,=,Inhibition,%,46.0,INH,%,46.0,CCOc1ccc(C(=O)c2cnc3ccc(Cl)cc3c2N2CCCC2)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,COc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCCC2)cc1,CHEMBL4330136,=,=,Inhibition,%,90.9,INH,%,90.9,COc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCCC2)cc1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,CCOC(=O)N1CCN(c2c(Nc3ccc4c(c3)OCCO4)c(=O)c2=O)CC1,CHEMBL4330136,=,=,Inhibition,%,15.9,INH,%,15.9,CCOC(=O)N1CCN(c2c(Nc3ccc4c(c3)OCCO4)c(=O)c2=O)CC1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,CN1CCN(C(=O)Cn2nc(Cc3ccncc3)c3ccccc3c2=O)CC1,CHEMBL4330136,=,=,Inhibition,%,18.9,INH,%,18.9,CN1CCN(C(=O)Cn2nc(Cc3ccncc3)c3ccccc3c2=O)CC1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,CCOC(=O)N1CCC(N2C(=O)c3ccccc3C2Nc2cccc(Cl)c2C)CC1,CHEMBL4330136,=,=,Inhibition,%,48.7,INH,%,48.7,CCOC(=O)N1CCC(N2C(=O)c3ccccc3C2Nc2cccc(Cl)c2C)CC1,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,COc1ccc(Nc2c(-c3cccc(O)c3)nc3ncccn23)cc1OC,CHEMBL4330136,=,=,Inhibition,%,17.0,INH,%,17.0,COc1ccc(Nc2c(-c3cccc(O)c3)nc3ncccn23)cc1OC,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,COc1ccc2c(c1)CCc1c(C(=O)Nc3ccc(C)c(C)c3)noc1-2,CHEMBL4330136,=,=,Inhibition,%,21.5,INH,%,21.5,COc1ccc2c(c1)CCc1c(C(=O)Nc3ccc(C)c(C)c3)noc1-2,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,O=C(Nc1cc(Br)ccc1O)c1noc2c1CCc1ccccc1-2,CHEMBL4330136,=,=,Inhibition,%,27.4,INH,%,27.4,O=C(Nc1cc(Br)ccc1O)c1noc2c1CCc1ccccc1-2,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,O=C(Nc1cc(Cl)ccc1O)c1noc2c1CCc1ccccc1-2,CHEMBL4330136,=,=,Inhibition,%,14.6,INH,%,14.6,O=C(Nc1cc(Cl)ccc1O)c1noc2c1CCc1ccccc1-2,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,O=C(Nc1cccc(Cl)c1)c1noc2c1CCc1ccccc1-2,CHEMBL4330136,=,=,Inhibition,%,16.7,INH,%,16.7,O=C(Nc1cccc(Cl)c1)c1noc2c1CCc1ccccc1-2,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,COc1ccc(Nc2c(-c3ccc(O)cc3)nc3cnccn23)cc1OC,CHEMBL4330136,=,=,Inhibition,%,37.8,INH,%,37.8,COc1ccc(Nc2c(-c3ccc(O)cc3)nc3cnccn23)cc1OC,2019.0
Inhibition of kinase tracer 236 binding to recombinant full length His-tagged human CDK8/CycC expressed in baculovirus expression system at 10 uM preincubated for 20 mins followed by tracer addition and measured after 2 hrs by FRET-based LanthaScreen Eu kinase binding assay relative to control,COc1cc(-c2nc3cnccn3c2Nc2ccc(OC)c(OC)c2)ccc1O,CHEMBL4330136,=,=,Inhibition,%,30.0,INH,%,30.0,COc1cc(-c2nc3cnccn3c2Nc2ccc(OC)c(OC)c2)ccc1O,2019.0
Inhibition of CDK8/CyclinC (unknown origin),CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1,CHEMBL4334547,=,=,IC50,nM,1.0,IC50,nM,1.0,CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1,2020.0
Inhibition of human CDK8/cyclin-C at 100 nM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay,COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1,CHEMBL4364276,=,=,Inhibition,%,2.74,INH,%,2.74,COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1,2019.0
Inhibition of tracer 236 binding to recombinant full length human His-tagged CDK8/cyclin C expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,CHEMBL4385643,=,=,Inhibition,%,24.2,INH,%,24.2,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,2019.0
Inhibition of tracer 236 binding to recombinant full length human His-tagged CDK8/cyclin C expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay,CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2,CHEMBL4385643,=,=,Inhibition,%,75.0,INH,%,75.0,CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2,2019.0
Inhibition of CDK8/CyclinC (unknown origin),CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4411304,=,=,Kd,nM,310.0,Kd,nM,310.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2019.0
Inhibition of recombinant human full-length GST/His-fused CDK8/CycC expressed in Sf9 insect cells using RBER-IRStide as substrate after 1 hr in presence of [gamma33P-ATP] by microbeta scintillation counting method,Fc1ccc2nccc(Nc3ccccc3F)c2c1,CHEMBL4411304,=,=,IC50,nM,386.0,IC50,nM,386.0,Fc1ccc2nccc(Nc3ccccc3F)c2c1,2019.0
Inhibition of recombinant human full-length GST/His-fused CDK8/CycC expressed in Sf9 insect cells using RBER-IRStide as substrate after 1 hr in presence of [gamma33P-ATP] by microbeta scintillation counting method,Cc1ccc(NC(=O)Nc2ccc(Cc3ccncc3)cc2)cc1C,CHEMBL4411304,=,=,IC50,nM,18.0,IC50,nM,18.0,Cc1ccc(NC(=O)Nc2ccc(Cc3ccncc3)cc2)cc1C,2019.0
Inhibition of recombinant human full-length GST/His-fused CDK8/CycC expressed in Sf9 insect cells using RBER-IRStide as substrate after 1 hr in presence of [gamma33P-ATP] by microbeta scintillation counting method,Cc1ccc(NC(=O)Nc2nnc(-c3cccc(F)c3)s2)cc1C,CHEMBL4411304,=,=,IC50,nM,47.0,IC50,nM,47.0,Cc1ccc(NC(=O)Nc2nnc(-c3cccc(F)c3)s2)cc1C,2019.0
Inhibition of recombinant full-length human His-tagged CDK8/cyclinC expressed in baculovirus expression system by Lantha screen assay,CC1CCc2nc(N)c(C#N)c(-c3cccnc3)c2C1,CHEMBL4411304,=,=,IC50,nM,500.0,IC50,uM,0.5,CC1CCc2nc(N)c(C#N)c(-c3cccnc3)c2C1,2019.0
Displacement of Kinase tracer 236 from recombinant full-length human N-terminal GST-fused CDK8 (1 to 464 residues)/cyclin C (1 to 283 residues) expressed in baculovirus expression system after 60 mins by TR-FRET assay,O=C(/C=C/c1cnccc1-c1ccc(F)cc1)Nc1ccc(CCc2nnco2)cc1,CHEMBL4411304,=,=,IC50,nM,23.0,IC50,nM,23.0,O=C(/C=C/c1cnccc1-c1ccc(F)cc1)Nc1ccc(CCc2nnco2)cc1,2019.0
Displacement of Kinase tracer 236 from recombinant full-length human N-terminal GST-fused CDK8 (1 to 464 residues)/cyclin C (1 to 283 residues) expressed in baculovirus expression system after 60 mins by TR-FRET assay,Cc1ncccc1Oc1sc(C(N)=O)c2c1-c1c(cnn1C)CC2,CHEMBL4411304,=,=,IC50,nM,1.6,IC50,nM,1.6,Cc1ncccc1Oc1sc(C(N)=O)c2c1-c1c(cnn1C)CC2,2019.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4425119,=,=,IC50,nM,32.5,IC50,nM,32.5,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1ncc(Oc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)c(N)n1,CHEMBL4425119,=,=,IC50,nM,14.6,IC50,nM,14.6,CNc1ncc(Oc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)c(N)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CCN(c2ccc3nncn3n2)C1,CHEMBL4425119,=,=,IC50,nM,4.2,IC50,nM,4.2,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CCN(c2ccc3nncn3n2)C1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@@H]1CCN(c2ccc3nncn3n2)C1,CHEMBL4425119,=,=,IC50,nM,166.0,IC50,nM,166.0,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@@H]1CCN(c2ccc3nncn3n2)C1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CCN(c2ccc(C(F)(F)F)nc2)C1,CHEMBL4425119,=,=,IC50,nM,117.0,IC50,nM,117.0,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CCN(c2ccc(C(F)(F)F)nc2)C1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CCN(c2ccncn2)C1,CHEMBL4425119,=,=,IC50,nM,60.3,IC50,nM,60.3,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CCN(c2ccncn2)C1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,Nc1nccc(N2CC[C@H](NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,42.3,IC50,nM,42.3,Nc1nccc(N2CC[C@H](NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,10.1,IC50,nM,10.1,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CCNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,8.9,IC50,nM,8.9,CCNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CCN(c2ccnc(NC3CC3)n2)C1,CHEMBL4425119,=,=,IC50,nM,20.3,IC50,nM,20.3,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@H]1CCN(c2ccnc(NC3CC3)n2)C1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(C)c(Cl)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,18.4,IC50,nM,18.4,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(C)c(Cl)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3cccc(C#N)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,3478.0,IC50,nM,3478.0,CNc1nccc(N2CC[C@H](NC(=O)Nc3cccc(C#N)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(OC(F)F)cc3)C2)n1,CHEMBL4425119,=,=,IC50,nM,143.0,IC50,nM,143.0,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(OC(F)F)cc3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(OC)cc3)C2)n1,CHEMBL4425119,=,=,IC50,nM,7157.0,IC50,nM,7157.0,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(OC)cc3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3cccc(OC)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,3619.0,IC50,nM,3619.0,CNc1nccc(N2CC[C@H](NC(=O)Nc3cccc(OC)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3cc(OC)cc(OC)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,5012.0,IC50,nM,5012.0,CNc1nccc(N2CC[C@H](NC(=O)Nc3cc(OC)cc(OC)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(OC(F)(F)F)cc3)C2)n1,CHEMBL4425119,=,=,IC50,nM,44.1,IC50,nM,44.1,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(OC(F)(F)F)cc3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,20.5,IC50,nM,20.5,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCOCC4)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,17.4,IC50,nM,17.4,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCOCC4)c(C(F)(F)F)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CCN1CCN(Cc2ccc(NC(=O)N[C@H]3CCN(c4ccnc(NC)n4)C3)cc2C(F)(F)F)CC1,CHEMBL4425119,=,=,IC50,nM,14.7,IC50,nM,14.7,CCN1CCN(Cc2ccc(NC(=O)N[C@H]3CCN(c4ccnc(NC)n4)C3)cc2C(F)(F)F)CC1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN(C)C)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,40.1,IC50,nM,40.1,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN(C)C)c(C(F)(F)F)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCCC4)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,157.0,IC50,nM,157.0,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCCC4)c(C(F)(F)F)c3)C2)n1,2016.0
Displacement of tracer236 from full-length His-tagged CDK8/cyclin C (unknown origin) incubated for 1 hr by TR-FRET analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCC4)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,99.9,IC50,nM,99.9,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCC4)c(C(F)(F)F)c3)C2)n1,2016.0
Inhibition of full-length human recombinant His-tagged CDK8/cyclin C at 1 uM,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(C)c(Cl)c3)C2)n1,CHEMBL4425119,>,>,Inhibition,%,30.0,INH,%,30.0,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(C)c(Cl)c3)C2)n1,2016.0
Inhibition of full-length human recombinant His-tagged CDK8/cyclin C at 0.1 uM,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4425119,>,>,Inhibition,%,50.0,INH,%,50.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2016.0
Inhibition of full-length human recombinant His-tagged CDK8/cyclin C at 0.1 uM,CNc1ncc(Oc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)c(N)n1,CHEMBL4425119,>,>,Inhibition,%,50.0,INH,%,50.0,CNc1ncc(Oc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)c(N)n1,2016.0
Inhibition of kinase tracer 236 binding to recombinant human full-length His-tagged CDK8/cyclin C expressed in baculovirus expression system measured after 1 hr by LanthaScreen Eu Kinase Binding Assay,C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1,CHEMBL4610118,=,=,IC50,nM,4490.0,IC50,nM,4490.0,C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1,2020.0
Binding affinity to CDK8/cyclin C (unknown origin),Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCCCNC(=O)OC(C)(C)C)cc1,CHEMBL4613207,=,=,Kd,nM,10.0,Kd,uM,0.01,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCCCNC(=O)OC(C)(C)C)cc1,2019.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system at 0.1 uM incubated for 60 mins by Lanthascreen assay relative to control,O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12,CHEMBL4665643,=,=,Inhibition,%,38.0,INH,%,38.0,O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12,2019.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system at 0.1 uM incubated for 60 mins by Lanthascreen assay relative to control,Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1,CHEMBL4665643,=,=,Inhibition,%,14.0,INH,%,14.0,Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1,2019.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system at 0.1 uM incubated for 60 mins by Lanthascreen assay relative to control,O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12,CHEMBL4665643,=,=,Inhibition,%,24.0,INH,%,24.0,O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12,2019.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control,CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21,CHEMBL4665648,=,=,Inhibition,%,14.0,INH,%,14.0,CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21,2019.0
Inhibition of N-terminal His6-tagged thrombin cleavage site-fused human CDK8 (M1 to Y463 residues)/cyclin D3 (M1 to S283 residues) expressed in baculovirus infected Sf9 insect cells,CN1CC[C@@H](c2c(OP(=O)(O)O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO,CHEMBL4699469,=,=,IC50,nM,12.0,IC50,nM,12.0,CN1CC[C@@H](c2c(OP(=O)(O)O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO,2020.0
Inhibition of CDK8/cyclin C (unknown origin) at 0.1 uM relative to control,CC(=O)N1CCN([C@H]2CC[C@@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,CHEMBL4725370,=,=,Inhibition,%,39.0,INH,%,39.0,CC(=O)N1CCN([C@H]2CC[C@@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,2020.0
Inhibition of CDK8/cyclin C (unknown origin) at 0.1 uM relative to control,CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CCN6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)CC4)CC3)c12,CHEMBL4725370,=,=,Inhibition,%,69.0,INH,%,69.0,CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CCN6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)CC4)CC3)c12,2020.0
Inhibition of CDK8/cyclin C (unknown origin),CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CCN6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)CC4)CC3)c12,CHEMBL4725370,=,=,IC50,nM,36.0,IC50,nM,36.0,CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CCN6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)CC4)CC3)c12,2020.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,Cn1cc(-c2ccc(-c3cncc(Cl)c3-n3ccc(C(=O)O)c3)cc2)cn1,CHEMBL4732199,=,=,Ki,nM,4190.0,Ki,uM,4.19,Cn1cc(-c2ccc(-c3cncc(Cl)c3-n3ccc(C(=O)O)c3)cc2)cn1,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,Cn1cc(-c2ccc(-c3cncc(Cl)c3-n3ccc(C(N)=O)c3)cc2)cn1,CHEMBL4732199,=,=,Ki,nM,1090.0,Ki,uM,1.09,Cn1cc(-c2ccc(-c3cncc(Cl)c3-n3ccc(C(N)=O)c3)cc2)cn1,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,CNC(=O)c1ccn(-c2c(Cl)cncc2-c2ccc(-c3cnn(C)c3)cc2)c1,CHEMBL4732199,=,=,Ki,nM,2030.0,Ki,uM,2.03,CNC(=O)c1ccn(-c2c(Cl)cncc2-c2ccc(-c3cnn(C)c3)cc2)c1,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cnn(-c3ccccc3)c1)CC2,CHEMBL4732199,=,=,Ki,nM,42.0,Ki,uM,0.042,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cnn(-c3ccccc3)c1)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cnn(Cc3ccccc3)c1)CC2,CHEMBL4732199,=,=,Ki,nM,346.0,Ki,uM,0.34600000000000003,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cnn(Cc3ccccc3)c1)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cnn(N3CCOCC3)c1)CC2,CHEMBL4732199,=,=,Ki,nM,124.0,Ki,uM,0.124,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cnn(N3CCOCC3)c1)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,CC(C)(C)OC(=O)N1CCC(n2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cn2)CC1,CHEMBL4732199,=,=,Ki,nM,700.0,Ki,uM,0.7,CC(C)(C)OC(=O)N1CCC(n2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cn2)CC1,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL4732199,=,=,Ki,nM,9.0,Ki,uM,0.009000000000000001,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,Cn1ncc2cc(Nc3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4732199,=,=,Ki,nM,670.0,Ki,uM,0.67,Cn1ncc2cc(Nc3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,Cn1ncc2c(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cccc21,CHEMBL4732199,=,=,Ki,nM,458.0,Ki,uM,0.45799999999999996,Cn1ncc2c(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cccc21,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,Cn1cc2c(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cccc2n1,CHEMBL4732199,=,=,Ki,nM,52.0,Ki,uM,0.052000000000000005,Cn1cc2c(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cccc2n1,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3[nH]ccc13)CC2,CHEMBL4732199,=,=,Ki,nM,19.0,Ki,uM,0.019,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3[nH]ccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cncc3ccccc13)CC2,CHEMBL4732199,=,=,Ki,nM,66.0,Ki,uM,0.066,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cncc3ccccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccnc3ccccc13)CC2,CHEMBL4732199,=,=,Ki,nM,138.0,Ki,uM,0.138,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccnc3ccccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3ncccc13)CC2,CHEMBL4732199,=,=,Ki,nM,22.0,Ki,uM,0.022000000000000002,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3ncccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3cnccc13)CC2,CHEMBL4732199,=,=,Ki,nM,52.0,Ki,uM,0.052000000000000005,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3cnccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3ccncc13)CC2,CHEMBL4732199,=,=,Ki,nM,3140.0,Ki,uM,3.14,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3ccncc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3cccnc13)CC2,CHEMBL4732199,=,=,Ki,nM,114.0,Ki,uM,0.114,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3cccnc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3ccccc13)CC2,CHEMBL4732199,=,=,Ki,nM,16.0,Ki,uM,0.016,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3ccccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,Cc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)c2ccccc12,CHEMBL4732199,=,=,Ki,nM,22.0,Ki,uM,0.022000000000000002,Cc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)c2ccccc12,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,COc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)c2ccccc12,CHEMBL4732199,=,=,Ki,nM,26.0,Ki,uM,0.026000000000000002,COc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)c2ccccc12,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3c1oc1ccccc13)CC2,CHEMBL4732199,=,=,Ki,nM,16.0,Ki,uM,0.016,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3c1oc1ccccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3c1sc1ccccc13)CC2,CHEMBL4732199,=,=,Ki,nM,24.0,Ki,uM,0.024,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccc3c1sc1ccccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3[nH]1)CC2,CHEMBL4732199,=,=,Ki,nM,156.0,Ki,uM,0.156,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3[nH]1)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,Cn1c(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)cc2ccccc21,CHEMBL4732199,=,=,Ki,nM,79.0,Ki,uM,0.079,Cn1c(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)cc2ccccc21,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cn(Cc3ccccc3)c3ccccc13)CC2,CHEMBL4732199,=,=,Ki,nM,58.0,Ki,uM,0.057999999999999996,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cn(Cc3ccccc3)c3ccccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cn(S(=O)(=O)c3ccccc3)c3ccccc13)CC2,CHEMBL4732199,=,=,Ki,nM,645.0,Ki,uM,0.645,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cn(S(=O)(=O)c3ccccc3)c3ccccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1c[nH]c3ccccc13)CC2,CHEMBL4732199,=,=,Ki,nM,56.0,Ki,uM,0.055999999999999994,O=C1NCCC12CCN(c1c(Cl)cncc1-c1c[nH]c3ccccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cn(S(=O)(=O)c3ccccc3)c3ncccc13)CC2,CHEMBL4732199,=,=,Ki,nM,50.0,Ki,uM,0.05,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cn(S(=O)(=O)c3ccccc3)c3ncccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1c[nH]c3ncccc13)CC2,CHEMBL4732199,=,=,Ki,nM,14.0,Ki,uM,0.013999999999999999,O=C1NCCC12CCN(c1c(Cl)cncc1-c1c[nH]c3ncccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2,CHEMBL4732199,=,=,Ki,nM,14.0,Ki,uM,0.013999999999999999,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3s1)CC2,CHEMBL4732199,=,=,Ki,nM,48.0,Ki,uM,0.048,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3s1)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1coc3ccccc13)CC2,CHEMBL4732199,=,=,Ki,nM,1300.0,Ki,uM,1.3,O=C1NCCC12CCN(c1c(Cl)cncc1-c1coc3ccccc13)CC2,2021.0
Inhibition of CDK8/cyclin C (unknown origin) using RBER-IRStide as substrate incubated for 60 mins in presence of [gamma33P]ATP by scintillation counting method,O=C1NCCC12CCN(c1c(Cl)cncc1-c1csc3ccccc13)CC2,CHEMBL4732199,=,=,Ki,nM,21.0,Ki,uM,0.021,O=C1NCCC12CCN(c1c(Cl)cncc1-c1csc3ccccc13)CC2,2021.0
Inhibition of CDK8/cyclin-C (unknown origin) at 1 uM,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2,CHEMBL4732199,,,Inhibition,%,,INH,,,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2,2021.0
Inhibition of CDK8/cyclin-C (unknown origin) at 1 uM,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3s1)CC2,CHEMBL4732199,,,Inhibition,%,,INH,,,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3s1)CC2,2021.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,NC(=O)c1ccc([N+](=O)[O-])c(Nc2ccc(N3CC(OCCO)C3)cc2)c1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,NC(=O)c1ccc([N+](=O)[O-])c(Nc2ccc(N3CC(OCCO)C3)cc2)c1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,COc1cc(Nc2ccc(N3CCN(CC(C)(C)C(=O)O)CC3)cc2)c([N+](=O)[O-])cc1F,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,COc1cc(Nc2ccc(N3CCN(CC(C)(C)C(=O)O)CC3)cc2)c([N+](=O)[O-])cc1F,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,CC(=O)c1ccc(C(N)=O)cc1Nc1ccc(OCCOCCCC(=O)O)cc1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,CC(=O)c1ccc(C(N)=O)cc1Nc1ccc(OCCOCCCC(=O)O)cc1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(N2CC(OCCO)C2)cc1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(N2CC(OCCO)C2)cc1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,CC(=O)c1ccc(C(N)=O)c(Oc2ccc(N3CC(OCCO)C3)cc2)c1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,CC(=O)c1ccc(C(N)=O)c(Oc2ccc(N3CC(OCCO)C3)cc2)c1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOCCOC(C)C)cc1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOCCOC(C)C)cc1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,C[C@@H](O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,C[C@@H](O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,CNC(=O)c1ccc([N+](=O)[O-])c(Nc2ccc(N3CC(OCCO)C3)cc2)c1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,CNC(=O)c1ccc([N+](=O)[O-])c(Nc2ccc(N3CC(OCCO)C3)cc2)c1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,NC(=O)c1ccc([N+](=O)[O-])c(Nc2ccc(OCCOC3CCOCC3)cc2)c1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,NC(=O)c1ccc([N+](=O)[O-])c(Nc2ccc(OCCOC3CCOCC3)cc2)c1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,NC(=O)c1ccc(C(F)(F)F)c(Oc2ccc(OCCOC3CCOCC3)cc2)c1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,NC(=O)c1ccc(C(F)(F)F)c(Oc2ccc(OCCOC3CCOCC3)cc2)c1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,CC(C)OCCOCCOc1ccc(Oc2cc(C(N)=O)ccc2C(F)(F)F)cc1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,CC(C)OCCOCCOc1ccc(Oc2cc(C(N)=O)ccc2C(F)(F)F)cc1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOC2)cc1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOC2)cc1,2020.0
Inhibition of human CDK8/cyclin C at 1 uM incubated for 30 mins by ELISA,C=C(F)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1,CHEMBL4739709,>=,>=,Inhibition,%,90.0,INH,%,90.0,C=C(F)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1,2020.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cccs1)Nc1ccc(CCc2nnco2)cc1,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(/C=C/c1cnccc1-c1cccs1)Nc1ccc(CCc2nnco2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cc1nn(C)cc1-c1ccncc1/C=C/C(=O)Nc1ccc(CCc2nnco2)cc1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,Cc1nn(C)cc1-c1ccncc1/C=C/C(=O)Nc1ccc(CCc2nnco2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cn[nH]c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,O=C(/C=C/c1cnccc1-c1cn[nH]c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOC(C)(C)C3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,97.0,INH,%,97.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOC(C)(C)C3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2F)cn1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2F)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)c(Cl)c2)cn1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)c(Cl)c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CC(c1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1)N1CCOCC1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,CC(c1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1)N1CCOCC1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(CC2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,O=C(/C=C/c1cnccc1-c1cnn(CC2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(Cc2ccccn2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(/C=C/c1cnccc1-c1cnn(Cc2ccccn2)c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CNC3CC3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,95.0,INH,%,95.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CNC3CC3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC4CCC(C3)O4)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC4CCC(C3)O4)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC4CC3CO4)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC4CC3CO4)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,C[C@@H]1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2)C[C@H](C)O1,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,C[C@@H]1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2)C[C@H](C)O1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CC1COCCN1Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,CC1COCCN1Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CC1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2)CCO1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,CC1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2)CCO1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC(F)(F)OC(F)(F)C3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,97.0,INH,%,97.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC(F)(F)OC(F)(F)C3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCC(F)(F)C3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCC(F)(F)C3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC(F)(F)C3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC(F)(F)C3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CNCC(F)(F)C(F)(F)F)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CNCC(F)(F)C(F)(F)F)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCCC3CO)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,104.0,INH,%,104.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCCC3CO)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCN4CCCC4C3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCN4CCCC4C3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCC4(CC3)COC4)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,97.0,INH,%,97.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCC4(CC3)COC4)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CNC3CC(F)(F)C3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CNC3CC(F)(F)C3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CCN3CCOCC3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CCN3CCOCC3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CCn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,CCn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(Cc2ccccc2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(/C=C/c1cnccc1-c1cnn(Cc2ccccc2)c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,92.0,INH,%,92.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C(F)F)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,O=C(/C=C/c1cnccc1-c1cnn(C(F)F)c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CCn1cc(-c2ccncc2CCC(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,90.0,INH,%,90.0,CCn1cc(-c2ccncc2CCC(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COc1ccsc1-c1ccncc1/C=C/C(=O)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,97.0,INH,%,97.0,COc1ccsc1-c1ccncc1/C=C/C(=O)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn2ccccc12)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,O=C(/C=C/c1cnccc1-c1cnn2ccccc12)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(CC2CC2)c1)Nc1ccc(CCN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,94.0,INH,%,94.0,O=C(/C=C/c1cnccc1-c1cnn(CC2CC2)c1)Nc1ccc(CCN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cc1cc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)ccc1CN1CCOCC1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,Cc1cc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)ccc1CN1CCOCC1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)OCC3)cn1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)OCC3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CC(C)(C)O)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CC(C)(C)O)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CCC(F)(F)F)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CCC(F)(F)F)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(Oc3ccncc3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,95.0,INH,%,95.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(Oc3ccncc3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cc1cc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)ccc1CN1CCOCC1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,Cc1cc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)ccc1CN1CCOCC1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CC(C)(O)Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)cc1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,CC(C)(O)Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnsc1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,90.0,INH,%,90.0,O=C(/C=C/c1cnccc1-c1cnsc1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)c(O)c2)cn1,CHEMBL4742385,=,=,Inhibition,%,97.0,INH,%,97.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)c(O)c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)c(C#N)c2)cn1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)c(C#N)c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cc1ncc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,CHEMBL4742385,=,=,Inhibition,%,95.0,INH,%,95.0,Cc1ncc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3cnccc3c2)cn1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3cnccc3c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3cc[nH]c3c2)cn1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3cc[nH]c3c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3ccncc3c2)cn1,CHEMBL4742385,=,=,Inhibition,%,94.0,INH,%,94.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3ccncc3c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(N3CCOCC3)c(Cl)c2)cn1,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(N3CCOCC3)c(Cl)c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)OCO3)cn1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)OCO3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)OCCO3)cn1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)OCCO3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3ncsc3c2)cn1,CHEMBL4742385,=,=,Inhibition,%,94.0,INH,%,94.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3ncsc3c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCO3)cn1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCO3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(ccn3C)c2)cn1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(ccn3C)c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCC3=O)cn1,CHEMBL4742385,=,=,Inhibition,%,92.0,INH,%,92.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCC3=O)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2cccc(-c3cccnc3)c2)cn1,CHEMBL4742385,=,=,Inhibition,%,84.0,INH,%,84.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2cccc(-c3cccnc3)c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCCC3=O)cn1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCCC3=O)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1F,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1F,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cncs1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,94.0,INH,%,94.0,O=C(/C=C/c1cnccc1-c1cncs1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1ccns1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(/C=C/c1cnccc1-c1ccns1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CN1CCc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2C1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,CN1CCc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2C1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)(F)F)CC3)cn1,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)(F)F)CC3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CC(=O)n1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,CC(=O)n1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COc1ccc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,CHEMBL4742385,=,=,Inhibition,%,93.0,INH,%,93.0,COc1ccc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COc1ncc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,COc1ncc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1ccc2nccn2c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(/C=C/c1cnccc1-c1ccc2nccn2c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CN(C)CCc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,CN(C)CCc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cnc2ccc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)cc21,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,Cn1cnc2ccc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)cc21,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2cc(F)c(CN3CCOCC3)cc2F)cn1,CHEMBL4742385,=,=,Inhibition,%,94.0,INH,%,94.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2cc(F)c(CN3CCOCC3)cc2F)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COCc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,COCc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1ccc2[nH]cnc2c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,O=C(/C=C/c1cnccc1-c1ccc2[nH]cnc2c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1ccc2[nH]ncc2c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,O=C(/C=C/c1cnccc1-c1ccc2[nH]ncc2c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CC(=O)N(C)Cc1cc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)ccc1C,CHEMBL4742385,=,=,Inhibition,%,95.0,INH,%,95.0,CC(=O)N(C)Cc1cc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)ccc1C,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(CC(F)(F)F)CC2,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(CC(F)(F)F)CC2,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(C(=O)C(F)(F)F)CC2,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(C(=O)C(F)(F)F)CC2,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)c(F)c2)cn1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)c(F)c2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COc1ncc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2F)s1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,COc1ncc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2F)s1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1ccc2cc(NC(=O)/C=C/c3cnccc3-c3cnn(C4CC4)c3)ccc21,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,Cn1ccc2cc(NC(=O)/C=C/c3cnccc3-c3cnn(C4CC4)c3)ccc21,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CN(C)CCOc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,CN(C)CCOc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COCCOc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,COCCOc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CCN1CCc2cc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)ccc2C1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,CCN1CCc2cc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)ccc2C1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CCN1CCc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2C1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,CCN1CCc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2C1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CCC2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,96.0,INH,%,96.0,O=C(/C=C/c1cnccc1-c1cnn(C2CCC2)c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2F)cn1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2F)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc2cc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)ccc2n1,CHEMBL4742385,=,=,Inhibition,%,97.0,INH,%,97.0,Cn1cc2cc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)ccc2n1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(ccn2CC(F)(F)F)c1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(ccn2CC(F)(F)F)c1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COC(C)c1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)cc1,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,COC(C)c1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COC(C)(C)Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)cc1,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,COC(C)(C)Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1F,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1F,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(Cn3cccn3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(Cn3cccn3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(Cn3ccnc3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(Cn3ccnc3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CC(F)(F)F)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CC(F)(F)F)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCN(CC(F)(F)F)C3)cn1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCN(CC(F)(F)F)C3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCN3)cn1,CHEMBL4742385,=,=,Inhibition,%,97.0,INH,%,97.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCN3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C4CC4)c3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,92.0,INH,%,92.0,Cn1cc(-c2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C4CC4)c3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1ccc2ncn(CC3CC3)c2c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,95.0,INH,%,95.0,O=C(/C=C/c1cnccc1-c1ccc2ncn(CC3CC3)c2c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CC#N)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,92.0,INH,%,92.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CC#N)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(CC2(F)CC2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,O=C(/C=C/c1cnccc1-c1cnn(CC2(F)CC2)c1)Nc1ccc(CN2CCOCC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)(F)F)C3)cn1,CHEMBL4742385,=,=,Inhibition,%,98.0,INH,%,98.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)(F)F)C3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(C2CC2)cc1,CHEMBL4742385,=,=,Inhibition,%,95.0,INH,%,95.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(C2CC2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(COC(F)F)cc1,CHEMBL4742385,=,=,Inhibition,%,97.0,INH,%,97.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(COC(F)F)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CC(C)(F)Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)cc1,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,CC(C)(F)Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COCCn1cnc2ccc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)cc21,CHEMBL4742385,=,=,Inhibition,%,103.0,INH,%,103.0,COCCn1cnc2ccc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)cc21,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cn[nH]c2)c(F)c1,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cn[nH]c2)c(F)c1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cnc2ccc(-c3ccncc3/C=C/C(=O)Nc3ccc4c(ccn4CC(F)(F)F)c3)cc21,CHEMBL4742385,=,=,Inhibition,%,85.0,INH,%,85.0,Cn1cnc2ccc(-c3ccncc3/C=C/C(=O)Nc3ccc4c(ccn4CC(F)(F)F)c3)cc21,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(CC(F)(F)C(F)(F)F)CC2,CHEMBL4742385,=,=,Inhibition,%,97.0,INH,%,97.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(CC(F)(F)C(F)(F)F)CC2,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3(COC3)C2)cc1,CHEMBL4742385,=,=,Inhibition,%,110.0,INH,%,110.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3(COC3)C2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,CHEMBL4742385,=,=,Inhibition,%,105.0,INH,%,105.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cc1noc(C)c1-c1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)c(F)c1,CHEMBL4742385,=,=,Inhibition,%,103.0,INH,%,103.0,Cc1noc(C)c1-c1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C3CC3)c2)c(F)c1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CCN(CC(F)(F)F)C2,CHEMBL4742385,=,=,Inhibition,%,103.0,INH,%,103.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CCN(CC(F)(F)F)C2,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(CC(F)(F)F)C2,CHEMBL4742385,=,=,Inhibition,%,103.0,INH,%,103.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(CC(F)(F)F)C2,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COC1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C4CC4)c3)cc2)C1,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,COC1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C4CC4)c3)cc2)C1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CC1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C4CC4)c3)cc2)C1,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,CC1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C4CC4)c3)cc2)C1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(CC(F)(F)F)C2,CHEMBL4742385,=,=,Inhibition,%,104.0,INH,%,104.0,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(CC(F)(F)F)C2,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)(F)F)C3)cn1,CHEMBL4742385,=,=,Inhibition,%,106.0,INH,%,106.0,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)(F)F)C3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(COCC(F)(F)F)cc1F,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(COCC(F)(F)F)cc1F,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)OCCO2,CHEMBL4742385,=,=,Inhibition,%,103.0,INH,%,103.0,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)OCCO2,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CC(C)(O)Cc1ccc(NC(=O)/C=C/c2cncc(F)c2-c2cnn(C3CC3)c2)c(F)c1,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,CC(C)(O)Cc1ccc(NC(=O)/C=C/c2cncc(F)c2-c2cnn(C3CC3)c2)c(F)c1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3CC(C2)O3)cc1,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3CC(C2)O3)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(CC(F)(F)CO)C2,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CN(CC(F)(F)CO)C2,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)F)C3)cn1,CHEMBL4742385,=,=,Inhibition,%,105.0,INH,%,105.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)F)C3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COC1CN(Cc2ccc(NC(=O)/C=C/c3cncc(F)c3-c3cnn(C4CC4)c3)c(F)c2)C1,CHEMBL4742385,=,=,Inhibition,%,103.0,INH,%,103.0,COC1CN(Cc2ccc(NC(=O)/C=C/c3cncc(F)c3-c3cnn(C4CC4)c3)c(F)c2)C1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,COC1CN(Cc2ccc(NC(=O)/C=C/c3cncc(F)c3-c3cnn(C4CC4)c3)cc2)C1,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,COC1CN(Cc2ccc(NC(=O)/C=C/c3cncc(F)c3-c3cnn(C4CC4)c3)cc2)C1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CC(C)(F)Cc1ccc(NC(=O)/C=C/c2cncc(F)c2-c2cnn(C3CC3)c2)cc1,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,CC(C)(F)Cc1ccc(NC(=O)/C=C/c2cncc(F)c2-c2cnn(C3CC3)c2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(C)(F)F)C3)cn1,CHEMBL4742385,=,=,Inhibition,%,106.0,INH,%,106.0,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(C)(F)F)C3)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cnc2ccc(-c3c(F)cncc3/C=C/C(=O)Nc3ccc4c(c3)CN(CC(F)(F)F)C4)cc21,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,Cn1cnc2ccc(-c3c(F)cncc3/C=C/C(=O)Nc3ccc4c(c3)CN(CC(F)(F)F)C4)cc21,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cnc2ccc(-c3c(F)cncc3/C=C/C(=O)Nc3ccc(CN4CC(F)(F)C4)cc3)cc21,CHEMBL4742385,=,=,Inhibition,%,87.0,INH,%,87.0,Cn1cnc2ccc(-c3c(F)cncc3/C=C/C(=O)Nc3ccc(CN4CC(F)(F)C4)cc3)cc21,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc(CN3CC(F)(F)C3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,103.0,INH,%,103.0,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc(CN3CC(F)(F)C3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(N3CC(F)(F)C3)cc2)cn1,CHEMBL4742385,=,=,Inhibition,%,105.0,INH,%,105.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(N3CC(F)(F)C3)cc2)cn1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)C2)cc1,CHEMBL4742385,=,=,Inhibition,%,107.0,INH,%,107.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)C2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1F,CHEMBL4742385,=,=,Inhibition,%,105.0,INH,%,105.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1F,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1.O=S(=O)(O)O,CHEMBL4742385,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1.O=S(=O)(O)O,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1.O=P(O)(O)O.O=P(O)(O)O,CHEMBL4742385,=,=,Inhibition,%,100.0,INH,%,100.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1.O=P(O)(O)O.O=P(O)(O)O,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,CS(=O)(=O)O.O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,CS(=O)(=O)O.O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1.O=C(O)/C=C/C(=O)O,CHEMBL4742385,=,=,Inhibition,%,99.0,INH,%,99.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1.O=C(O)/C=C/C(=O)O,2019.0
Inhibition of human CDK8/Cyc C expressed in Sf21 cells at 1 uM measured after 1 hr by fluorescence plate reader relative to control,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1.O=C(O)CCC(=O)O,CHEMBL4742385,=,=,Inhibition,%,102.0,INH,%,102.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1.O=C(O)CCC(=O)O,2019.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,COc1ccccc1-c1c(C(N)=O)[nH]c2c1C(C)(C)Oc1cnccc1-2,CHEMBL4742387,=,=,IC50,10^-8mol/L,5.54,IC50,10^-8mol/L,5.54,COc1ccccc1-c1c(C(N)=O)[nH]c2c1C(C)(C)Oc1cnccc1-2,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CC1(C)Oc2cnccc2-c2[nH]c(C(N)=O)c(-c3ccccc3O)c21,CHEMBL4742387,=,=,IC50,10^-7mol/L,1.12,IC50,10^-7mol/L,1.12,CC1(C)Oc2cnccc2-c2[nH]c(C(N)=O)c(-c3ccccc3O)c21,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CC1(C)Oc2cnccc2-c2[nH]c(C(N)=O)c(-c3ccc4[nH]ncc4c3)c21,CHEMBL4742387,=,=,IC50,10^-5 mol/L,1.0,IC50,10^-5 mol/L,1.0,CC1(C)Oc2cnccc2-c2[nH]c(C(N)=O)c(-c3ccc4[nH]ncc4c3)c21,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCC1,CHEMBL4742387,=,=,IC50,10^-10mol/L,1.91,IC50,10^-10mol/L,1.91,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,Cn1c(C(N)=O)cc2c1-c1ccncc1OC21CCC1,CHEMBL4742387,=,=,IC50,10^-10mol/L,4.66,IC50,10^-10mol/L,4.66,Cn1c(C(N)=O)cc2c1-c1ccncc1OC21CCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)c(-c2ccccc2OC)c2c1-c1ccncc1OC2(C)C,CHEMBL4742387,=,=,IC50,10^-9mol/L,3.23,IC50,10^-9mol/L,3.23,CCn1c(C(N)=O)c(-c2ccccc2OC)c2c1-c1ccncc1OC2(C)C,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCCCC1,CHEMBL4742387,=,=,IC50,10^-8mol/L,1.93,IC50,10^-8mol/L,1.93,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCCCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,NC(=O)c1cc2c([nH]1)-c1ccncc1O[C@H]2C1CCCCC1,CHEMBL4742387,=,=,IC50,10^-9mol/L,8.5,IC50,10^-9mol/L,8.5,NC(=O)c1cc2c([nH]1)-c1ccncc1O[C@H]2C1CCCCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCOCC1,CHEMBL4742387,=,=,IC50,10^-7mol/L,2.81,IC50,10^-7mol/L,2.81,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCOCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCOCC1,CHEMBL4742387,=,=,IC50,10^-9mol/L,4.46,IC50,10^-9mol/L,4.46,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCOCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,COc1ccccc1-c1c2c(n(CCF)c1C(N)=O)-c1ccncc1OC2(C)C,CHEMBL4742387,=,=,IC50,10^-7mol/L,1.39,IC50,10^-7mol/L,1.39,COc1ccccc1-c1c2c(n(CCF)c1C(N)=O)-c1ccncc1OC2(C)C,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CC1(C)Oc2cnccc2-c2[nH]c(C(N)=O)c(-c3ccccc3C(F)(F)F)c21,CHEMBL4742387,=,=,IC50,10^-7mol/L,2.11,IC50,10^-7mol/L,2.11,CC1(C)Oc2cnccc2-c2[nH]c(C(N)=O)c(-c3ccccc3C(F)(F)F)c21,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)c(-c2ccccc2C(F)(F)F)c2c1-c1ccncc1OC2(C)C,CHEMBL4742387,=,=,IC50,10^-8mol/L,1.44,IC50,10^-8mol/L,1.44,CCn1c(C(N)=O)c(-c2ccccc2C(F)(F)F)c2c1-c1ccncc1OC2(C)C,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,NC(=O)c1cc2c(n1CCF)-c1ccncc1OC21CCC1,CHEMBL4742387,=,=,IC50,10^-10mol/L,2.62,IC50,10^-10mol/L,2.62,NC(=O)c1cc2c(n1CCF)-c1ccncc1OC21CCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CC(=O)N1CCC2(CC1)Oc1cnccc1-c1[nH]c(C(N)=O)cc12,CHEMBL4742387,=,=,IC50,10^-9mol/L,7.48,IC50,10^-9mol/L,7.48,CC(=O)N1CCC2(CC1)Oc1cnccc1-c1[nH]c(C(N)=O)cc12,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,COc1ccccc1-c1c2c(n(CCF)c1C(=O)NCCF)-c1ccncc1OC2(C)C,CHEMBL4742387,=,=,IC50,10^-7mol/L,4.84,IC50,10^-7mol/L,4.84,COc1ccccc1-c1c2c(n(CCF)c1C(=O)NCCF)-c1ccncc1OC2(C)C,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCN(CC(F)(F)F)CC1,CHEMBL4742387,=,=,IC50,10^-9mol/L,1.11,IC50,10^-9mol/L,1.11,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCN(CC(F)(F)F)CC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1,CHEMBL4742387,=,=,IC50,10^-10mol/L,3.14,IC50,10^-10mol/L,3.14,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,Cn1c(C(N)=O)cc2c1-c1ccncc1OC21CCOCC1,CHEMBL4742387,=,=,IC50,10^-9mol/L,3.83,IC50,10^-9mol/L,3.83,Cn1c(C(N)=O)cc2c1-c1ccncc1OC21CCOCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCOCC1,CHEMBL4742387,=,=,IC50,10^-9mol/L,2.19,IC50,10^-9mol/L,2.19,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCOCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,Cn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1,CHEMBL4742387,=,=,IC50,10^-10mol/L,2.78,IC50,10^-10mol/L,2.78,Cn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,COc1cccc(-c2c(C(N)=O)[nH]c3c2C(C)(C)Oc2cnccc2-3)c1,CHEMBL4742387,=,=,IC50,10^-7mol/L,1.27,IC50,10^-7mol/L,1.27,COc1cccc(-c2c(C(N)=O)[nH]c3c2C(C)(C)Oc2cnccc2-3)c1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CC1(C)Oc2cnccc2-c2[nH]c(C(N)=O)c(C3CC3)c21,CHEMBL4742387,=,=,IC50,10^-9mol/L,4.33,IC50,10^-9mol/L,4.33,CC1(C)Oc2cnccc2-c2[nH]c(C(N)=O)c(C3CC3)c21,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,COCCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCOCC1,CHEMBL4742387,=,=,IC50,10^-8mol/L,1.42,IC50,10^-8mol/L,1.42,COCCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCOCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)c(-c2cccc(OC)c2)c2c1-c1ccncc1OC2(C)C,CHEMBL4742387,=,=,IC50,10^-8mol/L,1.39,IC50,10^-8mol/L,1.39,CCn1c(C(N)=O)c(-c2cccc(OC)c2)c2c1-c1ccncc1OC2(C)C,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2C1CCCCC1,CHEMBL4742387,=,=,IC50,10^-10mol/L,4.07,IC50,10^-10mol/L,4.07,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2C1CCCCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2C1CCCCC1,CHEMBL4742387,=,=,IC50,10^-9mol/L,1.36,IC50,10^-9mol/L,1.36,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2C1CCCCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1.Cl,CHEMBL4742387,=,=,IC50,10^-7mol/L,3.01,IC50,10^-7mol/L,3.01,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1.Cl,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,NC(=O)c1cc2c(n1CCF)-c1ccncc1OC21CCOCC1,CHEMBL4742387,<,<,IC50,10^-9mol/L,1.41,IC50,10^-9mol/L,1.41,NC(=O)c1cc2c(n1CCF)-c1ccncc1OC21CCOCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)c(C2CC2)c2c1-c1ccncc1OC2(C)C,CHEMBL4742387,=,=,IC50,10^-9mol/L,2.65,IC50,10^-9mol/L,2.65,CCn1c(C(N)=O)c(C2CC2)c2c1-c1ccncc1OC2(C)C,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2C1CCOCC1,CHEMBL4742387,<,<,IC50,10^-9mol/L,1.41,IC50,10^-9mol/L,1.41,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2C1CCOCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2C1CCOCC1,CHEMBL4742387,<,<,IC50,10^-9mol/L,1.41,IC50,10^-9mol/L,1.41,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2C1CCOCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)c(Cl)c2c1-c1ccncc1OC21CCOCC1,CHEMBL4742387,=,=,IC50,10^-9mol/L,2.41,IC50,10^-9mol/L,2.41,CCn1c(C(N)=O)c(Cl)c2c1-c1ccncc1OC21CCOCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,CCn1c(C(N)=O)c(Cl)c2c1-c1ccncc1OC21CCCCC1,CHEMBL4742387,<,<,IC50,10^-9mol/L,1.41,IC50,10^-9mol/L,1.41,CCn1c(C(N)=O)c(Cl)c2c1-c1ccncc1OC21CCCCC1,2018.0
Inhibition of kinase tracer 236 binding to full-length His-tagged recombinant human CDK8/cyclin C incubated for 60 mins by FRET based LanthaScreen Eu-Kinase binding assay,NC(=O)c1cc2c(n1CCF)-c1ccncc1OC21CCCCC1,CHEMBL4742387,=,=,IC50,10^-9mol/L,1.41,IC50,10^-9mol/L,1.41,NC(=O)c1cc2c(n1CCF)-c1ccncc1OC21CCCCC1,2018.0
Inhibition of CDK8/Cyclin C (unknown origin) preincubated for 20 mins followed by ATP addition and measured after 120 mins in presence of [33P-gamma] ATP by hotspot kinase assay,COc1cc(F)ccc1-c1nc(Nc2ccc3c(N4CCOCC4)c(C(C)=O)c(=O)oc3c2)ncc1F,CHEMBL4765336,=,=,IC50,nM,6500.0,IC50,nM,6500.0,COc1cc(F)ccc1-c1nc(Nc2ccc3c(N4CCOCC4)c(C(C)=O)c(=O)oc3c2)ncc1F,2020.0
Inhibition of kinase tracer 236 binding to His-tagged CDK8/cyclin C (unknown origin) incubated for 60 mins by LanthaScreen Eu-Kinase binding assay,Nc1nccc2c(Br)cc3cc(C(=O)[O-])ccc3c12.[Na+],CHEMBL4806958,<,<,IC50,nM,300.0,IC50,nM,300.0,Nc1nccc2c(Br)cc3cc(C(=O)[O-])ccc3c12.[Na+],2020.0
Inhibition of CDK8/Cyclin C (unknown origin) assessed as residual activity measured at 1 uM,Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1,CHEMBL4806967,>,>,Activity,%,75.0,Activity,%,75.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1,2020.0
Inhibition of CDK8/Cyclin C (unknown origin) assessed as residual activity measured at 1 uM,Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1,CHEMBL4806967,>,>,Activity,%,75.0,Activity,%,75.0,Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1,2020.0
Inhibition of CDK8/Cyclin C (unknown origin) assessed as residual activity measured at 1 uM,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,CHEMBL4806967,>,>,Activity,%,75.0,Activity,%,75.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,2020.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccco1)CC2,CHEMBL4811251,=,=,Ki,nM,26.0,Ki,uM,0.026000000000000002,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccco1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccoc1)CC2,CHEMBL4811251,=,=,Ki,nM,42.0,Ki,uM,0.042,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccoc1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccs1)CC2,CHEMBL4811251,=,=,Ki,nM,10.0,Ki,uM,0.01,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cccs1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccsc1)CC2,CHEMBL4811251,=,=,Ki,nM,18.0,Ki,uM,0.018000000000000002,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccsc1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc[nH]c1)CC2,CHEMBL4811251,=,=,Ki,nM,14.0,Ki,uM,0.013999999999999999,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc[nH]c1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,Cc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)o1,CHEMBL4811251,=,=,Ki,nM,22.0,Ki,uM,0.022000000000000002,Cc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)o1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=Cc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)o1,CHEMBL4811251,=,=,Ki,nM,82.0,Ki,uM,0.08199999999999999,O=Cc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)o1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,CCOCOCc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)o1,CHEMBL4811251,=,=,Ki,nM,36.0,Ki,uM,0.036000000000000004,CCOCOCc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)o1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,Cc1ccsc1-c1cncc(Cl)c1N1CCC2(CCNC2=O)CC1,CHEMBL4811251,=,=,Ki,nM,8.0,Ki,uM,0.008,Cc1ccsc1-c1cncc(Cl)c1N1CCC2(CCNC2=O)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,Cc1csc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)c1,CHEMBL4811251,=,=,Ki,nM,10.0,Ki,uM,0.01,Cc1csc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,Cc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)s1,CHEMBL4811251,=,=,Ki,nM,10.0,Ki,uM,0.01,Cc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)s1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(Cl)s1)CC2,CHEMBL4811251,=,=,Ki,nM,14.0,Ki,uM,0.013999999999999999,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(Cl)s1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,CC(=O)c1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)s1,CHEMBL4811251,=,=,Ki,nM,66.0,Ki,uM,0.066,CC(=O)c1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)s1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=Cc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)s1,CHEMBL4811251,=,=,Ki,nM,67.0,Ki,uM,0.067,O=Cc1ccc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)s1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,Cc1cc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)sc1C=O,CHEMBL4811251,=,=,Ki,nM,119.0,Ki,uM,0.11900000000000001,Cc1cc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)sc1C=O,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3ccccc3)s1)CC2,CHEMBL4811251,=,=,Ki,nM,5.0,Ki,uM,0.005,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3ccccc3)s1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(CN3CCCC3)s1)CC2,CHEMBL4811251,=,=,Ki,nM,132.0,Ki,uM,0.132,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(CN3CCCC3)s1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(CN3CCCCC3)s1)CC2,CHEMBL4811251,=,=,Ki,nM,106.0,Ki,uM,0.106,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(CN3CCCCC3)s1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(CN3CCOCC3)s1)CC2,CHEMBL4811251,=,=,Ki,nM,32.0,Ki,uM,0.032,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(CN3CCOCC3)s1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,CC(C)(C)OC(=O)N1CCN(Cc2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)s2)CC1,CHEMBL4811251,=,=,Ki,nM,46.0,Ki,uM,0.046,CC(C)(C)OC(=O)N1CCN(Cc2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)s2)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,Cn1cccc1-c1cncc(Cl)c1N1CCC2(CCNC2=O)CC1,CHEMBL4811251,=,=,Ki,nM,30.0,Ki,uM,0.03,Cn1cccc1-c1cncc(Cl)c1N1CCC2(CCNC2=O)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=Cc1cc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)co1,CHEMBL4811251,=,=,Ki,nM,185.0,Ki,uM,0.185,O=Cc1cc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)co1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,CC(=O)c1sccc1-c1cncc(Cl)c1N1CCC2(CCNC2=O)CC1,CHEMBL4811251,=,=,Ki,nM,4655.0,Ki,uM,4.655,CC(=O)c1sccc1-c1cncc(Cl)c1N1CCC2(CCNC2=O)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=Cc1sccc1-c1cncc(Cl)c1N1CCC2(CCNC2=O)CC1,CHEMBL4811251,=,=,Ki,nM,1745.0,Ki,uM,1.745,O=Cc1sccc1-c1cncc(Cl)c1N1CCC2(CCNC2=O)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=Cc1cscc1-c1cncc(Cl)c1N1CCC2(CCNC2=O)CC1,CHEMBL4811251,=,=,Ki,nM,845.0,Ki,uM,0.845,O=Cc1cscc1-c1cncc(Cl)c1N1CCC2(CCNC2=O)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=Cc1cc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)cs1,CHEMBL4811251,=,=,Ki,nM,52.0,Ki,uM,0.052000000000000005,O=Cc1cc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)cs1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cn[nH]c1)CC2,CHEMBL4811251,=,=,Ki,nM,254.0,Ki,uM,0.254,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cn[nH]c1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,Cn1cc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)cn1,CHEMBL4811251,=,=,Ki,nM,230.0,Ki,uM,0.23,Cn1cc(-c2cncc(Cl)c2N2CCC3(CCNC3=O)CC2)cn1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cnn(C(F)F)c1)CC2,CHEMBL4811251,=,=,Ki,nM,93.0,Ki,uM,0.09300000000000001,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cnn(C(F)F)c1)CC2,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,Nc1ncc(-c2cc3ccccc3o2)c(N2CCC3(CCNC3=O)CC2)c1Cl,CHEMBL4811251,=,=,Ki,nM,9.0,Ki,uM,0.009000000000000001,Nc1ncc(-c2cc3ccccc3o2)c(N2CCC3(CCNC3=O)CC2)c1Cl,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,Nc1ncc(-c2cc3ccccc3s2)c(N2CCC3(CCNC3=O)CC2)c1Cl,CHEMBL4811251,=,=,Ki,nM,7.0,Ki,uM,0.006999999999999999,Nc1ncc(-c2cc3ccccc3s2)c(N2CCC3(CCNC3=O)CC2)c1Cl,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP incubated for 60 mins by microplate scintillation counter analysis,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4811251,=,=,Ki,nM,11.0,Ki,uM,0.011000000000000001,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,2.0,IC50,nM,2.0,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]ncc4c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,178.0,IC50,nM,178.0,Cn1ncc2cc(-c3cnc4[nH]ncc4c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]cnc4c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,10.0,IC50,nM,10.0,Cn1ncc2cc(-c3cnc4[nH]cnc4c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4sccc4c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,206.0,IC50,nM,206.0,Cn1ncc2cc(-c3cnc4sccc4c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,O=C1NCCC12CCN(c1c(-c3ccc4scnc4c3)cnc3[nH]ccc13)CC2,CHEMBL4825780,=,=,IC50,nM,6.0,IC50,nM,6.0,O=C1NCCC12CCN(c1c(-c3ccc4scnc4c3)cnc3[nH]ccc13)CC2,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1cnc2ccc(-c3cnc4[nH]ccc4c3N3CCC4(CCNC4=O)CC3)cc21,CHEMBL4825780,=,=,IC50,nM,7.0,IC50,nM,7.0,Cn1cnc2ccc(-c3cnc4[nH]ccc4c3N3CCC4(CCNC4=O)CC3)cc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,O=C1NCCC12CCN(c1c(-c3ccc4ncsc4c3)cnc3[nH]ccc13)CC2,CHEMBL4825780,=,=,IC50,nM,25.0,IC50,nM,25.0,O=C1NCCC12CCN(c1c(-c3ccc4ncsc4c3)cnc3[nH]ccc13)CC2,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1cnc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,32.0,IC50,nM,32.0,Cn1cnc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,O=C1NCCC12CCN(c1c(-c3ccc4ncnn4c3)cnc3[nH]ccc13)CC2,CHEMBL4825780,=,=,IC50,nM,274.0,IC50,nM,274.0,O=C1NCCC12CCN(c1c(-c3ccc4ncnn4c3)cnc3[nH]ccc13)CC2,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,O=C1NCCC12CCN(c1c(-c3ccc4[nH]cnc4c3)cnc3[nH]ccc13)CC2,CHEMBL4825780,=,=,IC50,nM,5.0,IC50,nM,5.0,O=C1NCCC12CCN(c1c(-c3ccc4[nH]cnc4c3)cnc3[nH]ccc13)CC2,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,O=C1NCCC12CCN(c1c(-c3ccn4ccnc4c3)cnc3[nH]ccc13)CC2,CHEMBL4825780,=,=,IC50,nM,76.0,IC50,nM,76.0,O=C1NCCC12CCN(c1c(-c3ccn4ccnc4c3)cnc3[nH]ccc13)CC2,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]cc(Cl)c4c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,2.0,IC50,nM,2.0,Cn1ncc2cc(-c3cnc4[nH]cc(Cl)c4c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]nc(Cl)c4c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,1.0,IC50,nM,1.0,Cn1ncc2cc(-c3cnc4[nH]nc(Cl)c4c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CC4(CNC(=O)C4)C3)ccc21,CHEMBL4825780,=,=,IC50,nM,916.0,IC50,nM,916.0,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CC4(CNC(=O)C4)C3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CC4(CCNC4=O)C3)ccc21,CHEMBL4825780,=,=,IC50,nM,538.0,IC50,nM,538.0,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CC4(CCNC4=O)C3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CCNC4=O)C3)ccc21,CHEMBL4825780,=,=,IC50,nM,55.0,IC50,nM,55.0,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CCNC4=O)C3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CC3)NC(=O)NC4=O)ccc21,CHEMBL4825780,=,=,IC50,nM,3.0,IC50,nM,3.0,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CC3)NC(=O)NC4=O)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CCCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,3.0,IC50,nM,3.0,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CCCNC4=O)CC3)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CC3)CNC4=O)ccc21,CHEMBL4825780,=,=,IC50,nM,6.0,IC50,nM,6.0,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CC3)CNC4=O)ccc21,2021.0
Inhibition of tracer 236 binding to recombinant human His-tagged full length CDK8/Cyclin C expressed in baculovirus expression system by Lanthascreen assay,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CC3)CNC(=O)O4)ccc21,CHEMBL4825780,=,=,IC50,nM,7.0,IC50,nM,7.0,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CC3)CNC(=O)O4)ccc21,2021.0
Inhibition of human CDK8/cyclin C incubated for 2 hrs by [gamma-33P]-ATP assay,CC(=O)c1c(N2CCOCC2)c2ccc(Nc3nccc(-c4ccc5nn(C)c(C(C)C)c5c4)n3)cc2oc1=O,CHEMBL4828743,=,=,IC50,nM,20.1,IC50,nM,20.1,CC(=O)c1c(N2CCOCC2)c2ccc(Nc3nccc(-c4ccc5nn(C)c(C(C)C)c5c4)n3)cc2oc1=O,2021.0
Inhibition of human CDK8/cyclin C incubated for 2 hrs by [gamma-33P]-ATP assay,CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C,CHEMBL4828743,=,=,IC50,nM,1.0,IC50,nM,1.0,CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4831484,=,=,Inhibition,%,100.0,INH,%,100.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,NC(=O)/C=C/c1ccncc1Br,CHEMBL4831484,=,=,Inhibition,%,81.0,INH,%,81.0,NC(=O)/C=C/c1ccncc1Br,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CN1CCN(c2ccc(Nc3cnccc3/C=C/C(N)=O)cc2)CC1,CHEMBL4831484,=,=,Inhibition,%,75.0,INH,%,75.0,CN1CCN(c2ccc(Nc3cnccc3/C=C/C(N)=O)cc2)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,NC(=O)/C=C/c1ccncc1Nc1ccc(F)cc1,CHEMBL4831484,=,=,Inhibition,%,70.0,INH,%,70.0,NC(=O)/C=C/c1ccncc1Nc1ccc(F)cc1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CCOC(=O)/C=C/c1ccncc1-c1ccc2c(cnn2C)c1,CHEMBL4831484,=,=,Inhibition,%,100.0,INH,%,100.0,CCOC(=O)/C=C/c1ccncc1-c1ccc2c(cnn2C)c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CCOC(=O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,CHEMBL4831484,=,=,Inhibition,%,100.0,INH,%,100.0,CCOC(=O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CCOC(=O)/C=C/c1ccncc1-c1ccc2c(ccn2C)c1,CHEMBL4831484,=,=,Inhibition,%,100.0,INH,%,100.0,CCOC(=O)/C=C/c1ccncc1-c1ccc2c(ccn2C)c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CCOC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,CHEMBL4831484,=,=,Inhibition,%,104.0,INH,%,104.0,CCOC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CCOC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,102.0,INH,%,102.0,CCOC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,Cn1ncc2cc(-c3cnccc3/C=C/C(=O)O)ccc21,CHEMBL4831484,=,=,Inhibition,%,102.0,INH,%,102.0,Cn1ncc2cc(-c3cnccc3/C=C/C(=O)O)ccc21,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,CHEMBL4831484,=,=,Inhibition,%,102.0,INH,%,102.0,O=C(O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,Cn1ccc2cc(-c3cnccc3/C=C/C(=O)O)ccc21,CHEMBL4831484,=,=,Inhibition,%,102.0,INH,%,102.0,Cn1ccc2cc(-c3cnccc3/C=C/C(=O)O)ccc21,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,CHEMBL4831484,=,=,Inhibition,%,103.0,INH,%,103.0,O=C(O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,102.0,INH,%,102.0,O=C(O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc(F)cc2)C1,CHEMBL4831484,=,=,Inhibition,%,77.0,INH,%,77.0,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc(F)cc2)C1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CN1CCN(C(=O)/C=C/c2ccncc2-c2ccc(F)cc2)CC1,CHEMBL4831484,=,=,Inhibition,%,84.0,INH,%,84.0,CN1CCN(C(=O)/C=C/c2ccncc2-c2ccc(F)cc2)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,COc1ccc(-c2cnccc2/C=C/C(=O)N2CC(OC)C2)cc1OC,CHEMBL4831484,=,=,Inhibition,%,87.0,INH,%,87.0,COc1ccc(-c2cnccc2/C=C/C(=O)N2CC(OC)C2)cc1OC,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc3[nH]ncc3c2)C1,CHEMBL4831484,=,=,Inhibition,%,98.0,INH,%,98.0,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc3[nH]ncc3c2)C1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,Cn1ncc2cc(-c3cnccc3/C=C/C(=O)N3CCOCC3)ccc21,CHEMBL4831484,=,=,Inhibition,%,95.0,INH,%,95.0,Cn1ncc2cc(-c3cnccc3/C=C/C(=O)N3CCOCC3)ccc21,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)/C=C/c1ccncc1-c1ccc2c(cnn2C)c1,CHEMBL4831484,=,=,Inhibition,%,98.0,INH,%,98.0,CNC(=O)/C=C/c1ccncc1-c1ccc2c(cnn2C)c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,Cn1ncc2ccc(-c3cnccc3/C=C/C(=O)N3CCOCC3)cc21,CHEMBL4831484,=,=,Inhibition,%,89.0,INH,%,89.0,Cn1ncc2ccc(-c3cnccc3/C=C/C(=O)N3CCOCC3)cc21,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)/C=C/c1ccncc1-c1ccc2cnn(C)c2c1,CHEMBL4831484,=,=,Inhibition,%,99.0,INH,%,99.0,CNC(=O)/C=C/c1ccncc1-c1ccc2cnn(C)c2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(/C=C/c1ccncc1-c1ccc2[nH]ccc2c1)N1CCOCC1,CHEMBL4831484,=,=,Inhibition,%,97.0,INH,%,97.0,O=C(/C=C/c1ccncc1-c1ccc2[nH]ccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,CHEMBL4831484,=,=,Inhibition,%,100.0,INH,%,100.0,CNC(=O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,Cn1ccc2cc(-c3cnccc3/C=C/C(=O)N3CCOCC3)ccc21,CHEMBL4831484,=,=,Inhibition,%,97.0,INH,%,97.0,Cn1ccc2cc(-c3cnccc3/C=C/C(=O)N3CCOCC3)ccc21,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)/C=C/c1ccncc1-c1ccc2c(ccn2C)c1,CHEMBL4831484,=,=,Inhibition,%,99.0,INH,%,99.0,CNC(=O)/C=C/c1ccncc1-c1ccc2c(ccn2C)c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(/C=C/c1ccncc1-c1ccc2cc[nH]c2c1)N1CCOCC1,CHEMBL4831484,=,=,Inhibition,%,102.0,INH,%,102.0,O=C(/C=C/c1ccncc1-c1ccc2cc[nH]c2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,CHEMBL4831484,=,=,Inhibition,%,103.0,INH,%,103.0,CNC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(/C=C/c1ccncc1-c1ccc2ncccc2c1)N1CCOCC1,CHEMBL4831484,=,=,Inhibition,%,80.0,INH,%,80.0,O=C(/C=C/c1ccncc1-c1ccc2ncccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)/C=C/c1ccncc1-c1ccc2ncccc2c1,CHEMBL4831484,=,=,Inhibition,%,97.0,INH,%,97.0,CNC(=O)/C=C/c1ccncc1-c1ccc2ncccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(/C=C/c1ccncc1-c1ccc2cccnc2c1)N1CCOCC1,CHEMBL4831484,=,=,Inhibition,%,33.0,INH,%,33.0,O=C(/C=C/c1ccncc1-c1ccc2cccnc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)/C=C/c1ccncc1-c1ccc2cccnc2c1,CHEMBL4831484,=,=,Inhibition,%,82.0,INH,%,82.0,CNC(=O)/C=C/c1ccncc1-c1ccc2cccnc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,CHEMBL4831484,=,=,Inhibition,%,99.0,INH,%,99.0,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,101.0,INH,%,101.0,CNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)NC1CC1,CHEMBL4831484,=,=,Inhibition,%,102.0,INH,%,102.0,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)NC1CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)C1,CHEMBL4831484,=,=,Inhibition,%,100.0,INH,%,100.0,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)C1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CN1CCN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)CC1,CHEMBL4831484,=,=,Inhibition,%,101.0,INH,%,101.0,CN1CCN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CN(C)C(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,100.0,INH,%,100.0,CN(C)C(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(O)CCNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,91.0,INH,%,91.0,O=C(O)CCNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(O)[C@@H]1CCCN1C(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,67.0,INH,%,67.0,O=C(O)[C@@H]1CCCN1C(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CC(C)[C@@H](NC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1)C(=O)O,CHEMBL4831484,=,=,Inhibition,%,77.0,INH,%,77.0,CC(C)[C@@H](NC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1)C(=O)O,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,NC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,102.0,INH,%,102.0,NC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,COC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,102.0,INH,%,102.0,COC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(O)CCc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,101.0,INH,%,101.0,O=C(O)CCc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,COC(=O)CCc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,98.0,INH,%,98.0,COC(=O)CCc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)CCc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,100.0,INH,%,100.0,CNC(=O)CCc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(CCc1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,CHEMBL4831484,=,=,Inhibition,%,100.0,INH,%,100.0,O=C(CCc1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,NNC(=O)CCc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,102.0,INH,%,102.0,NNC(=O)CCc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(O)COc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,16.0,INH,%,16.0,O=C(O)COc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,COC(=O)COc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,11.0,INH,%,11.0,COC(=O)COc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,CNC(=O)COc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,4.0,INH,%,4.0,CNC(=O)COc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,O=C(COc1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,CHEMBL4831484,=,=,Inhibition,%,9.0,INH,%,9.0,O=C(COc1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) at 10 uM measured after 1 hr by plate reader assay relative to control,NNC(=O)COc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,Inhibition,%,19.0,INH,%,19.0,NNC(=O)COc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4831484,=,=,IC50,nM,100.0,IC50,nM,100.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4C)c2n1,CHEMBL4831484,=,=,IC50,nM,0.9,IC50,nM,0.9,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4C)c2n1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,NC(=O)/C=C/c1ccncc1Br,CHEMBL4831484,=,=,IC50,nM,2420.0,IC50,nM,2420.0,NC(=O)/C=C/c1ccncc1Br,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CN1CCN(c2ccc(Nc3cnccc3/C=C/C(N)=O)cc2)CC1,CHEMBL4831484,,,IC50,,,IC50,,,CN1CCN(c2ccc(Nc3cnccc3/C=C/C(N)=O)cc2)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,NC(=O)/C=C/c1ccncc1Nc1ccc(F)cc1,CHEMBL4831484,,,IC50,,,IC50,,,NC(=O)/C=C/c1ccncc1Nc1ccc(F)cc1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CCOC(=O)/C=C/c1ccncc1-c1ccc2c(cnn2C)c1,CHEMBL4831484,=,=,IC50,nM,101.8,IC50,nM,101.8,CCOC(=O)/C=C/c1ccncc1-c1ccc2c(cnn2C)c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CCOC(=O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,CHEMBL4831484,=,=,IC50,nM,107.4,IC50,nM,107.4,CCOC(=O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CCOC(=O)/C=C/c1ccncc1-c1ccc2c(ccn2C)c1,CHEMBL4831484,=,=,IC50,nM,144.1,IC50,nM,144.1,CCOC(=O)/C=C/c1ccncc1-c1ccc2c(ccn2C)c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CCOC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,CHEMBL4831484,=,=,IC50,nM,12.1,IC50,nM,12.1,CCOC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CCOC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,53.3,IC50,nM,53.3,CCOC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,Cn1ncc2cc(-c3cnccc3/C=C/C(=O)O)ccc21,CHEMBL4831484,=,=,IC50,nM,34.6,IC50,nM,34.6,Cn1ncc2cc(-c3cnccc3/C=C/C(=O)O)ccc21,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,CHEMBL4831484,=,=,IC50,nM,17.0,IC50,nM,17.0,O=C(O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,Cn1ccc2cc(-c3cnccc3/C=C/C(=O)O)ccc21,CHEMBL4831484,=,=,IC50,nM,26.8,IC50,nM,26.8,Cn1ccc2cc(-c3cnccc3/C=C/C(=O)O)ccc21,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,CHEMBL4831484,=,=,IC50,nM,2.4,IC50,nM,2.4,O=C(O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,5.0,IC50,nM,5.0,O=C(O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc(F)cc2)C1,CHEMBL4831484,,,IC50,,,IC50,,,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc(F)cc2)C1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CN1CCN(C(=O)/C=C/c2ccncc2-c2ccc(F)cc2)CC1,CHEMBL4831484,=,=,IC50,nM,1213.0,IC50,nM,1213.0,CN1CCN(C(=O)/C=C/c2ccncc2-c2ccc(F)cc2)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,COc1ccc(-c2cnccc2/C=C/C(=O)N2CC(OC)C2)cc1OC,CHEMBL4831484,=,=,IC50,nM,1215.0,IC50,nM,1215.0,COc1ccc(-c2cnccc2/C=C/C(=O)N2CC(OC)C2)cc1OC,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc3[nH]ncc3c2)C1,CHEMBL4831484,=,=,IC50,nM,146.4,IC50,nM,146.4,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc3[nH]ncc3c2)C1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,Cn1ncc2cc(-c3cnccc3/C=C/C(=O)N3CCOCC3)ccc21,CHEMBL4831484,=,=,IC50,nM,355.9,IC50,nM,355.9,Cn1ncc2cc(-c3cnccc3/C=C/C(=O)N3CCOCC3)ccc21,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)/C=C/c1ccncc1-c1ccc2c(cnn2C)c1,CHEMBL4831484,=,=,IC50,nM,86.7,IC50,nM,86.7,CNC(=O)/C=C/c1ccncc1-c1ccc2c(cnn2C)c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,Cn1ncc2ccc(-c3cnccc3/C=C/C(=O)N3CCOCC3)cc21,CHEMBL4831484,=,=,IC50,nM,853.1,IC50,nM,853.1,Cn1ncc2ccc(-c3cnccc3/C=C/C(=O)N3CCOCC3)cc21,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)/C=C/c1ccncc1-c1ccc2cnn(C)c2c1,CHEMBL4831484,=,=,IC50,nM,121.6,IC50,nM,121.6,CNC(=O)/C=C/c1ccncc1-c1ccc2cnn(C)c2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(/C=C/c1ccncc1-c1ccc2[nH]ccc2c1)N1CCOCC1,CHEMBL4831484,=,=,IC50,nM,190.2,IC50,nM,190.2,O=C(/C=C/c1ccncc1-c1ccc2[nH]ccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,CHEMBL4831484,=,=,IC50,nM,51.9,IC50,nM,51.9,CNC(=O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,Cn1ccc2cc(-c3cnccc3/C=C/C(=O)N3CCOCC3)ccc21,CHEMBL4831484,=,=,IC50,nM,247.0,IC50,nM,247.0,Cn1ccc2cc(-c3cnccc3/C=C/C(=O)N3CCOCC3)ccc21,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)/C=C/c1ccncc1-c1ccc2c(ccn2C)c1,CHEMBL4831484,=,=,IC50,nM,77.6,IC50,nM,77.6,CNC(=O)/C=C/c1ccncc1-c1ccc2c(ccn2C)c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(/C=C/c1ccncc1-c1ccc2cc[nH]c2c1)N1CCOCC1,CHEMBL4831484,=,=,IC50,nM,43.9,IC50,nM,43.9,O=C(/C=C/c1ccncc1-c1ccc2cc[nH]c2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,CHEMBL4831484,=,=,IC50,nM,18.6,IC50,nM,18.6,CNC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(/C=C/c1ccncc1-c1ccc2ncccc2c1)N1CCOCC1,CHEMBL4831484,=,=,IC50,nM,1588.0,IC50,nM,1588.0,O=C(/C=C/c1ccncc1-c1ccc2ncccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)/C=C/c1ccncc1-c1ccc2ncccc2c1,CHEMBL4831484,=,=,IC50,nM,250.0,IC50,nM,250.0,CNC(=O)/C=C/c1ccncc1-c1ccc2ncccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(/C=C/c1ccncc1-c1ccc2cccnc2c1)N1CCOCC1,CHEMBL4831484,,,IC50,,,IC50,,,O=C(/C=C/c1ccncc1-c1ccc2cccnc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)/C=C/c1ccncc1-c1ccc2cccnc2c1,CHEMBL4831484,=,=,IC50,nM,1761.0,IC50,nM,1761.0,CNC(=O)/C=C/c1ccncc1-c1ccc2cccnc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,CHEMBL4831484,=,=,IC50,nM,60.3,IC50,nM,60.3,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,12.4,IC50,nM,12.4,CNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)NC1CC1,CHEMBL4831484,=,=,IC50,nM,40.1,IC50,nM,40.1,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)NC1CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)C1,CHEMBL4831484,=,=,IC50,nM,42.8,IC50,nM,42.8,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)C1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CN1CCN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)CC1,CHEMBL4831484,=,=,IC50,nM,43.6,IC50,nM,43.6,CN1CCN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)CC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CN(C)C(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,30.1,IC50,nM,30.1,CN(C)C(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(O)CCNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,869.6,IC50,nM,869.6,O=C(O)CCNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(O)[C@@H]1CCCN1C(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,,,IC50,,,IC50,,,O=C(O)[C@@H]1CCCN1C(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CC(C)[C@@H](NC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1)C(=O)O,CHEMBL4831484,,,IC50,,,IC50,,,CC(C)[C@@H](NC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1)C(=O)O,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,NC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,10.5,IC50,nM,10.5,NC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,COC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,40.6,IC50,nM,40.6,COC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(O)CCc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,50.5,IC50,nM,50.5,O=C(O)CCc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,COC(=O)CCc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,258.6,IC50,nM,258.6,COC(=O)CCc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)CCc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,21.1,IC50,nM,21.1,CNC(=O)CCc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(CCc1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,CHEMBL4831484,=,=,IC50,nM,45.5,IC50,nM,45.5,O=C(CCc1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,NNC(=O)CCc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,=,=,IC50,nM,7.7,IC50,nM,7.7,NNC(=O)CCc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(O)COc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,,,IC50,,,IC50,,,O=C(O)COc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,COC(=O)COc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,,,IC50,,,IC50,,,COC(=O)COc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,CNC(=O)COc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,,,IC50,,,IC50,,,CNC(=O)COc1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,O=C(COc1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,CHEMBL4831484,,,IC50,,,IC50,,,O=C(COc1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) measured after 1 hr by plate reader assay,NNC(=O)COc1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,,,IC50,,,IC50,,,NNC(=O)COc1ccncc1-c1ccc2ccccc2c1,2021.0
CDK8_CYCLINC Invitrogen selectivity data (BI),CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1,CHEMBL4507276,,,% Ctrl,%,94.0,% Ctrl,%,94.0,CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1,2021.0
CDK8/cyclin C Kinase screen,C[C@@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1,CHEMBL4507291,,,Inhibition,%,8.751,% Inhibition,%,8.7512,C[C@@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1,2021.0
CDK8/CycC ProQinase selectivity panel,O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21,CHEMBL4507316,,,% Residual activity with Skepinone-L,%,105.0,% Residual activity with Skepinone-L,%,105.0,O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21,2021.0
CDK8/cyclinC Kinase panel,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,CHEMBL4879554,,,Inhibition,%,13.5,% Inhibition,%,13.5,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,2021.0
CDK8_CYCLINC Invitrogen Lab (UK) kinase screen (BI),CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12,CHEMBL4800722,,,% Ctrl,%,82.0,% Ctrl,%,82.0,CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-IRStide as substrate by radiometric assay,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,CHEMBL5241055,=,=,IC50,nM,12.0,IC50,nM,12.0,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-IRStide as substrate by radiometric assay,CCCNc1ncnc2ccc(Br)cc12,CHEMBL5241055,=,=,IC50,nM,6100.0,IC50,uM,6.1,CCCNc1ncnc2ccc(Br)cc12,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-IRStide as substrate by radiometric assay,N#Cc1ccc2ncnc(NCCc3ccc4ccccc4c3)c2c1,CHEMBL5241055,=,=,IC50,nM,740.0,IC50,uM,0.74,N#Cc1ccc2ncnc(NCCc3ccc4ccccc4c3)c2c1,2021.0
Inhibition of CDK8/Cyclin C (unknown origin) using RBER-IRStide as substrate by radiometric assay,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,CHEMBL5241055,=,=,IC50,nM,640.0,IC50,uM,0.64,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,2021.0
Inhibition of CDK8 at 3 uM,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1,CHEMBL1142492,<,<,Inhibition,%,10.0,INH,%,10.0,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1,2008.0
Binding affinity to human CDK8 at 5 uM,Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1,CHEMBL1136966,=,=,Activity,%,19.0,Activity,%,19.0,Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1,2009.0
Binding affinity to human CDK8 at 5 uM,Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1,CHEMBL1136966,=,=,Activity,%,2.0,Activity,%,2.0,Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1,2009.0
Binding constant for CDK8 kinase domain,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,CHEMBL1150977,=,=,Kd,nM,95.0,Kd,nM,95.0,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,2008.0
Binding constant for CDK8 kinase domain,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,2008.0
Binding constant for CDK8 kinase domain,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,CHEMBL1150977,=,=,Kd,nM,1.4,Kd,nM,1.4,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,2008.0
Binding constant for CDK8 kinase domain,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,2008.0
Binding constant for CDK8 kinase domain,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,CHEMBL1150977,=,=,Kd,nM,220.0,Kd,nM,220.0,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,2008.0
Binding constant for CDK8 kinase domain,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,CHEMBL1150977,=,=,Kd,nM,1200.0,Kd,nM,1200.0,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,2008.0
Binding constant for CDK8 kinase domain,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,2008.0
Binding constant for CDK8 kinase domain,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,2008.0
Binding constant for CDK8 kinase domain,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,2008.0
Binding constant for CDK8 kinase domain,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,2008.0
Binding constant for CDK8 kinase domain,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,CHEMBL1150977,=,=,Kd,nM,2300.0,Kd,nM,2300.0,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,2008.0
Binding constant for CDK8 kinase domain,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,2008.0
Binding constant for CDK8 kinase domain,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,2008.0
Binding constant for CDK8 kinase domain,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2008.0
Binding constant for CDK8 kinase domain,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,CHEMBL1150977,=,=,Kd,nM,120.0,Kd,nM,120.0,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,2008.0
Binding constant for CDK8 kinase domain,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,2008.0
Binding constant for CDK8 kinase domain,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,2008.0
Binding constant for CDK8 kinase domain,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,2008.0
Binding constant for CDK8 kinase domain,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,2008.0
Binding constant for CDK8 kinase domain,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,2008.0
Binding constant for CDK8 kinase domain,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2008.0
Binding constant for CDK8 kinase domain,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,2008.0
Binding constant for CDK8 kinase domain,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,2008.0
Binding constant for CDK8 kinase domain,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,2008.0
Binding constant for CDK8 kinase domain,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,2008.0
Binding constant for CDK8 kinase domain,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2008.0
Binding constant for CDK8 kinase domain,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,2008.0
Binding constant for CDK8 kinase domain,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,2008.0
Binding constant for CDK8 kinase domain,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2008.0
Binding constant for CDK8 kinase domain,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2008.0
Binding constant for CDK8 kinase domain,NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,2008.0
Binding constant for CDK8 kinase domain,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL1150977,=,=,Kd,nM,310.0,Kd,nM,310.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2008.0
Binding constant for CDK8 kinase domain,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL1150977,=,=,Kd,nM,510.0,Kd,nM,510.0,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2008.0
Binding constant for CDK8 kinase domain,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,2008.0
Binding constant for CDK8 kinase domain,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,2008.0
Binding constant for CDK8 kinase domain,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,2008.0
Binding constant for CDK8 kinase domain,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,2008.0
Binding constant for CDK8 kinase domain,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,2008.0
Inhibition of CDK8 assessed as enzyme activity at 1 uM relative to untreated control,Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl,CHEMBL1155237,=,=,Activity,%,100.0,Activity,%,100.0,Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl,2009.0
Inhibition of CDK8,Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21,CHEMBL1154951,=,=,Kd,nM,40000.0,Kd,uM,40.0,Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21,2010.0
Inhibition of CDK8 at 1 uM,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1,2010.0
Inhibition of CDK8 at 1 uM,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1,2010.0
Inhibition of CDK8 at 1 uM,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1,2010.0
Inhibition of CDK8 at 1 uM,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1,2010.0
Inhibition of CDK8 at 1 uM,FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21,2010.0
Inhibition of CDK8 at 1 uM,CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1,2010.0
Inhibition of CDK8 at 10 uM,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1,CHEMBL1177794,=,=,Inhibition,%,8.2,INH,%,8.2,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1,2010.0
Inhibition of CDK8 at 10 uM,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1,CHEMBL1177794,=,=,Inhibition,%,18.0,INH,%,18.0,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1,2010.0
Binding affinity to CDK8,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,CHEMBL1240346,>,>,Kd,nM,10000.0,Kd,uM,10.0,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,2009.0
Binding affinity to CDK8,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL1240346,>,>,Kd,nM,10000.0,Kd,uM,10.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2009.0
Binding affinity to CDK8,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL1240346,=,=,Kd,nM,310.0,Kd,nM,310.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2009.0
Binding affinity to CDK8,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,CHEMBL1240346,>,>,Kd,nM,10000.0,Kd,uM,10.0,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,2009.0
Binding affinity to CDK8,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,CHEMBL1240346,>,>,Kd,nM,10000.0,Kd,uM,10.0,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,2009.0
Binding affinity to CDK8,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,CHEMBL1240346,>,>,Kd,nM,10000.0,Kd,uM,10.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,2009.0
Binding affinity to CDK8,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,CHEMBL1240346,>,>,Kd,nM,10000.0,Kd,uM,10.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,2009.0
Binding affinity to human CDK8 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control,c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1,CHEMBL1782045,=,=,Activity,%,3.4,Activity,%,3.4,c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1,2011.0
Binding affinity to human CDK8 incubated for 1 hr by kinase binding assay,c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1,CHEMBL1782045,,,Kd,,,Kd,,,c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1,2011.0
Binding affinity to human CDK8 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control,CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1,CHEMBL1782045,>,>,Activity,%,50.0,Activity,%,50.0,CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1,2011.0
Binding affinity to human CDK8 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control,O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1,CHEMBL1782045,>,>,Activity,%,50.0,Activity,%,50.0,O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1,2011.0
Activity of CDK8 kinase at 1 uM,CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,CHEMBL1821651,=,=,Activity,%,91.0,Activity,%,91.0,CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,2011.0
Binding constant for CDK8 kinase domain,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,2011.0
Binding constant for CDK8 kinase domain,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,2011.0
Binding constant for CDK8 kinase domain,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,2011.0
Binding constant for CDK8 kinase domain,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2011.0
Binding constant for CDK8 kinase domain,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2011.0
Binding constant for CDK8 kinase domain,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2011.0
Binding constant for CDK8 kinase domain,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,2011.0
Binding constant for CDK8 kinase domain,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,2011.0
Binding constant for CDK8 kinase domain,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,2011.0
Binding constant for CDK8 kinase domain,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,2011.0
Binding constant for CDK8 kinase domain,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,2011.0
Binding constant for CDK8 kinase domain,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2011.0
Binding constant for CDK8 kinase domain,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,2011.0
Binding constant for CDK8 kinase domain,CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl,2011.0
Binding constant for CDK8 kinase domain,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2011.0
Binding constant for CDK8 kinase domain,Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,2011.0
Binding constant for CDK8 kinase domain,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,2011.0
Binding constant for CDK8 kinase domain,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2011.0
Binding constant for CDK8 kinase domain,COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1,2011.0
Binding constant for CDK8 kinase domain,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,CHEMBL1908390,=,=,Kd,nM,1900.0,Kd,nM,1900.0,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2011.0
Binding constant for CDK8 kinase domain,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,2011.0
Binding constant for CDK8 kinase domain,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,CHEMBL1908390,=,=,Kd,nM,130.0,Kd,nM,130.0,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,2011.0
Binding constant for CDK8 kinase domain,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,2011.0
Binding constant for CDK8 kinase domain,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,CHEMBL1908390,=,=,Kd,nM,6300.0,Kd,nM,6300.0,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,2011.0
Binding constant for CDK8 kinase domain,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,2011.0
Binding constant for CDK8 kinase domain,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,CHEMBL1908390,=,=,Kd,nM,3500.0,Kd,nM,3500.0,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,2011.0
Binding constant for CDK8 kinase domain,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,CHEMBL1908390,=,=,Kd,nM,220.0,Kd,nM,220.0,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,2011.0
Binding constant for CDK8 kinase domain,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,CHEMBL1908390,=,=,Kd,nM,120.0,Kd,nM,120.0,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,2011.0
Binding constant for CDK8 kinase domain,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2011.0
Binding constant for CDK8 kinase domain,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,CHEMBL1908390,=,=,Kd,nM,4500.0,Kd,nM,4500.0,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,2011.0
Binding constant for CDK8 kinase domain,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,2011.0
Binding constant for CDK8 kinase domain,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,2011.0
Binding constant for CDK8 kinase domain,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,2011.0
Binding constant for CDK8 kinase domain,OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1,2011.0
Binding constant for CDK8 kinase domain,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,2011.0
Binding constant for CDK8 kinase domain,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,2011.0
Binding constant for CDK8 kinase domain,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,2011.0
Binding constant for CDK8 kinase domain,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,CHEMBL1908390,=,=,Kd,nM,95.0,Kd,nM,95.0,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,2011.0
Binding constant for CDK8 kinase domain,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,CHEMBL1908390,=,=,Kd,nM,1200.0,Kd,nM,1200.0,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,2011.0
Binding constant for CDK8 kinase domain,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,2011.0
Binding constant for CDK8 kinase domain,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,2011.0
Binding constant for CDK8 kinase domain,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,2011.0
Binding constant for CDK8 kinase domain,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,2011.0
Binding constant for CDK8 kinase domain,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,2011.0
Binding constant for CDK8 kinase domain,COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,2011.0
Binding constant for CDK8 kinase domain,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,2011.0
Binding constant for CDK8 kinase domain,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,CHEMBL1908390,=,=,Kd,nM,8000.0,Kd,nM,8000.0,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,2011.0
Binding constant for CDK8 kinase domain,CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12,2011.0
Binding constant for CDK8 kinase domain,COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C,2011.0
Binding constant for CDK8 kinase domain,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2011.0
Binding constant for CDK8 kinase domain,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,2011.0
Binding constant for CDK8 kinase domain,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,2011.0
Binding constant for CDK8 kinase domain,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,2011.0
Binding constant for CDK8 kinase domain,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,2011.0
Binding constant for CDK8 kinase domain,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,CHEMBL1908390,=,=,Kd,nM,1.4,Kd,nM,1.4,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,2011.0
Binding constant for CDK8 kinase domain,C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,2011.0
Binding constant for CDK8 kinase domain,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,2011.0
Binding constant for CDK8 kinase domain,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,2011.0
Binding constant for CDK8 kinase domain,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,2011.0
Binding constant for CDK8 kinase domain,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,2011.0
Binding constant for CDK8 kinase domain,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2011.0
Binding constant for CDK8 kinase domain,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL1908390,=,=,Kd,nM,310.0,Kd,nM,310.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2011.0
Binding constant for CDK8 kinase domain,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,2011.0
Binding constant for CDK8 kinase domain,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,2011.0
Binding constant for CDK8 kinase domain,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,2011.0
Binding constant for CDK8 kinase domain,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,2011.0
Binding constant for CDK8 kinase domain,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL1908390,=,=,Kd,nM,510.0,Kd,nM,510.0,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2011.0
Binding constant for CDK8 kinase domain,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,2011.0
Binding constant for CDK8 kinase domain,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,2011.0
Binding constant for CDK8 kinase domain,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,2011.0
Binding constant for CDK8 kinase domain,CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1,2011.0
Binding constant for CDK8 kinase domain,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,2011.0
Inhibition of CDK8 assessed as residual activity at 10 uM relative to control,O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1,CHEMBL2203081,=,=,Activity,%,100.0,Activity,%,100.0,O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1,2012.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,2013.0
Inhibition of CDK8 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,CHEMBL2417377,<,<,Inhibition,%,35.0,INH,%,35.0,O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,2013.0
Competitive binding affinity to CDK8 (unknown origin) at 10 uM in presence of ATP relative to control,O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1,CHEMBL2424622,<,<,Inhibition,%,50.0,INH,%,50.0,O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1,2013.0
Competitive binding affinity to CDK8 (unknown origin) at 10 uM in presence of ATP relative to control,O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1,CHEMBL2424622,<,<,Inhibition,%,50.0,INH,%,50.0,O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1,2013.0
Competitive binding affinity to CDK8 (unknown origin) at 10 uM in presence of ATP relative to control,O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1,CHEMBL2424622,=,=,Inhibition,%,82.0,INH,%,82.0,O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1,2013.0
Inhibition of active state of CDK8 (unknown origin) at 1 uM,COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(Cl)c3)ccc2n1,CHEMBL3098110,,,Inhibition,%,,INH,,,COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(Cl)c3)ccc2n1,2014.0
Inhibition of CDK8 (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control,O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1,CHEMBL3108735,=,=,Activity,%,13.0,Activity,%,13.0,O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1,2014.0
Inhibition of CDK8 (unknown origin) at 1 uM relative to control,CCOC(=O)c1sc(-c2ccncc2)nc1O,CHEMBL3259739,=,=,Inhibition,%,82.0,INH,%,82.0,CCOC(=O)c1sc(-c2ccncc2)nc1O,2014.0
Inhibition of CDK8 (unknown origin) at 1 uM relative to control,NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl,CHEMBL3259739,=,=,Inhibition,%,97.0,INH,%,97.0,NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl,2014.0
Inhibition of CDK8 (unknown origin) at 1 uM relative to control,COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1,CHEMBL3259739,=,=,Inhibition,%,84.0,INH,%,84.0,COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1,2014.0
Inhibition of CDK8 (unknown origin),C[C@@H]1CN(C)CC[C@@H]1c1cc2c(cc1-c1ccccc1F)OCC1=NNC(=O)[C@@H](C)N12,CHEMBL3352406,,,Inhibition,%,,INH,,,C[C@@H]1CN(C)CC[C@@H]1c1cc2c(cc1-c1ccccc1F)OCC1=NNC(=O)[C@@H](C)N12,2015.0
Inhibition of CDK8 (unknown origin),C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4F)c([C@@H]4CCN(C)C[C@@H]4C)cc3N21,CHEMBL3352406,,,Inhibition,%,,INH,,,C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4F)c([C@@H]4CCN(C)C[C@@H]4C)cc3N21,2015.0
Inhibition of CDK8 (unknown origin),Cc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c(F)c1,CHEMBL3352406,,,Inhibition,%,,INH,,,Cc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c(F)c1,2015.0
Inhibition of CDK8 (unknown origin),COc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c(F)c1,CHEMBL3352406,,,Inhibition,%,,INH,,,COc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c(F)c1,2015.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(N)=O)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,270.0,IC50,uM,0.27,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(N)=O)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)NC5CC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,100.0,IC50,uM,0.1,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)NC5CC5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,25.0,IC50,uM,0.025,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC(O)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,94.0,IC50,uM,0.094,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC(O)C5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,COC1CN(C(=O)c2ccc3[nH]nc(Cc4ccc(-c5cnn(C)c5)cc4)c3c2)C1,CHEMBL3774357,=,=,IC50,nM,9.0,IC50,uM,0.009,COC1CN(C(=O)c2ccc3[nH]nc(Cc4ccc(-c5cnn(C)c5)cc4)c3c2)C1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCCC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,5.0,IC50,uM,0.005,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCCC5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCC(F)(F)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,27.0,IC50,uM,0.027,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCC(F)(F)C5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,11.0,IC50,uM,0.011,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCNCC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,140.0,IC50,uM,0.14,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCNCC5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCCCC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,13.0,IC50,uM,0.013,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCCCC5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CC[C@H](O)C5)cc34)ccc21,CHEMBL3774357,=,=,IC50,nM,43.0,IC50,uM,0.043,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CC[C@H](O)C5)cc34)ccc21,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CCC(F)(F)C5)cc34)ccc21,CHEMBL3774357,=,=,IC50,nM,56.0,IC50,uM,0.056,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CCC(F)(F)C5)cc34)ccc21,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CC(O)C5)cc34)ccc21,CHEMBL3774357,=,=,IC50,nM,160.0,IC50,uM,0.16,Cn1ncc2cc(Cc3n[nH]c4ccc(C(=O)N5CC(O)C5)cc34)ccc21,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,COC1CN(C(=O)c2ccc3[nH]nc(Cc4ccc5c(cnn5C)c4)c3c2)C1,CHEMBL3774357,=,=,IC50,nM,18.0,IC50,uM,0.018,COC1CN(C(=O)c2ccc3[nH]nc(Cc4ccc5c(cnn5C)c4)c3c2)C1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,CNC(=O)c1ccc2[nH]nc(CC(C)C)c2c1,CHEMBL3774357,>,>,IC50,nM,10000.0,IC50,uM,10.0,CNC(=O)c1ccc2[nH]nc(CC(C)C)c2c1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc(OC)c(OC)c3)c2c1,CHEMBL3774357,>,>,IC50,nM,10000.0,IC50,uM,10.0,CNC(=O)c1ccc2[nH]nc(Cc3ccc(OC)c(OC)c3)c2c1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,CNC(=O)c1ccc2[nH]nc(Cc3cccc(C)c3)c2c1,CHEMBL3774357,=,=,IC50,nM,1900.0,IC50,uM,1.9,CNC(=O)c1ccc2[nH]nc(Cc3cccc(C)c3)c2c1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc4cnn(C)c4c3)c2c1,CHEMBL3774357,=,=,IC50,nM,2000.0,IC50,uM,2.0,CNC(=O)c1ccc2[nH]nc(Cc3ccc4cnn(C)c4c3)c2c1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,CHEMBL3774357,=,=,IC50,nM,65.0,IC50,uM,0.065,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,2016.0
Inhibition of CDK8-dependent WNT signalling in human LS174T cells in absence of WNT ligand,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,CHEMBL3774357,=,=,IC50,nM,340.0,IC50,nM,340.0,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,2016.0
Inhibition of CDK8-dependent WNT signalling in human LS174T cells in presence of WNT3a ligand,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,CHEMBL3774357,=,=,IC50,nM,710.0,IC50,nM,710.0,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,2016.0
Inhibition of CDK8-mediated STAT1 phosphorylation at serine727 in human SW620 cells harboring APC mutant,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,CHEMBL3774357,=,=,IC50,nM,49.0,IC50,nM,49.0,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3774357,=,=,IC50,nM,55.0,IC50,uM,0.055,CNC(=O)c1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,CNC(=O)c1ccc2[nH]nc(Cc3ccc(-c4cnn(CC(C)(C)O)c4)cc3)c2c1,CHEMBL3774357,=,=,IC50,nM,76.0,IC50,uM,0.076,CNC(=O)c1ccc2[nH]nc(Cc3ccc(-c4cnn(CC(C)(C)O)c4)cc3)c2c1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cnc(-c2ccc3[nH]nc(Cc4ccc(-c5cnn(C)c5)cc4)c3c2)c1,CHEMBL3774357,=,=,IC50,nM,200.0,IC50,uM,0.2,Cn1cnc(-c2ccc3[nH]nc(Cc4ccc(-c5cnn(C)c5)cc4)c3c2)c1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(-c5nccn5C)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,1900.0,IC50,uM,1.9,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(-c5nccn5C)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(-c5cc(N)ccn5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,1500.0,IC50,uM,1.5,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(-c5cc(N)ccn5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,CC(=O)Nc1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3774357,=,=,IC50,nM,110.0,IC50,uM,0.11,CC(=O)Nc1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(NS(C)(=O)=O)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,710.0,IC50,uM,0.71,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(NS(C)(=O)=O)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(N5CCCC5=O)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,82.0,IC50,uM,0.082,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(N5CCCC5=O)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,CC(=O)NCCNc1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3774357,>,>,IC50,nM,10000.0,IC50,uM,10.0,CC(=O)NCCNc1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(N5CCOCC5)cc34)cc2)cn1,CHEMBL3774357,>,>,IC50,nM,30000.0,IC50,uM,30.0,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(N5CCOCC5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(S(=O)(=O)NC5CC5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,313.0,IC50,uM,0.313,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(S(=O)(=O)NC5CC5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@H](O)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,53.0,IC50,uM,0.053,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@H](O)C5)cc34)cc2)cn1,2016.0
Inhibition of CDK8 (unknown origin) expressed in 7dF3 clone of human HEK293 cells preincubated for 2 hrs followed by addition of beta-estradiol by luciferase assay,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,IC50,nM,42.0,IC50,uM,0.042,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(CCO)c3)cc1)CC2,CHEMBL3797072,=,=,IC50,nM,5.5,IC50,nM,5.5,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(CCO)c3)cc1)CC2,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CC(C)(O)Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,1.6,IC50,nM,1.6,CC(C)(O)Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN(C)CCn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,28.0,IC50,nM,28.0,CN(C)CCn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(CCN4CCCC4)c3)cc1)CC2,CHEMBL3797072,=,=,IC50,nM,26.9,IC50,nM,26.9,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(CCN4CCCC4)c3)cc1)CC2,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cc1nc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1C,CHEMBL3797072,=,=,IC50,nM,20.5,IC50,nM,20.5,Cc1nc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1C,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3)CC2,CHEMBL3797072,=,=,IC50,nM,2.4,IC50,nM,2.4,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3)CC2,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,2.4,IC50,nM,2.4,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,3.7,IC50,nM,3.7,CN1c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Nc1n[nH]c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,CHEMBL3797072,=,=,IC50,nM,1.7,IC50,nM,1.7,Nc1n[nH]c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)COC(=O)N4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,555.0,IC50,nM,555.0,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)COC(=O)N4)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,10.8,IC50,nM,10.8,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,2.3,IC50,nM,2.3,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)OC(=O)NC4(C)C)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,14.2,IC50,nM,14.2,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)OC(=O)NC4(C)C)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NCNC4=O)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,3.9,IC50,nM,3.9,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NCNC4=O)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,7.0,IC50,nM,7.0,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,2.4,IC50,nM,2.4,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CC1=NC2(CCN(c3c(Cl)cncc3-c3ccc4c(c3)CS(=O)(=O)N4C)CC2)C(=O)N1,CHEMBL3797072,=,=,IC50,nM,4.5,IC50,nM,4.5,CC1=NC2(CCN(c3c(Cl)cncc3-c3ccc4c(c3)CS(=O)(=O)N4C)CC2)C(=O)N1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)CNC4=O)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,4.2,IC50,nM,4.2,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)CNC4=O)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CC1=NNC(=O)C12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,CHEMBL3797072,=,=,IC50,nM,2.7,IC50,nM,2.7,CC1=NNC(=O)C12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)C(=O)NN=C4C(F)(F)F)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,12.0,IC50,nM,12.0,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)C(=O)NN=C4C(F)(F)F)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN(C)CCC1(C#N)CCN(c2c(Cl)cncc2-c2ccc3c(c2)CS(=O)(=O)N3C)CC1,CHEMBL3797072,=,=,IC50,nM,10.4,IC50,nM,10.4,CN(C)CCC1(C#N)CCN(c2c(Cl)cncc2-c2ccc3c(c2)CS(=O)(=O)N3C)CC1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,CHEMBL3797072,=,=,IC50,nM,37.4,IC50,nM,37.4,CN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,COCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,CHEMBL3797072,=,=,IC50,nM,702.0,IC50,nM,702.0,COCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,COCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,CHEMBL3797072,=,=,IC50,nM,49.2,IC50,nM,49.2,COCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,COCCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,CHEMBL3797072,=,=,IC50,nM,141.0,IC50,nM,141.0,COCCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CCCN4CCCS(C)(=O)=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,146.0,IC50,nM,146.0,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CCCN4CCCS(C)(=O)=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,79.3,IC50,nM,79.3,Cn1cc(-c2ccc(-c3cncc(F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cncc(F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,3.8,IC50,nM,3.8,CN1c2ccc(-c3cncc(F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,20.6,IC50,nM,20.6,Cn1cc(-c2ccc(-c3cncc(F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cncc(F)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,4.3,IC50,nM,4.3,CN1c2ccc(-c3cncc(F)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,14.7,IC50,nM,14.7,Cn1cc(-c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,3.3,IC50,nM,3.3,CN1c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,32.8,IC50,nM,32.8,Cn1cc(-c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,5.0,IC50,nM,5.0,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CC(C)(O)Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,16.4,IC50,nM,16.4,CC(C)(O)Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Nc1ncc(-c2ccc3c(N)n[nH]c3c2)c(N2CCC3(CCNC3=O)CC2)c1Cl,CHEMBL3797072,=,=,IC50,nM,2.1,IC50,nM,2.1,Nc1ncc(-c2ccc3c(N)n[nH]c3c2)c(N2CCC3(CCNC3=O)CC2)c1Cl,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,2.3,IC50,nM,2.3,CN1c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,9.5,IC50,nM,9.5,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,1.9,IC50,nM,1.9,CN1c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,2.8,IC50,nM,2.8,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cnc(N)c(F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,3.3,IC50,nM,3.3,CN1c2ccc(-c3cnc(N)c(F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1c2ccc(-c3cnc(N)c(F)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,5.5,IC50,nM,5.5,CN1c2ccc(-c3cnc(N)c(F)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cnc(N)c(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,9.3,IC50,nM,9.3,Cn1cc(-c2ccc(-c3cnc(N)c(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cnc(N)c(C(F)(F)F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,12.1,IC50,nM,12.1,Cn1cc(-c2ccc(-c3cnc(N)c(C(F)(F)F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CNc1n[nH]c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,CHEMBL3797072,=,=,IC50,nM,2.8,IC50,nM,2.8,CNc1n[nH]c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1nc(N)c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc21,CHEMBL3797072,=,=,IC50,nM,3.2,IC50,nM,3.2,Cn1nc(N)c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc21,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN(C)c1nn(C)c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,CHEMBL3797072,=,=,IC50,nM,47.0,IC50,nM,47.0,CN(C)c1nn(C)c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1C(=O)NC(=O)C12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,CHEMBL3797072,=,=,IC50,nM,17.5,IC50,nM,17.5,CN1C(=O)NC(=O)C12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CN1CNC(=O)C12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,CHEMBL3797072,=,=,IC50,nM,5.7,IC50,nM,5.7,CN1CNC(=O)C12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)C(=O)NCN4CC(F)(F)F)cc2)cn1,CHEMBL3797072,,,IC50,,,IC50,,,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)C(=O)NCN4CC(F)(F)F)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CC(C)n1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,29.5,IC50,nM,29.5,CC(C)n1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL3797072,=,=,IC50,nM,2.3,IC50,nM,2.3,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)ccc21,CHEMBL3797072,=,=,IC50,nM,11.4,IC50,nM,11.4,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)ccc21,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,CC(C)n1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL3797072,=,=,IC50,nM,54.1,IC50,nM,54.1,CC(C)n1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,2016.0
Binding affinity to His-tagged CDK8 (unknown origin) after 60 mins by FRET based lanthascreen binding assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,7.2,IC50,nM,7.2,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Inhibition of partial length wild type human CDK8 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control,CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F,CHEMBL3797029,=,=,Activity,%,85.0,Activity,%,85.0,CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F,2016.0
Inhibition of CDK8 in human HCT116 cells assessed as reduction in IFN-gamma-induced STAT1 phosphorylation at Ser727 at 2 uM after 24 hrs by immunoblot analysis,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(N)c2s1,CHEMBL3804775,,,Inhibition,%,,INH,,,NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(N)c2s1,2016.0
Inhibition of CDK8 (unknown origin),CC(=O)N1CCC(n2cc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)cn2)CC1,CHEMBL3822394,=,=,IC50,nM,42.0,IC50,uM,0.042,CC(=O)N1CCC(n2cc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)cn2)CC1,2016.0
Inhibition of CDK8 (unknown origin),Cc1nn(C2CCN(C(=O)[C@@H](C)O)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,CHEMBL3822394,=,=,IC50,nM,810.0,IC50,uM,0.81,Cc1nn(C2CCN(C(=O)[C@@H](C)O)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CNC(=O)c1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2n1,CHEMBL3826875,=,=,IC50,nM,0.2,IC50,nM,0.2,CNC(=O)c1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2n1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CNC(=O)c1ccc2cncc(-c3ccc4c(cnn4C)c3)c2n1,CHEMBL3826875,=,=,IC50,nM,3.4,IC50,nM,3.4,CNC(=O)c1ccc2cncc(-c3ccc4c(cnn4C)c3)c2n1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CNC(=O)c1ccc2cncc(-c3ccc4cnn(C)c4c3)c2n1,CHEMBL3826875,=,=,IC50,nM,4.6,IC50,nM,4.6,CNC(=O)c1ccc2cncc(-c3ccc4cnn(C)c4c3)c2n1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4C)c2n1,CHEMBL3826875,=,=,IC50,nM,1.7,IC50,nM,1.7,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4C)c2n1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4)c2n1,CHEMBL3826875,=,=,IC50,nM,11.2,IC50,nM,11.2,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4)c2n1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(N)=O)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,0.5,IC50,nM,0.5,Cn1cc(-c2ccc(-c3cncc4ccc(C(N)=O)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)O)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,590.0,IC50,nM,590.0,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)O)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(C#N)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,396.0,IC50,nM,396.0,Cn1cc(-c2ccc(-c3cncc4ccc(C#N)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,2.0,IC50,nM,2.0,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCC5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,COC1CN(C(=O)c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,CHEMBL3826875,=,=,IC50,nM,2.5,IC50,nM,2.5,COC1CN(C(=O)c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CC(F)(F)C5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,12.6,IC50,nM,12.6,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CC(F)(F)C5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,9.9,IC50,nM,9.9,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCCC5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCOCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,27.8,IC50,nM,27.8,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCOCC5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCNCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,65.0,IC50,nM,65.0,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CCNCC5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CC(=O)Nc1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2n1,CHEMBL3826875,=,=,IC50,nM,17.5,IC50,nM,17.5,CC(=O)Nc1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2n1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCCC5=O)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,30.0,IC50,nM,30.0,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCCC5=O)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCNC5=O)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,4.2,IC50,nM,4.2,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCNC5=O)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,COC1CN(c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,CHEMBL3826875,=,=,IC50,nM,1418.0,IC50,nM,1418.0,COC1CN(c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCOCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,2554.0,IC50,nM,2554.0,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCOCC5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ccnn5C)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,1946.0,IC50,nM,1946.0,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ccnn5C)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ccn(C)n5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,1232.0,IC50,nM,1232.0,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ccn(C)n5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ncco5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,45.0,IC50,nM,45.0,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ncco5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5nccn5C)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,4.7,IC50,nM,4.7,Cn1cc(-c2ccc(-c3cncc4ccc(-c5nccn5C)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CNC(=O)c1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3826875,=,=,IC50,nM,0.6,IC50,nM,0.6,CNC(=O)c1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)NC5CC5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,1.1,IC50,nM,1.1,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)NC5CC5)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,COC1CN(C(=O)c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,CHEMBL3826875,=,=,IC50,nM,16.0,IC50,nM,16.0,COC1CN(C(=O)c2ccc3cncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,19.4,IC50,nM,19.4,Cn1cc(-c2ccc(-c3cncc4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CC(=O)Nc1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3826875,=,=,IC50,nM,34.0,IC50,nM,34.0,CC(=O)Nc1ccc2cncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ncco5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,16.0,IC50,nM,16.0,Cn1cc(-c2ccc(-c3cncc4ccc(-c5ncco5)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(-c5nccn5C)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,7.3,IC50,nM,7.3,Cn1cc(-c2ccc(-c3cncc4ccc(-c5nccn5C)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCOC5=O)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,4.7,IC50,nM,4.7,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCOC5=O)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCCS5(=O)=O)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,87.0,IC50,nM,87.0,Cn1cc(-c2ccc(-c3cncc4ccc(N5CCCS5(=O)=O)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc4ccc(S(N)(=O)=O)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,43.0,IC50,nM,43.0,Cn1cc(-c2ccc(-c3cncc4ccc(S(N)(=O)=O)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCNCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,559.0,IC50,nM,559.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCNCC5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCOCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,73.0,IC50,nM,73.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCOCC5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,CHEMBL3826875,=,=,IC50,nM,7.2,IC50,nM,7.2,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,10.7,IC50,nM,10.7,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCC5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,COC1(C)CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,CHEMBL3826875,=,=,IC50,nM,8.2,IC50,nM,8.2,COC1(C)CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3n2)C1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(F)(F)C5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,5.8,IC50,nM,5.8,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(F)(F)C5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(C)(F)C5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,9.8,IC50,nM,9.8,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(C)(F)C5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCCC5)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,35.5,IC50,nM,35.5,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCCC5)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(-c5nccn5C)nc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,87.0,IC50,nM,87.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(-c5nccn5C)nc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCC5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,70.0,IC50,nM,70.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CCC5)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,CHEMBL3826875,=,=,IC50,nM,21.0,IC50,nM,21.0,COC1CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,COC1(C)CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,CHEMBL3826875,=,=,IC50,nM,23.1,IC50,nM,23.1,COC1(C)CN(C(=O)c2ccc3c(N)ncc(-c4ccc(-c5cnn(C)c5)cc4)c3c2)C1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,17.9,IC50,nM,17.9,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(F)(F)C5)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(C)(F)C5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,20.2,IC50,nM,20.2,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)N5CC(C)(F)C5)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CC(=O)Nc1ccc2c(N)ncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL3826875,=,=,IC50,nM,76.0,IC50,nM,76.0,CC(=O)Nc1ccc2c(N)ncc(-c3ccc(-c4cnn(C)c4)cc3)c2c1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)NC5CC5)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,9.0,IC50,nM,9.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(C(=O)NC5CC5)cc34)cc2)cn1,2016.0
Binding affinity to CDK8 (unknown origin) expressed in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(N5CCOC5=O)cc34)cc2)cn1,CHEMBL3826875,=,=,IC50,nM,24.0,IC50,nM,24.0,Cn1cc(-c2ccc(-c3cnc(N)c4ccc(N5CCOC5=O)cc34)cc2)cn1,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CCOc1ccccc1CNC(=O)c1nn2c(C)ncc2s1,CHEMBL3853318,=,=,IC50,nM,1650.0,IC50,nM,1650.0,CCOc1ccccc1CNC(=O)c1nn2c(C)ncc2s1,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CCOc1ccccc1C(C)NC(=O)c1nn2c(C)ncc2s1,CHEMBL3853318,=,=,IC50,nM,2450.0,IC50,nM,2450.0,CCOc1ccccc1C(C)NC(=O)c1nn2c(C)ncc2s1,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1ncc2sc(C(=O)N3CCCC3c3ccccc3)nn12,CHEMBL3853318,=,=,IC50,nM,415.0,IC50,nM,415.0,Cc1ncc2sc(C(=O)N3CCCC3c3ccccc3)nn12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1ncc2sc(C(=O)N3CCCC3c3ccc(F)cc3)nn12,CHEMBL3853318,=,=,IC50,nM,290.0,IC50,nM,290.0,Cc1ncc2sc(C(=O)N3CCCC3c3ccc(F)cc3)nn12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1ncc2sc(C(=O)N3CCCC3c3ccc(Cl)cc3)nn12,CHEMBL3853318,=,=,IC50,nM,100.0,IC50,nM,100.0,Cc1ncc2sc(C(=O)N3CCCC3c3ccc(Cl)cc3)nn12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1ncc2sc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)nn12,CHEMBL3853318,=,=,IC50,nM,70.0,IC50,nM,70.0,Cc1ncc2sc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)nn12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1ncc2sc(C(=O)N3CCC[C@@H]3c3ccc(Cl)cc3)nn12,CHEMBL3853318,=,=,IC50,nM,1600.0,IC50,nM,1600.0,Cc1ncc2sc(C(=O)N3CCC[C@@H]3c3ccc(Cl)cc3)nn12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,O=C(c1ccc2[nH]ncc2c1)N1CCC[C@H]1c1ccc(Cl)cc1,CHEMBL3853318,=,=,IC50,nM,100.0,IC50,nM,100.0,O=C(c1ccc2[nH]ncc2c1)N1CCC[C@H]1c1ccc(Cl)cc1,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,0.6,IC50,nM,0.6,Cc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1nnc2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cn12,CHEMBL3853318,>,>,IC50,nM,10000.0,IC50,nM,10000.0,Cc1nnc2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cn12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1ncc2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cn12,CHEMBL3853318,=,=,IC50,nM,90.0,IC50,nM,90.0,Cc1ncc2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cn12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,28.0,IC50,nM,28.0,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Br)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,19.0,IC50,nM,19.0,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Br)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(F)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,120.0,IC50,nM,120.0,Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(F)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Nc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(F)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,435.0,IC50,nM,435.0,Nc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(F)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Nc1n[nH]c2ccc(C(=O)N3CCCC[C@H]3c3ccc(F)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,800.0,IC50,nM,800.0,Nc1n[nH]c2ccc(C(=O)N3CCCC[C@H]3c3ccc(F)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Nc1n[nH]c2ccc(C(=O)N3CC[C@@H](c4ccc(Cl)cc4)C3)cc12,CHEMBL3853318,=,=,IC50,nM,150.0,IC50,nM,150.0,Nc1n[nH]c2ccc(C(=O)N3CC[C@@H](c4ccc(Cl)cc4)C3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,CNc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,12.0,IC50,nM,12.0,CNc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,2.0,IC50,nM,2.0,Cc1n[nH]c2ccc(C(=O)N3CC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1n[nH]c2ccc(C(=O)N3CCN(C)CC3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,230.0,IC50,nM,230.0,Cc1n[nH]c2ccc(C(=O)N3CCN(C)CC3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1n[nH]c2ccc(C(=O)N3CCOCC3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,115.0,IC50,nM,115.0,Cc1n[nH]c2ccc(C(=O)N3CCOCC3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1n[nH]c2cnc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,125.0,IC50,nM,125.0,Cc1n[nH]c2cnc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)nc12,CHEMBL3853318,=,=,IC50,nM,2.8,IC50,nM,2.8,Cc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)nc12,2016.0
Inhibition of CDK8 in human 7dF3 cells preincubated for 2 hrs followed by beta-oestradiol addition measured after 24 hrs by luciferase reporter gene assay,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,6.5,IC50,nM,6.5,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,8.0,IC50,nM,8.0,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human LS174T cells expressing beta-catenin mutant assessed as suppression of WNT pathway by luciferase reporter gene assay,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,32.0,IC50,nM,32.0,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human COLO205 cells expressing APC mutant assessed as suppression of WNT pathway by luciferase reporter gene assay,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,9.0,IC50,nM,9.0,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 in human PA1 cells assessed as suppression of WNT3a ligand-induced WNT pathway by luciferase reporter gene assay,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL3853318,=,=,IC50,nM,52.0,IC50,nM,52.0,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2016.0
Inhibition of CDK8 (unknown origin) after 60 mins by TR-FRET assay,CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1,CHEMBL4007384,>,>,IC50,nM,10000.0,IC50,uM,10.0,CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1,2016.0
Inhibition of CDK8 (unknown origin) after 60 mins by TR-FRET assay,FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12,CHEMBL4007384,>,>,IC50,nM,10000.0,IC50,uM,10.0,FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12,2016.0
Inhibition of CDK8 (unknown origin) after 60 mins by TR-FRET assay,FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12,CHEMBL4007384,=,=,IC50,nM,2110.0,IC50,uM,2.11,FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12,2016.0
Inhibition of CDK8 (unknown origin) after 60 mins by TR-FRET assay,CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21,CHEMBL4007384,>,>,IC50,nM,10000.0,IC50,uM,10.0,CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21,2016.0
Inhibition of CDK8 (unknown origin) after 60 mins by TR-FRET assay,Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12,CHEMBL4007384,>,>,IC50,nM,10000.0,IC50,uM,10.0,Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12,2016.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cnsc1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,EC50,nM,110.0,EC50,nM,110.0,O=C(/C=C/c1cnccc1-c1cnsc1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cncs1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,EC50,nM,140.0,EC50,nM,140.0,O=C(/C=C/c1cnccc1-c1cncs1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,COc1ncc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,CHEMBL4020708,=,=,EC50,nM,12.0,EC50,nM,12.0,COc1ncc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,COc1ccc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,CHEMBL4020708,=,=,EC50,nM,97.0,EC50,nM,97.0,COc1ccc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,NC(=O)c1ccc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,CHEMBL4020708,=,=,EC50,nM,690.0,EC50,nM,690.0,NC(=O)c1ccc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)s1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4020708,=,=,EC50,nM,13.0,EC50,nM,13.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cn[nH]c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,EC50,nM,21.0,EC50,nM,21.0,O=C(/C=C/c1cnccc1-c1cn[nH]c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1ccc2[nH]cnc2c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,EC50,nM,10.0,EC50,nM,10.0,O=C(/C=C/c1cnccc1-c1ccc2[nH]cnc2c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cnc2cc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)ccc21,CHEMBL4020708,>,>,EC50,nM,10000.0,EC50,nM,10000.0,Cn1cnc2cc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)ccc21,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cnc2ccc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)cc21,CHEMBL4020708,=,=,EC50,nM,2.4,EC50,nM,2.4,Cn1cnc2ccc(-c3ccncc3/C=C/C(=O)Nc3ccc(CN4CCOCC4)cc3)cc21,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,EC50,nM,11.0,EC50,nM,11.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cnn(C(F)F)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,EC50,nM,11.0,EC50,nM,11.0,O=C(/C=C/c1cnccc1-c1cnn(C(F)F)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cnn(CC(F)(F)F)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,EC50,nM,150.0,EC50,nM,150.0,O=C(/C=C/c1cnccc1-c1cnn(CC(F)(F)F)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cnn(Cc2ccccc2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,EC50,nM,28.0,EC50,nM,28.0,O=C(/C=C/c1cnccc1-c1cnn(Cc2ccccc2)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2cc(N)ncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4020708,=,=,EC50,nM,1300.0,EC50,nM,1300.0,Cn1cc(-c2cc(N)ncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccnc(O)c2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4020708,>,>,EC50,nM,10000.0,EC50,nM,10000.0,Cn1cc(-c2ccnc(O)c2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4020708,=,=,EC50,nM,3.6,EC50,nM,3.6,Cn1cc(-c2c(F)cncc2/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,EC50,nM,2.3,EC50,nM,2.3,O=C(/C=C/c1cncc(F)c1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccncc2/C=C/C(N)=O)cn1,CHEMBL4020708,>,>,EC50,nM,10000.0,EC50,nM,10000.0,Cn1cc(-c2ccncc2/C=C/C(N)=O)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccccc2)cn1,CHEMBL4020708,=,=,EC50,nM,110.0,EC50,nM,110.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccccc2)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,CC1COCCN1Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,CHEMBL4020708,=,=,EC50,nM,27.0,EC50,nM,27.0,CC1COCCN1Cc1ccc(NC(=O)/C=C/c2cnccc2-c2cnn(C)c2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,CC1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2)CCO1,CHEMBL4020708,=,=,EC50,nM,16.0,EC50,nM,16.0,CC1CN(Cc2ccc(NC(=O)/C=C/c3cnccc3-c3cnn(C)c3)cc2)CCO1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3C4CCC3COC4)cc2)cn1,CHEMBL4020708,=,=,EC50,nM,17.0,EC50,nM,17.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3C4CCC3COC4)cc2)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC4CC3CO4)cc2)cn1,CHEMBL4020708,=,=,EC50,nM,19.0,EC50,nM,19.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC4CC3CO4)cc2)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3CC2CO3)cc1,CHEMBL4020708,=,=,EC50,nM,3.1,EC50,nM,3.1,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3CC2CO3)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3CC(C2)O3)cc1,CHEMBL4020708,=,=,EC50,nM,5.5,EC50,nM,5.5,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC3CC(C2)O3)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCC(F)(F)C3)cc2)cn1,CHEMBL4020708,=,=,EC50,nM,17.0,EC50,nM,17.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CCC(F)(F)C3)cc2)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC(F)(F)C3)cc2)cn1,CHEMBL4020708,=,=,EC50,nM,84.0,EC50,nM,84.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc(CN3CC(F)(F)C3)cc2)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,CHEMBL4020708,=,=,EC50,nM,8.4,EC50,nM,8.4,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCN(CC(F)(F)F)C3)cn1,CHEMBL4020708,=,=,EC50,nM,7.0,EC50,nM,7.0,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CCN(CC(F)(F)F)C3)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CCN(CC(F)(F)F)C2,CHEMBL4020708,=,=,EC50,nM,14.0,EC50,nM,14.0,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc2c(c1)CCN(CC(F)(F)F)C2,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)(F)F)CC3)cn1,CHEMBL4020708,=,=,EC50,nM,8.4,EC50,nM,8.4,Cn1cc(-c2ccncc2/C=C/C(=O)Nc2ccc3c(c2)CN(CC(F)(F)F)CC3)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in STAT1 phosphorylation at Ser727 residues up to 30 nM after 1 day by Western blot method,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,CHEMBL4020708,,,Inhibition,%,,INH,,,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,2017.0
Inhibition of CDK8 in human EOL1 cells assessed as reduction in STAT1 phosphorylation at Ser727 residues up to 30 nM after 1 day by Western blot method,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,CHEMBL4020708,,,Inhibition,%,,INH,,,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,2017.0
Inhibition of CDK8 in human RPMI8226 cells assessed as reduction in STAT1 phosphorylation at Ser727 residues up to 30 nM after 1 day by Western blot method,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,CHEMBL4020708,,,Inhibition,%,,INH,,,O=C(/C=C/c1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CC(F)(F)C2)cc1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,Cn1cc(-c2ccncc2CCC(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,CHEMBL4020708,=,=,EC50,nM,95.0,EC50,nM,95.0,Cn1cc(-c2ccncc2CCC(=O)Nc2ccc(CN3CCOCC3)cc2)cn1,2017.0
Inhibition of CDK8 in human SW480 cells assessed as reduction in IFN-gamma induced STAT1 phosphorylation at Ser727 residues preincubated for 2 hrs followed by IFN-gamma addition measured after 1 hr by In-cell western assay,O=C(CCc1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,CHEMBL4020708,=,=,EC50,nM,130.0,EC50,nM,130.0,O=C(CCc1cnccc1-c1cnn(C2CC2)c1)Nc1ccc(CN2CCOCC2)cc1,2017.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1,CHEMBL4024706,=,=,Activity,%,100.0,Activity,%,100.0,C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1,2017.0
Binding affinity to partial length wild-type human CDK8 (M1 to T360residues) expressed in bacterial expression system by kinome scan assay,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,Kd,nM,46.0,Kd,nM,46.0,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 up to 30 nM after 1 day by Western blot method,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,,,Inhibition,%,,INH,,,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 induced beta-catenin transcriptional activity in human HCT116 cells by luciferase reporter gene assay,c1cc2cc(c1)-c1cnc3ccc(nn13)NCCCCCO2,CHEMBL4028808,=,=,EC50,nM,337.0,EC50,nM,337.0,c1cc2cc(c1)-c1cnc3ccc(nn13)NCCCCCO2,2017.0
Inhibition of CDK8 (unknown origin) at 1 uM by ADP-Glo assay,Brc1c(Br)c2c3c(nc(N4CCNCC4)n3CCC2)c1Br.Cl,CHEMBL4028808,=,=,Inhibition,%,96.0,INH,%,96.0,Brc1c(Br)c2c3c(nc(N4CCNCC4)n3CCC2)c1Br.Cl,2017.0
Inhibition of CDK8 in human A549 cells by mass spectrometric method,NC(=O)C[C@H]1CCc2sc3ncnc(O[C@H]4CC[C@H](N5CCOCC5)CC4)c3c21,CHEMBL4028808,=,=,IC50,nM,22.0,IC50,nM,22.0,NC(=O)C[C@H]1CCc2sc3ncnc(O[C@H]4CC[C@H](N5CCOCC5)CC4)c3c21,2017.0
Inhibition of CDK8 (unknown origin) assessed as reduction in RNAP2 C-terminal domain phosphorylation,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,CHEMBL4028808,=,=,IC50,nM,12.0,IC50,nM,12.0,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(N)=O)c2c1-c1c(cnn1C)CC2,CHEMBL4028808,=,=,EC50,nM,25.0,EC50,nM,25.0,CSc1sc(C(N)=O)c2c1-c1c(cnn1C)CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(N)=O)c2c1-c1nn(C)cc1CC2,CHEMBL4028808,>,>,EC50,nM,10000.0,EC50,nM,10000.0,CSc1sc(C(N)=O)c2c1-c1nn(C)cc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(N)=O)c2c1-c1[nH]ncc1CC2,CHEMBL4028808,=,=,EC50,nM,1300.0,EC50,nM,1300.0,CSc1sc(C(N)=O)c2c1-c1[nH]ncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(N)=O)c2c1-c1oncc1CC2,CHEMBL4028808,=,=,EC50,nM,200.0,EC50,nM,200.0,CSc1sc(C(N)=O)c2c1-c1oncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,8.9,EC50,nM,8.9,CSc1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(N)=O)c2c1-c1snnc1CC2,CHEMBL4028808,=,=,EC50,nM,550.0,EC50,nM,550.0,CSc1sc(C(N)=O)c2c1-c1snnc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(=O)O)c2c1-c1sncc1CC2,CHEMBL4028808,>,>,EC50,nM,10000.0,EC50,nM,10000.0,CSc1sc(C(=O)O)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C#N)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,490.0,EC50,nM,490.0,CSc1sc(C#N)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CNC(=O)c1sc(SC)c2c1CCc1cnsc1-2,CHEMBL4028808,=,=,EC50,nM,140.0,EC50,nM,140.0,CNC(=O)c1sc(SC)c2c1CCc1cnsc1-2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(=O)N(C)C)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,1700.0,EC50,nM,1700.0,CSc1sc(C(=O)N(C)C)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(=O)Nc2ccccc2)c2c1-c1sncc1CC2,CHEMBL4028808,>,>,EC50,nM,10000.0,EC50,nM,10000.0,CSc1sc(C(=O)Nc2ccccc2)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(=O)Nc2ccccn2)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,2800.0,EC50,nM,2800.0,CSc1sc(C(=O)Nc2ccccn2)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(=O)Nc2ccn(C)n2)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,1400.0,EC50,nM,1400.0,CSc1sc(C(=O)Nc2ccn(C)n2)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(=O)Nc2ccon2)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,890.0,EC50,nM,890.0,CSc1sc(C(=O)Nc2ccon2)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CSc1sc(C(=O)Nc2ccsn2)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,620.0,EC50,nM,620.0,CSc1sc(C(=O)Nc2ccsn2)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,C[S+]([O-])c1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,70.0,EC50,nM,70.0,C[S+]([O-])c1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CS(=O)(=O)c1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,220.0,EC50,nM,220.0,CS(=O)(=O)c1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,COc1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,9.1,EC50,nM,9.1,COc1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,NC(=O)c1sc(Oc2ccccc2)c2c1CCc1cnsc1-2,CHEMBL4028808,=,=,EC50,nM,0.77,EC50,nM,0.77,NC(=O)c1sc(Oc2ccccc2)c2c1CCc1cnsc1-2,2017.0
Inhibition of CDK8 in human MV411 cells assessed as decrease in STAT1 phosphorylation at Ser727 up to 30 nM after 1 day by Western blot method,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,,,Inhibition,%,,INH,,,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human Calu1 cells assessed as decrease in STAT1 phosphorylation at Ser727 up to 30 nM after 1 day by Western blot method,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,,,Inhibition,%,,INH,,,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human RPMI8226 cells assessed as decrease in STAT1 phosphorylation at Ser727 up to 30 nM after 1 day by Western blot method,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,,,Inhibition,%,,INH,,,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)c(C)n1,CHEMBL4028808,=,=,EC50,nM,0.35,EC50,nM,0.35,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)c(C)n1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CCOCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,EC50,nM,1.5,EC50,nM,1.5,CCOCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CC(C)(O)CNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,EC50,nM,7.4,EC50,nM,7.4,CC(C)(O)CNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,EC50,nM,1.3,EC50,nM,1.3,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CN(C)C(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,EC50,nM,21.0,EC50,nM,21.0,CN(C)C(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,NC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,EC50,nM,1.4,EC50,nM,1.4,NC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,EC50,nM,2.6,EC50,nM,2.6,CNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CC(=O)Nc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,EC50,nM,0.4,EC50,nM,0.4,CC(=O)Nc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,CNc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,EC50,nM,0.58,EC50,nM,0.58,CNc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,NC(=O)c1sc(Oc2ccc(N)nc2)c2c1CCc1cnsc1-2,CHEMBL4028808,=,=,EC50,nM,2.3,EC50,nM,2.3,NC(=O)c1sc(Oc2ccc(N)nc2)c2c1CCc1cnsc1-2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,Cc1c(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)ccc[n+]1[O-],CHEMBL4028808,=,=,EC50,nM,8.3,EC50,nM,8.3,Cc1c(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)ccc[n+]1[O-],2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,Cc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,EC50,nM,3.0,EC50,nM,3.0,Cc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,Cc1cncc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)c1,CHEMBL4028808,=,=,EC50,nM,28.0,EC50,nM,28.0,Cc1cncc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)c1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,Cc1ccncc1Oc1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,16.0,EC50,nM,16.0,Cc1ccncc1Oc1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Binding affinity to partial length wild-type human CDK8 (M1 to T360residues) expressed in bacterial expression system assessed as unbound drug level Kinomescan assay,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,CHEMBL4028808,=,=,Fu,,0.083,Fu,%,8.3,COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,Cc1ncccc1Oc1sc(C(N)=O)c2c1-c1sncc1CC2,CHEMBL4028808,=,=,EC50,nM,2.0,EC50,nM,2.0,Cc1ncccc1Oc1sc(C(N)=O)c2c1-c1sncc1CC2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,NC(=O)c1sc(Oc2cccnc2)c2c1CCc1cnsc1-2,CHEMBL4028808,=,=,EC50,nM,3.0,EC50,nM,3.0,NC(=O)c1sc(Oc2cccnc2)c2c1CCc1cnsc1-2,2017.0
Inhibition of CDK8 in human SW620 cells assessed as decrease in STAT1 phosphorylation at Ser727 after 2 hrs by Western blot method,NC(=O)c1sc(Oc2ccccn2)c2c1CCc1cnsc1-2,CHEMBL4028808,=,=,EC50,nM,66.0,EC50,nM,66.0,NC(=O)c1sc(Oc2ccccn2)c2c1CCc1cnsc1-2,2017.0
Inhibition of human CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control,CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1,CHEMBL4028866,=,=,Activity,%,0.0,Activity,%,0.0,CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1,2017.0
Inhibition of CDK8 Lysine 2 labelling site (unknown origin) at 10 uM,c1cc(-c2c[nH]c3cnccc23)ccn1,CHEMBL4033637,=,=,Inhibition,%,18.1,INH,%,18.1,c1cc(-c2c[nH]c3cnccc23)ccn1,2017.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control,COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl,CHEMBL4043093,=,=,Activity,%,85.0,Activity,%,85.0,COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl,2017.0
Inhibition of CDK8 labeling at conserved Lys2 (DLKPANILVMGEGPER) in human PBMC at 1 uM,CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1,CHEMBL4043168,=,=,Inhibition,%,1.5,INH,%,1.5,CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1,2017.0
Inhibition of CDK8 labeling at conserved Lys2 (DLKPANILVMGEGPER) in human PBMC at 0.1 uM,CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1,CHEMBL4043168,=,=,Inhibition,%,5.7,INH,%,5.7,CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1,2017.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N,CHEMBL4052645,=,=,Activity,%,100.0,Activity,%,100.0,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N,2017.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,CHEMBL4052645,=,=,Activity,%,86.0,Activity,%,86.0,COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,2017.0
Inhibition of CDK8 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPANILVMGEGPER probe by mass-spectrometric analysis relative to control,C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl,CHEMBL4118021,=,=,Inhibition,%,-48.5,INH,%,-48.5,C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl,2017.0
Inhibition of CDK8 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPANILVMGEGPER probe by mass-spectrometric analysis relative to control,C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl,CHEMBL4118021,=,=,Inhibition,%,-37.5,INH,%,-37.5,C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl,2017.0
Inhibition of CDK8 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPANILVMGEGPER probe by mass-spectrometric analysis relative to control,COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,CHEMBL4118021,=,=,Inhibition,%,-21.9,INH,%,-21.9,COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,2017.0
Induction of CDK8 degradation in human MOLT4 cells harboring CRBN deletion mutant at 0.1 to 5 uM measured after 24 hrs by immunoblot analysis,CN(C(=O)CCOCCOCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4145630,,,Activity,,,Activity,,,CN(C(=O)CCOCCOCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2018.0
Inhibition of CDK8 in human HepG2 cells assessed as reduction in IFNgamma-induced STAT1 phosphorylation at S727 measured after 18 hrs by Western blot analysis,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)C(c5ccc6ccncc6c5)=CCC24)C=C3[C@@H](O)[C@@H]1O,CHEMBL4145630,=,=,IC50,nM,17.0,IC50,nM,17.0,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)C(c5ccc6ccncc6c5)=CCC24)C=C3[C@@H](O)[C@@H]1O,2018.0
Inhibition of CDK8 in human HepG2 cells assessed as reduction in IFNgamma-induced STAT1 phosphorylation at S727 measured after 18 hrs by Western blot analysis,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)C(c5ccc6ccncc6c5)=CCC24)C=C3[C@@H](O)[C@@H]1O,CHEMBL4145630,,,Inhibition,%,,INH,,,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)C(c5ccc6ccncc6c5)=CCC24)C=C3[C@@H](O)[C@@H]1O,2018.0
Inhibition of CDK8 in human HepG2 cells assessed as reduction in IFNgamma-induced STAT1 phosphorylation at S727 measured after 18 hrs by Western blot analysis,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,CHEMBL4145630,,,Inhibition,%,,INH,,,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,2018.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,CHEMBL4145630,>,>,Inhibition,%,90.0,INH,%,90.0,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,2018.0
Inhibition of CDK8 (unknown origin),CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@@]2(C)C4CC[C@@H]2c2ccc4ccncc4c2)C=C3[C@@H](O)[C@@H]1O,CHEMBL4145630,=,=,IC50,nM,15.0,IC50,nM,15.0,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@@]2(C)C4CC[C@@H]2c2ccc4ccncc4c2)C=C3[C@@H](O)[C@@H]1O,2018.0
Inhibition of CDK8 (unknown origin),CN1C(=O)CCC(N2C(=O)c3cccc(NCCOCCOCCOCCOCCC(=O)N(C)[C@H]4CC[C@@]5(C)[C@@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](c7ccc8ccncc8c7)CC[C@@H]65)C4)c3C2=O)C1=O,CHEMBL4145630,=,=,IC50,nM,443.0,IC50,nM,443.0,CN1C(=O)CCC(N2C(=O)c3cccc(NCCOCCOCCOCCOCCC(=O)N(C)[C@H]4CC[C@@]5(C)[C@@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](c7ccc8ccncc8c7)CC[C@@H]65)C4)c3C2=O)C1=O,2018.0
Inhibition of CDK8 (unknown origin),CN(C(=O)CCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4145630,=,=,IC50,nM,192.0,IC50,nM,192.0,CN(C(=O)CCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2018.0
Inhibition of CDK8 (unknown origin),CN(C(=O)CCOCCOCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4145630,=,=,IC50,nM,159.0,IC50,nM,159.0,CN(C(=O)CCOCCOCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2018.0
Inhibition of CDK8 (unknown origin),CC(=O)N(C)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4145630,=,=,IC50,nM,34.0,IC50,nM,34.0,CC(=O)N(C)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](N3CCOCC3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,120.0,IC50,nM,120.0,C[C@]12CC[C@H](N3CCOCC3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](n3ccnn3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,24.0,IC50,nM,24.0,C[C@]12CC[C@H](n3ccnn3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,2018.0
Inhibition of CDK8 (unknown origin),CN[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4145630,=,=,IC50,nM,1320.0,IC50,nM,1320.0,CN[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2018.0
Inhibition of CDK8 (unknown origin),CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4145630,=,=,IC50,nM,64.0,IC50,nM,64.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2018.0
Inhibition of CDK8 (unknown origin),CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,CHEMBL4145630,=,=,IC50,nM,16.0,IC50,nM,16.0,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,2018.0
Inhibition of CDK8 (unknown origin),CN(C)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4145630,=,=,IC50,nM,24.0,IC50,nM,24.0,CN(C)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cnccc2c1,CHEMBL4145630,=,=,IC50,nM,6000.0,IC50,nM,6000.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cnccc2c1,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2c(N)n[nH]c2c1,CHEMBL4145630,=,=,IC50,nM,682.0,IC50,nM,682.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2c(N)n[nH]c2c1,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cn[nH]c2c1,CHEMBL4145630,=,=,IC50,nM,10000.0,IC50,nM,10000.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cn[nH]c2c1,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2[nH]ncc2c1,CHEMBL4145630,=,=,IC50,nM,10000.0,IC50,nM,10000.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2[nH]ncc2c1,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2nc(N)ncc2c1,CHEMBL4145630,=,=,IC50,nM,108.0,IC50,nM,108.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2nc(N)ncc2c1,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cnncc2c1,CHEMBL4145630,=,=,IC50,nM,10000.0,IC50,nM,10000.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cnncc2c1,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,208.0,IC50,nM,208.0,C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2ccncc2c1,CHEMBL4145630,=,=,IC50,nM,48.0,IC50,nM,48.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2ccncc2c1,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cnccc4c3)=CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,8240.0,IC50,nM,8240.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cnccc4c3)=CC[C@@H]12,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4c(N)n[nH]c4c3)=CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,1520.0,IC50,nM,1520.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4c(N)n[nH]c4c3)=CC[C@@H]12,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cn[nH]c4c3)=CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,10000.0,IC50,nM,10000.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cn[nH]c4c3)=CC[C@@H]12,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4[nH]ncc4c3)=CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,10000.0,IC50,nM,10000.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4[nH]ncc4c3)=CC[C@@H]12,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4nc(N)ncc4c3)=CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,2300.0,IC50,nM,2300.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4nc(N)ncc4c3)=CC[C@@H]12,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cnncc4c3)=CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,10000.0,IC50,nM,10000.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cnncc4c3)=CC[C@@H]12,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4ccncc4c3)=CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,1010.0,IC50,nM,1010.0,C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4ccncc4c3)=CC[C@@H]12,2018.0
Inhibition of CDK8 (unknown origin),C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4ccncc4c3)=CC[C@@H]12,CHEMBL4145630,=,=,IC50,nM,164.0,IC50,nM,164.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4ccncc4c3)=CC[C@@H]12,2018.0
Inhibition of human CDK8 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay,COc1ccc2c(c1)[nH]c1c(CO)nccc12,CHEMBL4145671,=,=,Activity,%,94.0,Activity,%,94.0,COc1ccc2c(c1)[nH]c1c(CO)nccc12,2018.0
Inhibition of human CDK8 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay,COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12,CHEMBL4145671,=,=,Activity,%,0.0,Activity,%,0.0,COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12,2018.0
Inhibition of human CDK8 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay,COc1ccc2c(c1)[nH]c1c(C)nccc12,CHEMBL4145671,=,=,Activity,%,55.0,Activity,%,55.0,COc1ccc2c(c1)[nH]c1c(C)nccc12,2018.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control,Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1,CHEMBL4152344,=,=,Activity,%,99.0,Activity,%,99.0,Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1,2018.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control,CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,CHEMBL4184148,=,=,Activity,%,100.0,Activity,%,100.0,CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,2017.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control,C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,CHEMBL4184148,=,=,Activity,%,78.0,Activity,%,78.0,C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,2017.0
Inhibition of CDK8 (unknown origin),CC1CCc2nc(N)c(C#N)c(-c3cccnc3)c2C1,CHEMBL4219051,=,=,IC50,nM,500.0,IC50,nM,500.0,CC1CCc2nc(N)c(C#N)c(-c3cccnc3)c2C1,2018.0
Inhibition of CDK8 (unknown origin),CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4219051,=,=,IC50,nM,199.0,IC50,nM,199.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2018.0
Inhibition of CDK8 (unknown origin) expressed in human 7dF3 cells harboring TCF/LEF WNT-reporter assessed as inhibition of Wnt pathway after 24 hrs by luciferase reporter gene assay,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4219051,=,=,IC50,nM,1620.0,IC50,uM,1.62,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2018.0
Inhibition of CDK8 in human LS174T cells harboring TCF/LEF WNT-reporter assessed as inhibition of Wnt pathway after 24 hrs by luciferase reporter gene assay,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4219051,=,=,IC50,nM,4520.0,IC50,uM,4.52,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2018.0
Inhibition of CDK8 (unknown origin),Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,CHEMBL4219051,=,=,IC50,nM,14.0,IC50,nM,14.0,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,2018.0
Inhibition of CDK8 (unknown origin) expressed in human 7dF3 cells harboring TCF/LEF WNT-reporter assessed as inhibition of Wnt pathway after 24 hrs by luciferase reporter gene assay,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,CHEMBL4219051,=,=,IC50,nM,1290.0,IC50,uM,1.29,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,2018.0
Inhibition of CDK8 in human LS174T cells harboring TCF/LEF WNT-reporter assessed as inhibition of Wnt pathway after 24 hrs by luciferase reporter gene assay,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,CHEMBL4219051,=,=,IC50,nM,5170.0,IC50,uM,5.17,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,2018.0
Inhibition of CDK8 (unknown origin),CCN1CCN(Cc2ccc(NC(=O)N[C@@H]3CCN(c4ccnc(NC)n4)C3)cc2C(F)(F)F)CC1,CHEMBL4219051,=,=,IC50,nM,17.4,IC50,nM,17.4,CCN1CCN(Cc2ccc(NC(=O)N[C@@H]3CCN(c4ccnc(NC)n4)C3)cc2C(F)(F)F)CC1,2018.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1,CHEMBL4229344,=,=,Activity,%,90.0,Activity,%,90.0,Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1,2018.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,CHEMBL4261600,=,=,Activity,%,100.0,Activity,%,100.0,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,2018.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control,CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl,CHEMBL4304811,=,=,Activity,%,100.0,Activity,%,100.0,CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl,2019.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N,CHEMBL4330132,=,=,Activity,%,84.0,Activity,%,84.0,CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N,2019.0
Inhibition of CDK8 in human SW620 cells assessed as reduction in STAT1 phosphorylation at Ser727 residue at 5 to 30 uM after 24 hrs by Western blot analysis,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL4330136,,,Inhibition,%,,INH,,,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2019.0
Inhibition of CDK8 in human SW620 cells assessed as reduction in STAT1 phosphorylation at Ser727 residue at 5 to 30 uM after 24 hrs by Western blot analysis,COc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCCC2)cc1,CHEMBL4330136,,,Inhibition,%,,INH,,,COc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCCC2)cc1,2019.0
Inhibition of CDK8 in human HCT116 cells assessed as reduction in STAT1 phosphorylation at Ser727 residue after 24 hrs by Western blot analysis,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL4330136,,,Inhibition,%,,INH,,,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2019.0
Inhibition of CDK8 in human HCT116 cells assessed as reduction in STAT1 phosphorylation at Ser727 residue after 24 hrs by Western blot analysis,COc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCCC2)cc1,CHEMBL4330136,,,Inhibition,%,,INH,,,COc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCCC2)cc1,2019.0
Inhibition of CDK8 in human HCC38 cells assessed as reduction in S6 phosphorylation after 24 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human HCC38 cells assessed as reduction in STAT3 phosphorylation after 24 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human HCC38 cells assessed as reduction in AXL expression after 24 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human HCC38 cells assessed as reduction in STAT1 phosphorylation at Ser727 residue after 24 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human MDA-MB-231 cells assessed as reduction in S6 phosphorylation after 24 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human MDA-MB-231 cells assessed as reduction in STAT3 phosphorylation after 24 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human MDA-MB-231 cells assessed as reduction in AXL expression after 24 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human MDA-MB-231 cells assessed as reduction in STAT1 phosphorylation at Ser727 residue after 24 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human HCC38 cells assessed as increase in P27 expression at 10 uM after 24 hrs by RT-PCR analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human HCC38 cells assessed as reduction in HK1 expression at 10 uM after 24 hrs by RT-PCR analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human MDA-MB-231 cells assessed as increase in P27 expression at 10 uM after 24 hrs by RT-PCR analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human MDA-MB-231 cells assessed as reduction in HK1 expression at 10 uM after 24 hrs by RT-PCR analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human HCC38 cells assessed as increase in P27 expression after 48 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human HCC38 cells assessed as reduction in skp2 expression after 48 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human MDA-MB-231 cells assessed as increase in P27 expression after 48 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 in human MDA-MB-231 cells assessed as reduction in skp2 expression after 48 hrs by Western blot analysis,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,CHEMBL4334510,,,Inhibition,%,,INH,,,COc1cc(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/c4ccc(O)cc4)O[C@H](COC(=O)/C=C/c4ccc(O)cc4)[C@@H](O)[C@@H]3OC(=O)/C=C/c3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,2019.0
Inhibition of CDK8 (unknown origin),CC(=O)c1ccc2cncc(N3CCN(c4ccc5cnn(C)c5c4)CC3)c2c1,CHEMBL4334547,,,Inhibition,%,,INH,,,CC(=O)c1ccc2cncc(N3CCN(c4ccc5cnn(C)c5c4)CC3)c2c1,2020.0
Inhibition of CDK8 (unknown origin),CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4C)c2n1,CHEMBL4334547,=,=,IC50,nM,0.9,IC50,nM,0.9,CNC(=O)c1ccc2cncc(-c3ccc4c(c3)CS(=O)(=O)N4C)c2n1,2020.0
Binding affinity to CDK8 (unknown origin),Cc1nc(CC(=O)N2CCN(c3cncc4ccccc34)CC2)co1,CHEMBL4334547,=,=,Kd,nM,600.0,Kd,nM,600.0,Cc1nc(CC(=O)N2CCN(c3cncc4ccccc34)CC2)co1,2020.0
Binding affinity to CDK8 (unknown origin),Cn1ncc2ccc(N3CCN(c4cncc5ccccc45)CC3)cc21,CHEMBL4334547,=,=,Kd,nM,30.0,Kd,nM,30.0,Cn1ncc2ccc(N3CCN(c4cncc5ccccc45)CC3)cc21,2020.0
Binding affinity to CDK8 (unknown origin),CC(=O)c1ccc2cncc(N3CCN(c4ccc5cnn(C)c5c4)CC3)c2c1,CHEMBL4334547,=,=,Kd,nM,32.0,Kd,nM,32.0,CC(=O)c1ccc2cncc(N3CCN(c4ccc5cnn(C)c5c4)CC3)c2c1,2020.0
Binding affinity to CDK8 (unknown origin),CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1,CHEMBL4334547,=,=,Kd,nM,0.77,Kd,nM,0.77,CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1,2020.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl,CHEMBL4354843,=,=,Activity,%,100.0,Activity,%,100.0,C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl,2020.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control,O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1,CHEMBL4364269,=,=,Activity,%,82.0,Activity,%,82.0,O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1,2019.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system measured after 1 hr by kinomescan method,O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1,CHEMBL4373706,=,=,Kd,nM,8020.0,Kd,uM,8.02,O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1,2019.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,CHEMBL4382192,=,=,Activity,%,90.0,Activity,%,90.0,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,2017.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control,O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1,CHEMBL4387741,=,=,Inhibition,%,53.0,INH,%,53.0,O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1,2019.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control,O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1,CHEMBL4387741,=,=,Inhibition,%,84.0,INH,%,84.0,O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1,2019.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,CHEMBL4390652,=,=,Activity,%,64.0,Activity,%,64.0,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,2019.0
Competitive reversible inhibition of CDK8 (unknown origin),CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12,CHEMBL4406837,=,=,IC50,nM,1200.0,IC50,nM,1200.0,CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12,2019.0
Competitive reversible inhibition of CDK8 (unknown origin),CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12,CHEMBL4406837,=,=,IC50,nM,90.0,IC50,nM,90.0,CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12,2019.0
Competitive reversible inhibition of CDK8 (unknown origin),CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12,CHEMBL4406837,=,=,IC50,nM,4200.0,IC50,nM,4200.0,CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12,2019.0
Binding affinity to wild-type partial length human CDK8 (M1 to T360 residues) expressed in bacterial expression system by Kinomescan assay,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,CHEMBL4411304,=,=,Kd,nM,17.0,Kd,nM,17.0,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,2019.0
Inhibition of CDK8 (unknown origin),Cc1c(Br)c(Br)c2c3c1nc(N1CCNCC1)n3CCC2.Cl,CHEMBL4411304,=,=,IC50,nM,4.4,IC50,nM,4.4,Cc1c(Br)c(Br)c2c3c1nc(N1CCNCC1)n3CCC2.Cl,2019.0
Binding affinity to wild-type partial length human CDK8 (M1 to T360 residues) expressed in bacterial expression system by Kinomescan assay,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,CHEMBL4411304,=,=,Kd,nM,2300.0,Kd,nM,2300.0,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,2019.0
Binding affinity to wild-type partial length human CDK8 (M1 to T360 residues) expressed in bacterial expression system by Kinomescan assay,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,CHEMBL4411304,=,=,Kd,nM,830.0,Kd,nM,830.0,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,2019.0
Inhibition of CDK8 in IFN-gamma-induced human HCT116 cells assessed as suppression of STAT1 phosphorylation at serine727 residue incubated for 24 hrs by infrared scanning analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,>,>,IC50,nM,10000.0,IC50,uM,10.0,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)C2)n1,2016.0
Inhibition of CDK8 in IFN-gamma-induced human HCT116 cells assessed as suppression of STAT1 phosphorylation at serine727 residue incubated for 24 hrs by infrared scanning analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,=,=,IC50,nM,4200.0,IC50,uM,4.2,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)C2)n1,2016.0
Inhibition of CDK8 in IFN-gamma-induced human HCT116 cells assessed as suppression of STAT1 phosphorylation at serine727 residue incubated for 24 hrs by infrared scanning analysis,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCOCC4)c(C(F)(F)F)c3)C2)n1,CHEMBL4425119,>,>,IC50,nM,10000.0,IC50,uM,10.0,CNc1nccc(N2CC[C@H](NC(=O)Nc3ccc(CN4CCOCC4)c(C(F)(F)F)c3)C2)n1,2016.0
Inhibition of CDK8 in IFN-gamma-induced human HCT116 cells assessed as suppression of STAT1 phosphorylation at serine727 residue incubated for 24 hrs by infrared scanning analysis,CCN1CCN(Cc2ccc(NC(=O)N[C@H]3CCN(c4ccnc(NC)n4)C3)cc2C(F)(F)F)CC1,CHEMBL4425119,=,=,IC50,nM,4000.0,IC50,uM,4.0,CCN1CCN(Cc2ccc(NC(=O)N[C@H]3CCN(c4ccnc(NC)n4)C3)cc2C(F)(F)F)CC1,2016.0
Binding affinity to human CDK8,CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C,CHEMBL4425136,>,>,Kd,nM,1000.0,Kd,nM,1000.0,CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C,2016.0
Inhibition of human CDK8,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,CHEMBL4602604,<,<,IC50,nM,1000.0,IC50,uM,1.0,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,2019.0
Inhibition of CDK8 (unknown origin),Cc1cc(NC2CCN(C(=O)O[C@H]3CCN(C(=O)/C=C/CN(C)C)C3)CC2)n2ncc(C(C)C)c2n1,CHEMBL4610077,>,>,IC50,nM,8000.0,IC50,uM,8.0,Cc1cc(NC2CCN(C(=O)O[C@H]3CCN(C(=O)/C=C/CN(C)C)C3)CC2)n2ncc(C(C)C)c2n1,2020.0
Inhibition of CDK8 (unknown origin),CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1,CHEMBL4610077,=,=,IC50,nM,194.0,IC50,nM,194.0,CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1,2020.0
Inhibition of CDK8 (unknown origin),CN(C)[C@H]1C[C@@]23CC[C@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,CHEMBL4613207,=,=,IC50,nM,12.0,IC50,nM,12.0,CN(C)[C@H]1C[C@@]23CC[C@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6ccncc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,2019.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual binding level at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Activity,%,18.0,Activity,%,18.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual binding level at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cncc(Cl)c4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Activity,%,0.0,Activity,%,0.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cncc(Cl)c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual binding level at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccncc4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Activity,%,49.0,Activity,%,49.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccncc4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual binding level at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cncc5ccccc45)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Activity,%,4.3,Activity,%,4.3,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cncc5ccccc45)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual binding level at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5cnccc45)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Activity,%,0.0,Activity,%,0.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5cnccc45)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual binding level at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5cnccc5c4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Activity,%,7.3,Activity,%,7.3,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5cnccc5c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual binding level at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Activity,%,0.0,Activity,%,0.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual binding level at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5[nH]ccc45)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Activity,%,68.0,Activity,%,68.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5[nH]ccc45)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual binding level at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5[nH]ccc5c4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Activity,%,100.0,Activity,%,100.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5[nH]ccc5c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 assessed as residual binding level at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5cc[nH]c5c4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Activity,%,83.0,Activity,%,83.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5cc[nH]c5c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Kd,nM,41.0,Kd,nM,41.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cncc(Cl)c4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Kd,nM,13.0,Kd,nM,13.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cncc(Cl)c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccncc4)=CC[C@@H]32)C1,CHEMBL4619723,,,Kd,,,Kd,,,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccncc4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cncc5ccccc45)=CC[C@@H]32)C1,CHEMBL4619723,,,Kd,,,Kd,,,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cncc5ccccc45)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5cnccc45)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Kd,nM,3.5,Kd,nM,3.5,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5cnccc45)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5cnccc5c4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Kd,nM,45.0,Kd,nM,45.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5cnccc5c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,CHEMBL4619723,=,=,Kd,nM,18.0,Kd,nM,18.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5[nH]ccc45)=CC[C@@H]32)C1,CHEMBL4619723,,,Kd,,,Kd,,,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5[nH]ccc45)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5[nH]ccc5c4)=CC[C@@H]32)C1,CHEMBL4619723,,,Kd,,,Kd,,,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5[nH]ccc5c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5cc[nH]c5c4)=CC[C@@H]32)C1,CHEMBL4619723,,,Kd,,,Kd,,,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5cc[nH]c5c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cncc(Cl)c4)=CC[C@@H]32)C1,CHEMBL4619723,>,>,Inhibition,%,80.0,INH,%,80.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cncc(Cl)c4)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5cnccc45)=CC[C@@H]32)C1,CHEMBL4619723,>,>,Inhibition,%,80.0,INH,%,80.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccc5cnccc45)=CC[C@@H]32)C1,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 at 50 nM measured after 1 hr by kinomescan assay relative to control,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,CHEMBL4619723,>,>,Inhibition,%,80.0,INH,%,80.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,2020.0
Binding affinity to CDK8 (unknown origin),CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6cnccc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,CHEMBL4619723,=,=,Kd,nM,17.0,Kd,nM,17.0,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6cnccc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,2020.0
Inhibition of biotinylated ligand binding to wild-type human partial length CDK8 (M1 to T360 residues) expressed in Escherichia coli BL21 measured after 1 hr by kinomescan assay,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6cnccc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,CHEMBL4619723,=,=,Kd,nM,17.0,Kd,nM,17.0,CN(C)[C@H]1C[C@@]23CC[C@@]4(O2)C(=CC[C@]2(C)[C@@H](c5ccc6cnccc6c5)CC[C@H]24)C=C3[C@@H](O)[C@@H]1O,2020.0
Inhibition of CDK8 (unknown origin) at 1 uM,O=C(Nc1ccccc1)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1Cc1ccccc1,CHEMBL4673362,,,Inhibition,%,,INH,,,O=C(Nc1ccccc1)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1Cc1ccccc1,2021.0
Inhibition of CDK8 (unknown origin) by TR-FRET assay,COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(O)CO)CC3)cc12,CHEMBL4699469,>,>,IC50,nM,1360.0,IC50,uM,1.36,COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(O)CO)CC3)cc12,2020.0
Inhibition of CDK8 (unknown origin) by TR-FRET assay,COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)cc12,CHEMBL4699469,>,>,IC50,nM,320.0,IC50,uM,0.32,COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)cc12,2020.0
Displacement of polymer supported probe 25 binding to CDK8 in human THP-1 cell lysates preincubated for 45 mins under shaking condition followed by probe addition and measured after 30 mins by mass spectrometry based chemoproteomic analysis,CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CCN6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)CC4)CC3)c12,CHEMBL4725370,=,=,Kd,nM,1400.0,Kd(app),uM,1.4,CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CCN6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)CC4)CC3)c12,2020.0
Inhibition of human partial length CDK8 (M1 to T360 residues) expressed in bacterial system assessed as residual activity at 10 uM by kinome scan method relative to control,COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,CHEMBL4732196,=,=,Activity,%,96.0,Activity,%,96.0,COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,2021.0
Inhibition of CDK8 in human MV4-11 cells assessed as reduction in STAT1 phosphorylation at s727 residues at 1 to 5 times of GI50 concentration after 2 hrs by Western blot analysis,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL4732199,,,Inhibition,%,,INH,,,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2021.0
Inhibition of CDK8 in human MV4-11 cells assessed as reduction in STAT1 phosphorylation at s727 residues at 1 to 5 times of GI50 concentration after 2 hrs by Western blot analysis,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2,CHEMBL4732199,,,Inhibition,%,,INH,,,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2,2021.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in IFNgamma-induced STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CCn1c(C(N)=O)c(-c2ccccc2OC)c2c1-c1ccncc1OC2(C)C,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,CCn1c(C(N)=O)c(-c2ccccc2OC)c2c1-c1ccncc1OC2(C)C,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in IFNgamma-induced STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCCCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCCCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in IFNgamma-induced STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,NC(=O)c1cc2c([nH]1)-c1ccncc1O[C@H]2C1CCCCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,NC(=O)c1cc2c([nH]1)-c1ccncc1O[C@H]2C1CCCCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in IFNgamma-induced STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCOCC1,CHEMBL4742387,=,=,INH,uM,0.5,INH,uM,0.5,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCOCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in IFNgamma-induced STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCOCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,NC(=O)c1cc2c([nH]1)-c1ccncc1OC2C1CCOCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in IFNgamma-induced STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,COc1ccccc1-c1c2c(n(CCF)c1C(N)=O)-c1ccncc1OC2(C)C,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,COc1ccccc1-c1c2c(n(CCF)c1C(N)=O)-c1ccncc1OC2(C)C,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in IFNgamma-induced STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2(C)C,CHEMBL4742387,=,=,INH,10^-10mol/L,0.64,INH,10^-10mol/L,0.64,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2(C)C,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in IFNgamma-induced STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,COCCn1c(C(N)=O)cc2c1-c1ccncc1OC2(C)C,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,COCCn1c(C(N)=O)cc2c1-c1ccncc1OC2(C)C,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in IFNgamma-induced STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CC1(C)Oc2cnccc2-c2c1cc(C(N)=O)n2CCF,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,CC1(C)Oc2cnccc2-c2c1cc(C(N)=O)n2CCF,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2(C)C,CHEMBL4742387,=,=,IC50,nM,1.5,IC50,10^-9M,1.5,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2(C)C,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,NC(=O)c1cc2c([nH]1)-c1ccncc1OC21CCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,NC(=O)c1cc2c([nH]1)-c1ccncc1OC21CCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CC1(C)Oc2cnccc2-c2c1cc(C(N)=O)n2CCF,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,CC1(C)Oc2cnccc2-c2c1cc(C(N)=O)n2CCF,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CCn1c(C(N)=O)c(-c2ccccc2OC)c2c1-c1ccncc1OC2(C)C,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,CCn1c(C(N)=O)c(-c2ccccc2OC)c2c1-c1ccncc1OC2(C)C,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,NC(=O)c1cc2c([nH]1)-c1ccncc1O[C@H]2C1CCCCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,NC(=O)c1cc2c([nH]1)-c1ccncc1O[C@H]2C1CCCCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,NC(=O)c1cc2c(n1CCF)-c1ccncc1OC21CCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,NC(=O)c1cc2c(n1CCF)-c1ccncc1OC21CCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCN(CC(F)(F)F)CC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCN(CC(F)(F)F)CC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCOCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCOCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,Cn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,Cn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CC1(C)Oc2cnccc2-c2[nH]c(C(N)=O)c(C3CC3)c21,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,CC1(C)Oc2cnccc2-c2[nH]c(C(N)=O)c(C3CC3)c21,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2C1CCCCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,CCn1c(C(N)=O)cc2c1-c1ccncc1OC2C1CCCCC1,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1.Cl,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,CCn1c(C(N)=O)cc2c1-c1ccncc1OC21CCCCC1.Cl,2018.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis,NC(=O)c1cc2c(n1CCF)-c1ccncc1OC21CCCCC1,CHEMBL4742387,<,<,INH,nM,500.0,INH,nM,500.0,NC(=O)c1cc2c(n1CCF)-c1ccncc1OC21CCCCC1,2018.0
Inhibition of CDK8 (unknown origin) assessed as residual ligand binding level at 10000 nM by kinome scan assay relative to control,NC(=O)c1sc2nccc(N3CCCN(c4ccccc4)CC3)c2c1N,CHEMBL4742393,,,Inhibition,%,,INH,,,NC(=O)c1sc2nccc(N3CCCN(c4ccccc4)CC3)c2c1N,2019.0
Inhibition of CDK8 (unknown origin) assessed as residual ligand binding level at 0.5 uM by kinome scan assay relative to control,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4742393,,,Inhibition,%,,INH,,,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2019.0
Inhibition of CDK8 in human HepG2 cells assessed as reduction in IFNgamma-induced STATl S727 phosphorylation incubated for 18 hrs by Western blot analysis,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,CHEMBL4742401,,,Inhibition,%,,INH,,,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4ccncc4c3)=CC[C@@H]12,CHEMBL4742401,=,=,IC50,nM,101.0,IC50,nM,101.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4ccncc4c3)=CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4ccncc4c3)=CC[C@@H]12,CHEMBL4742401,=,=,IC50,nM,701.0,IC50,nM,701.0,C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4ccncc4c3)=CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cnncc4c3)=CC[C@@H]12,CHEMBL4742401,>=,>=,IC50,nM,6001.0,IC50,nM,6001.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cnncc4c3)=CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4nc(N)ncc4c3)=CC[C@@H]12,CHEMBL4742401,=,=,IC50,nM,2001.0,IC50,nM,2001.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4nc(N)ncc4c3)=CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4c(N)n[nH]c4c3)=CC[C@@H]12,CHEMBL4742401,=,=,IC50,nM,701.0,IC50,nM,701.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4c(N)n[nH]c4c3)=CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4[nH]ncc4c3)=CC[C@@H]12,CHEMBL4742401,>=,>=,IC50,nM,6001.0,IC50,nM,6001.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4[nH]ncc4c3)=CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cn[nH]c4c3)=CC[C@@H]12,CHEMBL4742401,>=,>=,IC50,nM,6001.0,IC50,nM,6001.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cn[nH]c4c3)=CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2ccncc2c1,CHEMBL4742401,<=,<=,IC50,nM,100.0,IC50,nM,100.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2ccncc2c1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,CHEMBL4742401,=,=,IC50,nM,201.0,IC50,nM,201.0,C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cnncc2c1,CHEMBL4742401,>=,>=,IC50,nM,6001.0,IC50,nM,6001.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cnncc2c1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2nc(N)ncc2c1,CHEMBL4742401,=,=,IC50,nM,101.0,IC50,nM,101.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2nc(N)ncc2c1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2c(N)n[nH]c2c1,CHEMBL4742401,=,=,IC50,nM,301.0,IC50,nM,301.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2c(N)n[nH]c2c1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2[nH]ncc2c1,CHEMBL4742401,>=,>=,IC50,nM,6001.0,IC50,nM,6001.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2[nH]ncc2c1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cn[nH]c2c1,CHEMBL4742401,>=,>=,IC50,nM,6001.0,IC50,nM,6001.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cn[nH]c2c1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cnccc2c1,CHEMBL4742401,=,=,IC50,nM,2001.0,IC50,nM,2001.0,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2c1ccc2cnccc2c1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,CN(C)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,CHEMBL4742401,=,=,IC50,nM,101.0,IC50,nM,101.0,CN(C)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,CN(C)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4742401,<=,<=,IC50,nM,100.0,IC50,nM,100.0,CN(C)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,CHEMBL4742401,=,=,IC50,nM,201.0,IC50,nM,201.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4742401,<=,<=,IC50,nM,100.0,IC50,nM,100.0,CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,CHEMBL4742401,=,=,IC50,nM,101.0,IC50,nM,101.0,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4ccc5ccncc5c4)=CC[C@@H]32)C1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,CHEMBL4742401,<=,<=,IC50,nM,100.0,IC50,nM,100.0,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](N3CCOCC3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,CHEMBL4742401,=,=,IC50,nM,101.0,IC50,nM,101.0,C[C@]12CC[C@H](N3CCOCC3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](n3ccnn3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,CHEMBL4742401,<=,<=,IC50,nM,100.0,IC50,nM,100.0,C[C@]12CC[C@H](n3ccnn3)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc4ccncc4c3)CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,CN[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4742401,=,=,IC50,nM,701.0,IC50,nM,701.0,CN[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,CC(=O)N(C)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,CHEMBL4742401,<=,<=,IC50,nM,100.0,IC50,nM,100.0,CC(=O)N(C)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](c4ccc5ccncc5c4)CC[C@@H]32)C1,2019.0
Inhibition of CDK8 (unknown origin) by competitive kinase binding based Lantha-screen Eu kinase binding assay,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cnccc4c3)=CC[C@@H]12,CHEMBL4742401,>=,>=,IC50,nM,6001.0,IC50,nM,6001.0,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3ccc4cnccc4c3)=CC[C@@H]12,2019.0
Inhibition of CDK8 (unknown origin) at 10 uM relative to control,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,CHEMBL4742401,>,>,Inhibition,%,90.0,INH,%,90.0,CN(C)[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](c5ccc6ccncc6c5)[C@@]4(C)CC[C@@H]32)C1,2019.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 phosphorylation at Ser727 residues at 10 uM measured after 8 hrs relative to control,O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1,CHEMBL4765359,=,=,Inhibition,%,60.0,INH,%,60.0,O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1,2020.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 phosphorylation at Ser727 residues measured after 8 hrs,Nc1cc(N2C(=O)c3cccnc3Oc3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc32)ccn1,CHEMBL4765359,>,>,IC50,nM,10000.0,IC50,uM,10.0,Nc1cc(N2C(=O)c3cccnc3Oc3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc32)ccn1,2020.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 phosphorylation at Ser727 residues measured after 8 hrs,O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,CHEMBL4765359,>,>,IC50,nM,10000.0,IC50,uM,10.0,O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,2020.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 phosphorylation at Ser727 residues measured after 8 hrs,O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1,CHEMBL4765359,=,=,IC50,nM,1300.0,IC50,uM,1.3,O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1,2020.0
Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 phosphorylation at Ser727 residues measured after 8 hrs,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4765359,>,>,IC50,nM,10000.0,IC50,uM,10.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2020.0
Inhibition of CDK8 (unknown origin),CCCNC(=O)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,CHEMBL4765359,=,=,IC50,nM,5060.0,IC50,nM,5060.0,CCCNC(=O)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,2020.0
Inhibition of CDK8 (unknown origin),O=C(NCc1ccccc1F)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,CHEMBL4765359,=,=,IC50,nM,324.0,IC50,nM,324.0,O=C(NCc1ccccc1F)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,2020.0
Inhibition of CDK8 (unknown origin),O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,CHEMBL4765359,=,=,IC50,nM,9.96,IC50,nM,9.96,O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,2020.0
Inhibition of CDK8 (unknown origin),O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1cccnc1,CHEMBL4765359,=,=,IC50,nM,4080.0,IC50,nM,4080.0,O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1cccnc1,2020.0
Inhibition of CDK8 (unknown origin),O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccoc1,CHEMBL4765359,=,=,IC50,nM,593.0,IC50,nM,593.0,O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccoc1,2020.0
Inhibition of CDK8 (unknown origin),O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2Cc1ccncc1,CHEMBL4765359,=,=,IC50,nM,1780.0,IC50,nM,1780.0,O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2Cc1ccncc1,2020.0
Inhibition of CDK8 (unknown origin),O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ccccc1C(=O)N2c1ccncc1,CHEMBL4765359,=,=,IC50,nM,1150.0,IC50,nM,1150.0,O=C(Nc1ccccc1)Nc1ccc2c(c1)Oc1ccccc1C(=O)N2c1ccncc1,2020.0
Inhibition of CDK8 (unknown origin),O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)c1ccccc1,CHEMBL4765359,=,=,IC50,nM,2400.0,IC50,uM,2.4,O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)c1ccccc1,2020.0
Inhibition of CDK8 (unknown origin),O=C(Cc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,CHEMBL4765359,=,=,IC50,nM,2500.0,IC50,uM,2.5,O=C(Cc1ccccc1)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,2020.0
Inhibition of CDK8 (unknown origin),CC(O)(C(=O)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)C(F)(F)F,CHEMBL4765359,>,>,IC50,nM,10000.0,IC50,uM,10.0,CC(O)(C(=O)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)C(F)(F)F,2020.0
Inhibition of CDK8 (unknown origin),CC(C)(O)C(=O)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,CHEMBL4765359,=,=,IC50,nM,5100.0,IC50,uM,5.1,CC(C)(O)C(=O)Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1,2020.0
Inhibition of CDK8 (unknown origin),O=C1c2cccnc2Oc2cc(NC(=O)S(=O)(=O)c3ccccc3)ccc2N1c1ccncc1,CHEMBL4765359,>,>,IC50,nM,10000.0,IC50,uM,10.0,O=C1c2cccnc2Oc2cc(NC(=O)S(=O)(=O)c3ccccc3)ccc2N1c1ccncc1,2020.0
Inhibition of CDK8 (unknown origin),CNC(=O)c1cc(N2C(=O)c3cccnc3Oc3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc32)ccn1,CHEMBL4765359,=,=,IC50,nM,361.0,IC50,nM,361.0,CNC(=O)c1cc(N2C(=O)c3cccnc3Oc3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc32)ccn1,2020.0
Inhibition of CDK8 (unknown origin),O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1,CHEMBL4765359,=,=,IC50,nM,8.25,IC50,nM,8.25,O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1,2020.0
Inhibition of CDK8 (unknown origin),CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4765359,=,=,IC50,nM,36.6,IC50,nM,36.6,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2020.0
Inhibition of CDK8 (unknown origin),Nc1cc(N2C(=O)c3cccnc3Oc3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc32)ccn1,CHEMBL4765359,=,=,IC50,nM,57.5,IC50,nM,57.5,Nc1cc(N2C(=O)c3cccnc3Oc3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc32)ccn1,2020.0
"Potency index, ratio of sorafenib IC50 to test compound IC50 for inhibition of CDK8 (unknown origin)",O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1,CHEMBL4765359,=,=,Ratio IC50,,4.0,Ratio IC50,,4.0,O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1,2020.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1,CHEMBL4765359,<,<,Activity,%,35.0,Activity,%,35.0,O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1,2020.0
Binding affinity to wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4765359,<,<,Activity,%,35.0,Activity,%,35.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2020.0
Inhibition of CDK8 in human NCI-H929 cells by mass spectroscopic analysis,Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,% inhibition,uM,59.3,% inhibition,uM,59.3,Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of CDK8 in human NCI-H929 cells by mass spectroscopic analysis,CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1,CHEMBL4804281,=,=,% inhibition,uM,4.9,% inhibition,uM,4.9,CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1,2020.0
Inhibition of CDK8 in human NCI-H929 cells by mass spectroscopic analysis,COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1,CHEMBL4804281,=,=,% inhibition,uM,38.1,% inhibition,uM,38.1,COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1,2020.0
Inhibition of CDK8 in human NCI-H929 cells by mass spectroscopic analysis,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,% inhibition,uM,31.8,% inhibition,uM,31.8,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of CDK8 in human NCI-H929 cells by mass spectroscopic analysis,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,% inhibition,uM,31.3,% inhibition,uM,31.3,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of CDK8 in human NCI-H929 cells by mass spectroscopic analysis,Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,% inhibition,uM,35.5,% inhibition,uM,35.5,Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of CDK8 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control,Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,Inhibition,%,50.0,INH,%,50.0,Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of CDK8 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control,CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1,CHEMBL4804281,=,=,Inhibition,%,0.0,INH,%,0.0,CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1,2020.0
Inhibition of CDK8 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control,COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1,CHEMBL4804281,=,=,Inhibition,%,0.0,INH,%,0.0,COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1,2020.0
Inhibition of CDK8 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,Inhibition,%,0.0,INH,%,0.0,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of CDK8 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,Inhibition,%,0.0,INH,%,0.0,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of human CDK8 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,Activity,%,1.3,Activity,%,1.3,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of human CDK8 at 2000 nM by KINOMEscan assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,>,>,Inhibition,%,65.0,INH,%,65.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of human CDK8 by DiscoverX assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,Kd,nM,55.0,Kd,nM,55.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of human CDK8 by DiscoverX assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,Kd,nM,59.0,Kd,nM,59.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,CCCNc1ccnc2ccc(C#N)cc12,CHEMBL4804282,,,IC50,,,IC50,,,CCCNc1ccnc2ccc(C#N)cc12,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,N#Cc1ccc2nccc(NCc3ccccc3)c2c1,CHEMBL4804282,,,IC50,,,IC50,,,N#Cc1ccc2nccc(NCc3ccccc3)c2c1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,N#Cc1ccc2nccc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,IC50,nM,217.0,IC50,nM,217.0,N#Cc1ccc2nccc(NCCc3ccccc3)c2c1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4ccc(C#N)cc34)CC2)cc1,CHEMBL4804282,=,=,IC50,nM,82.0,IC50,nM,82.0,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4ccc(C#N)cc34)CC2)cc1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,65.0,IC50,nM,65.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4ccc(C#N)cc34)CC2)cc1,CHEMBL4804282,=,=,IC50,nM,203.0,IC50,nM,203.0,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4ccc(C#N)cc34)CC2)cc1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,O=[N+]([O-])c1ccc2nccc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,IC50,nM,346.0,IC50,nM,346.0,O=[N+]([O-])c1ccc2nccc(NCCc3ccccc3)c2c1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,CN1CCN(C(=O)c2ccc3nc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,195.0,IC50,nM,195.0,CN1CCN(C(=O)c2ccc3nc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,CN(C)C(=O)c1ccc2cc(CCNc3ccnc4ccc(C#N)cc34)ccc2c1,CHEMBL4804282,=,=,IC50,nM,103.0,IC50,nM,103.0,CN(C)C(=O)c1ccc2cc(CCNc3ccnc4ccc(C#N)cc34)ccc2c1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,N#Cc1ccc2nccc(NCCc3ccc4cc(C(=O)N5CCN(CCCO)CC5)ccc4c3)c2c1,CHEMBL4804282,=,=,IC50,nM,117.0,IC50,nM,117.0,N#Cc1ccc2nccc(NCCc3ccc4cc(C(=O)N5CCN(CCCO)CC5)ccc4c3)c2c1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,N#Cc1ccc2nccc(NCCc3ccc4cc(C(=O)N5CCNCC5)ccc4c3)c2c1,CHEMBL4804282,=,=,IC50,nM,449.0,IC50,nM,449.0,N#Cc1ccc2nccc(NCCc3ccc4cc(C(=O)N5CCNCC5)ccc4c3)c2c1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,117.0,IC50,nM,117.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,Cc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl)cc1,CHEMBL4804282,=,=,IC50,nM,13000.0,IC50,uM,13.0,Cc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl)cc1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,CHEMBL4804282,=,=,IC50,nM,4.5,IC50,nM,4.5,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells by NF-kappaB reporter assay,CC(C)Nc1ccnc2ccc(C#N)cc12,CHEMBL4804282,,,IC50,,,IC50,,,CC(C)Nc1ccnc2ccc(C#N)cc12,2020.0
Inhibition of CDK8 in TNF-alpha-induced CDK8 and CDK19-knockout HEK293 cells by NF-kappaB reporter assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,8765.0,IC50,nM,8765.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8 in TNF-alpha-induced CDK8 and CDK19-knockout HEK293 cells by NF-kappaB reporter assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,5981.0,IC50,nM,5981.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8 in TNF-alpha-induced CDK8 and CDK19-knockout HEK293 cells by NF-kappaB reporter assay,Cc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl)cc1,CHEMBL4804282,=,=,IC50,nM,12000.0,IC50,uM,12.0,Cc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl)cc1,2020.0
Inhibition of CDK8 in TNF-alpha-induced CDK8 and CDK19-knockout HEK293 cells by NF-kappaB reporter assay,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,CHEMBL4804282,=,=,IC50,nM,3.4,IC50,nM,3.4,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells at 1 uM by NF-kappaB reporter assay relative to control,Clc1ccc2nccc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,8.0,INH,%,8.0,Clc1ccc2nccc(NCCc3ccccc3)c2c1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells at 1 uM by NF-kappaB reporter assay relative to control,Brc1ccc2nccc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,10.0,INH,%,10.0,Brc1ccc2nccc(NCCc3ccccc3)c2c1,2020.0
Inhibition of CDK8 in TNF-alpha-induced HEK293 cells at 5 uM by NF-kappaB reporter assay relative to control,Nc1ccc2nccc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,5.0,INH,%,5.0,Nc1ccc2nccc(NCCc3ccccc3)c2c1,2020.0
Inhibition of human CDK8 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control,COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F,CHEMBL4804283,=,=,Activity,%,96.0,Activity,%,96.0,COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F,2020.0
Inhibition of DNA-tagged human CDK8 assessed as percent of control at 50000 nM by qPCR analysis relative to control,CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21,CHEMBL4804284,=,=,Activity,%,100.0,Activity,%,100.0,CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21,2020.0
Inhibition of CDK8 (unknown origin) at 10 uM relative to control,Cn1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)cn1,CHEMBL4804285,=,=,Inhibition,%,0.0,INH,%,0.0,Cn1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)cn1,2019.0
Inhibition of CDK8 (unknown origin) at 10 uM relative to control,Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1,CHEMBL4804285,=,=,Inhibition,%,22.0,INH,%,22.0,Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1,2019.0
Inhibition of CDK8 (unknown origin) at 10 uM relative to control,Cc1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)no1,CHEMBL4804285,=,=,Inhibition,%,40.0,INH,%,40.0,Cc1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)no1,2019.0
Inhibition of human CDK8 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,Activity,%,2.6,Activity,%,2.6,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of human CDK8 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,Activity,%,0.25,Activity,%,0.25,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of human CDK8 at 2000 nM by KINOMEscan assay,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,>,>,Inhibition,%,65.0,INH,%,65.0,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of human CDK8 by DiscoverX assay,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,Kd,nM,78.0,Kd,nM,78.0,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of human CDK8 by DiscoverX assay,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,Kd,nM,55.0,Kd,nM,55.0,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8 (unknown origin) by Pro-Qinase assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4806957,=,=,IC50,nM,24.0,IC50,nM,24.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2019.0
Inhibition of CDK8 in human HT1080 cells assessed as inhibition of IPTG-inducible p21 induced CMV-GFP expression by Hoechst 33342 staining-based fluorescence assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4806957,,,Inhibition,%,,INH,,,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2019.0
Inhibition of CDK8 (unknown origin),CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4806957,=,=,Kd,nM,140.0,Kd,nM,140.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2019.0
Inhibition of human CDK8 (M1 to T360 residues) expressed in bacterial expression system at 2000 nM by KINOMEscan assay relative to control,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4806957,=,=,Inhibition,%,97.8,INH,%,97.8,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2019.0
Inhibition of CDK8 in human MV4-11 cells assessed as reduction in phosphorylation of STAT1 at S727 residue at 3 to 10 uM after 24 hrs by Western blotting analysis,Nc1ncc(-c2cc3ccccc3o2)c(N2CCC3(CCNC3=O)CC2)c1Cl,CHEMBL4811251,,,Inhibition,%,,INH,,,Nc1ncc(-c2cc3ccccc3o2)c(N2CCC3(CCNC3=O)CC2)c1Cl,2021.0
Inhibition of CDK8 in human MV4-11 cells assessed as total STAT1 level at 3 to 10 uM after 24 hrs by Western blotting analysis,Nc1ncc(-c2cc3ccccc3o2)c(N2CCC3(CCNC3=O)CC2)c1Cl,CHEMBL4811251,,,Inhibition,%,,INH,,,Nc1ncc(-c2cc3ccccc3o2)c(N2CCC3(CCNC3=O)CC2)c1Cl,2021.0
Inhibition of CDK8 in human MV4-11 cells assessed as reduction in Rb phosphorylation at Ser780 at 3 to 10 uM after 24 hrs by Western blotting analysis,Nc1ncc(-c2cc3ccccc3o2)c(N2CCC3(CCNC3=O)CC2)c1Cl,CHEMBL4811251,,,Inhibition,%,,INH,,,Nc1ncc(-c2cc3ccccc3o2)c(N2CCC3(CCNC3=O)CC2)c1Cl,2021.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1,CHEMBL4825714,<,<,Activity,%,10.0,Activity,%,10.0,O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1,2021.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1,CHEMBL4825714,<,<,Activity,%,10.0,Activity,%,10.0,O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1,2021.0
Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,O=C(O)c1ccc(-c2ncnc3ccsc23)cc1C1CCCC1,CHEMBL4825714,<,<,Activity,%,10.0,Activity,%,10.0,O=C(O)c1ccc(-c2ncnc3ccsc23)cc1C1CCCC1,2021.0
Inhibition of human CDK8 in human Jurkat cells assessed as inhibition of STAT1 phosphorylation at S727 residue measured after 24 hrs by Western blot assay,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,46.0,IC50,nM,46.0,Cn1ncc2cc(-c3cnc4[nH]ccc4c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of human CDK8 in human Jurkat cells assessed as inhibition of STAT1 phosphorylation at S727 residue measured after 24 hrs by Western blot assay,Cn1ncc2cc(-c3cnc4[nH]nc(Cl)c4c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,2.0,IC50,nM,2.0,Cn1ncc2cc(-c3cnc4[nH]nc(Cl)c4c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of human CDK8 in human Jurkat cells assessed as inhibition of STAT1 phosphorylation at S727 residue measured after 24 hrs by Western blot assay,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL4825780,=,=,IC50,nM,5.0,IC50,nM,5.0,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Inhibition of human CDK8 in human Jurkat cells assessed as inhibition of STAT1 phosphorylation at S727 residue measured after 24 hrs by Western blot assay,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL4825780,=,=,IC50,nM,3.0,IC50,nM,3.0,Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,CCOC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,CHEMBL4831484,,,Inhibition,%,,INH,,,CCOC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,CCOC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,,,Inhibition,%,,INH,,,CCOC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,O=C(O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,,,Inhibition,%,,INH,,,O=C(O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,CNC(=O)/C=C/c1ccncc1-c1ccc2c(cnn2C)c1,CHEMBL4831484,,,Inhibition,%,,INH,,,CNC(=O)/C=C/c1ccncc1-c1ccc2c(cnn2C)c1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,CNC(=O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,CHEMBL4831484,,,Inhibition,%,,INH,,,CNC(=O)/C=C/c1ccncc1-c1ccc2[nH]ccc2c1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,CNC(=O)/C=C/c1ccncc1-c1ccc2c(ccn2C)c1,CHEMBL4831484,,,Inhibition,%,,INH,,,CNC(=O)/C=C/c1ccncc1-c1ccc2c(ccn2C)c1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,O=C(/C=C/c1ccncc1-c1ccc2cc[nH]c2c1)N1CCOCC1,CHEMBL4831484,,,Inhibition,%,,INH,,,O=C(/C=C/c1ccncc1-c1ccc2cc[nH]c2c1)N1CCOCC1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,CNC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,CHEMBL4831484,,,Inhibition,%,,INH,,,CNC(=O)/C=C/c1ccncc1-c1ccc2cc[nH]c2c1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,CHEMBL4831484,,,Inhibition,%,,INH,,,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)N1CCOCC1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,CNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,CHEMBL4831484,,,Inhibition,%,,INH,,,CNC(=O)/C=C/c1ccncc1-c1ccc2ccccc2c1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)NC1CC1,CHEMBL4831484,,,Inhibition,%,,INH,,,O=C(/C=C/c1ccncc1-c1ccc2ccccc2c1)NC1CC1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)C1,CHEMBL4831484,,,Inhibition,%,,INH,,,COC1CN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)C1,2021.0
Inhibition of CDK8 (unknown origin) at 10 uM,CN1CCN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)CC1,CHEMBL4831484,,,Inhibition,%,,INH,,,CN1CCN(C(=O)/C=C/c2ccncc2-c2ccc3ccccc3c2)CC1,2021.0
KinomeScan assay: inhibition of CDK8,CCC(=N\O)/C(C)=C/c1ccc(F)cc1,CHEMBL4507256,,,% Control,%,100.0,% Control,%,100.0,CCC(=N\O)/C(C)=C/c1ccc(F)cc1,2021.0
KinomeScan assay: inhibition of CDK8,CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1,CHEMBL4507256,,,% Control,%,73.0,% Control,%,73.0,CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1,2021.0
KinomeScan assay: inhibition of CDK8,Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1,CHEMBL4507257,,,% Control,%,66.0,% Control,%,66.0,Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1,2021.0
KinomeScan assay: inhibition of CDK8,Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1,CHEMBL4507257,,,% Control,%,100.0,% Control,%,100.0,Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1,2021.0
KinomeScan assay: inhibition of CDK8,CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC,CHEMBL4507258,,,% Control,%,100.0,% Control,%,100.0,CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC,2021.0
KinomeScan assay: inhibition of CDK8,CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC,CHEMBL4507258,,,% Control,%,78.0,% Control,%,78.0,CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC,2021.0
KinomeScan assay: inhibition of CDK8,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,CHEMBL4507260,,,% Control,%,100.0,% Control,%,100.0,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,2021.0
KinomeScan assay: inhibition of CDK8,CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1,CHEMBL4507260,,,% Control,%,87.0,% Control,%,87.0,CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1,2021.0
KinomeScan assay: inhibition of CDK8,CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1,CHEMBL4507261,,,% Control,%,76.0,% Control,%,76.0,CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1,2021.0
KinomeScan assay: inhibition of CDK8,CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1,CHEMBL4507261,,,% Control,%,86.0,% Control,%,86.0,CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1,2021.0
KinomeScan assay: inhibition of CDK8,COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1,CHEMBL4507262,,,% Control,%,100.0,% Control,%,100.0,COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1,2021.0
KinomeScan assay: inhibition of CDK8,COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1,CHEMBL4507262,,,% Control,%,100.0,% Control,%,100.0,COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1,2021.0
KinomeScan assay: inhibition of CDK8,CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1,CHEMBL4507263,,,% Control,%,93.2,% Control,%,93.2,CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(O)[C@H]1[C@H](Cn2nnc3ccccc3c2=O)CC[C@@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1,CHEMBL4507264,,,% Control,%,100.0,% Control,%,100.0,O=C(O)[C@H]1[C@H](Cn2nnc3ccccc3c2=O)CC[C@@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(O)[C@@H]1[C@@H](Cn2nnc3ccccc3c2=O)CC[C@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1,CHEMBL4507264,,,% Control,%,91.0,% Control,%,91.0,O=C(O)[C@@H]1[C@@H](Cn2nnc3ccccc3c2=O)CC[C@H]1C(=O)c1ccc(OCCC2CCOCC2)cc1,2021.0
KinomeScan assay: inhibition of CDK8,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,CHEMBL4507265,,,% Control,%,68.0,% Control,%,68.0,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,2021.0
KinomeScan assay: inhibition of CDK8,NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1,CHEMBL4507265,,,% Control,%,91.0,% Control,%,91.0,NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1,CHEMBL4507266,,,% Control,%,80.0,% Control,%,80.0,O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1,CHEMBL4507266,,,% Control,%,63.0,% Control,%,63.0,O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1,CHEMBL4507267,,,% Control,%,56.0,% Control,%,56.0,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1,CHEMBL4507267,,,% Control,%,100.0,% Control,%,100.0,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1,2021.0
KinomeScan assay: inhibition of CDK8,CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1,CHEMBL4507268,,,% Control,%,100.0,% Control,%,100.0,CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1,CHEMBL4507268,,,% Control,%,100.0,% Control,%,100.0,Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1,CHEMBL4507269,,,% Control,%,100.0,% Control,%,100.0,O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1,CHEMBL4507269,,,% Control,%,100.0,% Control,%,100.0,Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1,CHEMBL4507270,,,% Control,%,76.7,% Control,%,76.7,Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1,CHEMBL4507270,,,% Control,%,86.2,% Control,%,86.2,Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1,2021.0
KinomeScan assay: inhibition of CDK8,CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1,CHEMBL4507272,,,% Control,%,65.3,% Control,%,65.3,CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1,2021.0
KinomeScan assay: inhibition of CDK8,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,CHEMBL4507273,,,% Control,%,68.0,% Control,%,68.0,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,2021.0
KinomeScan assay: inhibition of CDK8,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,CHEMBL4507273,,,% Control,%,84.0,% Control,%,84.0,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12,CHEMBL4507274,,,% Control,%,69.0,% Control,%,69.0,Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12,2021.0
KinomeScan assay: inhibition of CDK8,Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21,CHEMBL4507274,,,% Control,%,97.0,% Control,%,97.0,Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21,2021.0
KinomeScan assay: inhibition of CDK8,O=C(NC[C@@H]1[C@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@@H]12)c1ccc2[nH]nnc2c1,CHEMBL4507275,,,% Control,%,100.0,% Control,%,100.0,O=C(NC[C@@H]1[C@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@@H]12)c1ccc2[nH]nnc2c1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1nccc(COC(=O)N2C[C@@H]3[C@@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@@H]3C2)n1,CHEMBL4507275,,,% Control,%,75.0,% Control,%,75.0,Cc1nccc(COC(=O)N2C[C@@H]3[C@@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@@H]3C2)n1,2021.0
KinomeScan assay: inhibition of CDK8,CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1,CHEMBL4507276,,,% Control,%,89.0,% Control,%,89.0,CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1,2021.0
KinomeScan assay: inhibition of CDK8,CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1,CHEMBL4507276,,,% Control,%,100.0,% Control,%,100.0,CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1,2021.0
KinomeScan assay: inhibition of CDK8,CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1,CHEMBL4507277,,,% Control,%,100.0,% Control,%,100.0,CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1,2021.0
KinomeScan assay: inhibition of CDK8,CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1,CHEMBL4507277,,,% Control,%,100.0,% Control,%,100.0,CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1,2021.0
KinomeScan assay: inhibition of CDK8,CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1,CHEMBL4507278,,,% Control,%,100.0,% Control,%,100.0,CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1,2021.0
KinomeScan assay: inhibition of CDK8,CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1,CHEMBL4507278,,,% Control,%,100.0,% Control,%,100.0,CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1,2021.0
KinomeScan assay: inhibition of CDK8,CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,CHEMBL4507279,,,% Control,%,100.0,% Control,%,100.0,CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,2021.0
KinomeScan assay: inhibition of CDK8,CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1,CHEMBL4507279,,,% Control,%,100.0,% Control,%,100.0,CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1,2021.0
KinomeScan assay: inhibition of CDK8,CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1,CHEMBL4507280,,,% Control,%,100.0,% Control,%,100.0,CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1,2021.0
KinomeScan assay: inhibition of CDK8,CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1,CHEMBL4507280,,,% Control,%,100.0,% Control,%,100.0,CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1,2021.0
KinomeScan assay: inhibition of CDK8,CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1,CHEMBL4507281,,,% Control,%,62.0,% Control,%,62.0,CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1,2021.0
KinomeScan assay: inhibition of CDK8,Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1,CHEMBL4507281,,,% Control,%,100.0,% Control,%,100.0,Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1,2021.0
KinomeScan assay: inhibition of CDK8,CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O,CHEMBL4507283,,,% Control,%,100.0,% Control,%,100.0,CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O,2021.0
KinomeScan assay: inhibition of CDK8,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C,CHEMBL4507284,,,% Control,%,68.0,% Control,%,68.0,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C,2021.0
KinomeScan assay: inhibition of CDK8,O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1,CHEMBL4507284,,,% Control,%,66.0,% Control,%,66.0,O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1,CHEMBL4507285,,,% Control,%,100.0,% Control,%,100.0,Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1,CHEMBL4507285,,,% Control,%,78.7,% Control,%,78.7,Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1,2021.0
KinomeScan assay: inhibition of CDK8,C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1,CHEMBL4507286,,,% Control,%,76.1,% Control,%,76.1,C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1,2021.0
KinomeScan assay: inhibition of CDK8,C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1,CHEMBL4507286,,,% Control,%,100.0,% Control,%,100.0,C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1,2021.0
KinomeScan assay: inhibition of CDK8,CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12,CHEMBL4507287,,,% Control,%,100.0,% Control,%,100.0,CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12,2021.0
KinomeScan assay: inhibition of CDK8,CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O,CHEMBL4507287,,,% Control,%,83.0,% Control,%,83.0,CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O,2021.0
KinomeScan assay: inhibition of CDK8,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,CHEMBL4507288,,,% Control,%,100.0,% Control,%,100.0,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,2021.0
KinomeScan assay: inhibition of CDK8,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,CHEMBL4507289,,,% Control,%,100.0,% Control,%,100.0,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,2021.0
KinomeScan assay: inhibition of CDK8,COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1,CHEMBL4507289,,,% Control,%,90.0,% Control,%,90.0,COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1,2021.0
KinomeScan assay: inhibition of CDK8,CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1,CHEMBL4507290,,,% Control,%,100.0,% Control,%,100.0,CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1,2021.0
KinomeScan assay: inhibition of CDK8,CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1,CHEMBL4507290,,,% Control,%,100.0,% Control,%,100.0,CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1,2021.0
KinomeScan assay: inhibition of CDK8,C[C@@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1,CHEMBL4507291,,,% Control,%,63.0,% Control,%,63.0,C[C@@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1,2021.0
KinomeScan assay: inhibition of CDK8,C[C@@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1,CHEMBL4507291,,,% Control,%,100.0,% Control,%,100.0,C[C@@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@H](C)O1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,CHEMBL4507292,,,% Control,%,100.0,% Control,%,100.0,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12,CHEMBL4507292,,,% Control,%,100.0,% Control,%,100.0,Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12,2021.0
KinomeScan assay: inhibition of CDK8,COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2,CHEMBL4507293,,,% Control,%,100.0,% Control,%,100.0,COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2,2021.0
KinomeScan assay: inhibition of CDK8,CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1,CHEMBL4507293,,,% Control,%,82.0,% Control,%,82.0,CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1,2021.0
KinomeScan assay: inhibition of CDK8,CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1,CHEMBL4507294,,,% Control,%,95.0,% Control,%,95.0,CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1,2021.0
KinomeScan assay: inhibition of CDK8,FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1,CHEMBL4507294,,,% Control,%,100.0,% Control,%,100.0,FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1,2021.0
KinomeScan assay: inhibition of CDK8,C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1,CHEMBL4507296,,,% Control,%,100.0,% Control,%,100.0,C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,CHEMBL4507297,,,% Control,%,100.0,% Control,%,100.0,O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1,CHEMBL4507297,,,% Control,%,100.0,% Control,%,100.0,O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1,2021.0
KinomeScan assay: inhibition of CDK8,COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1,CHEMBL4507300,,,% Control,%,73.4,% Control,%,73.4,COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1,2021.0
KinomeScan assay: inhibition of CDK8,C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N,CHEMBL4507301,,,% Control,%,100.0,% Control,%,100.0,C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N,2021.0
KinomeScan assay: inhibition of CDK8,C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N,CHEMBL4507301,,,% Control,%,92.0,% Control,%,92.0,C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N,2021.0
KinomeScan assay: inhibition of CDK8,Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,CHEMBL4507302,,,% Control,%,96.0,% Control,%,96.0,Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,2021.0
KinomeScan assay: inhibition of CDK8,Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,CHEMBL4507302,,,% Control,%,100.0,% Control,%,100.0,Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12,CHEMBL4507303,,,% Control,%,88.0,% Control,%,88.0,Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12,2021.0
KinomeScan assay: inhibition of CDK8,Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O,CHEMBL4507305,,,% Control,%,97.0,% Control,%,97.0,Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O,2021.0
KinomeScan assay: inhibition of CDK8,Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1,CHEMBL4507305,,,% Control,%,100.0,% Control,%,100.0,Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1,2021.0
KinomeScan assay: inhibition of CDK8,CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1,CHEMBL4507310,,,% Control,%,91.0,% Control,%,91.0,CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1,CHEMBL4507310,,,% Control,%,100.0,% Control,%,100.0,O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1,2021.0
KinomeScan assay: inhibition of CDK8,CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1,CHEMBL4507311,,,% Control,%,69.0,% Control,%,69.0,CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1,2021.0
KinomeScan assay: inhibition of CDK8,Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F,CHEMBL4507312,,,% Control,%,84.0,% Control,%,84.0,Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F,2021.0
KinomeScan assay: inhibition of CDK8,Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1,CHEMBL4507315,,,% Control,%,96.0,% Control,%,96.0,Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1,CHEMBL4507315,,,% Control,%,97.0,% Control,%,97.0,O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1,CHEMBL4507317,,,% Control,%,70.0,% Control,%,70.0,O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1,2021.0
KinomeScan assay: inhibition of CDK8,O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1,CHEMBL4507317,,,% Control,%,95.0,% Control,%,95.0,O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1,2021.0
KinomeScan assay: inhibition of CDK8,C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1,CHEMBL4507318,,,% Control,%,96.0,% Control,%,96.0,C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1,2021.0
KinomeScan assay: inhibition of CDK8,CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl,CHEMBL4507318,,,% Control,%,90.0,% Control,%,90.0,CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl,2021.0
KinomeScan assay: inhibition of CDK8,CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12,CHEMBL4507319,,,% Control,%,71.0,% Control,%,71.0,CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12,2021.0
KinomeScan assay: inhibition of CDK8,CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1,CHEMBL4507319,,,% Control,%,97.0,% Control,%,97.0,CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1,2021.0
KinomeScan assay: inhibition of CDK8,CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1,CHEMBL4507324,,,% Control,%,42.0,% Control,%,42.0,CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1,2021.0
KinomeScan assay: inhibition of CDK8,CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1,CHEMBL4507324,,,% Control,%,100.0,% Control,%,100.0,CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1,2021.0
CDK8(CDK8CGS1) Takeda global kinase panel,CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21,CHEMBL4507327,,,IC50,nM,1000.0,pIC50,,6.0,CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21,2021.0
CDK8(CDK8CGS1) Takeda global kinase panel,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,CHEMBL4507326,,,IC50,nM,1000.0,pIC50,,6.0,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,2021.0
CDK8(CDK8CGS1) Takeda global kinase panel,CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21,CHEMBL4507327,,,IC50,nM,1000.0,pIC50,,6.0,CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21,2021.0
KinomeScan assay: inhibition of CDK8,O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1,CHEMBL4507304,,,% Control,%,100.0,% Control,%,100.0,O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1,2021.0
KinomeScan assay: inhibition of CDK8,N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1,CHEMBL4507304,,,% Control,%,100.0,% Control,%,100.0,N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1,2021.0
KinomeScan assay: inhibition of CDK8,O=c1nc(-c2ccccn2)sc2ccccc12,CHEMBL4507329,,,% Control,%,36.0,% Control,%,36.0,O=c1nc(-c2ccccn2)sc2ccccc12,2021.0
KinomeScan assay: inhibition of CDK8,O=c1nc(-c2ccccn2)sc2ccccc12,CHEMBL4507329,>,>,Kd,nM,10000.0,Kd,nM,10000.0,O=c1nc(-c2ccccn2)sc2ccccc12,2021.0
KinomeScan assay: inhibition of CDK8,O=C1NC(c2ccccn2)Sc2ccccc21,CHEMBL4507329,,,% Control,%,78.0,% Control,%,78.0,O=C1NC(c2ccccn2)Sc2ccccc21,2021.0
KinomeScan assay: inhibition of CDK8,CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O,CHEMBL4507259,,,% Control,%,100.0,% Control,%,100.0,CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O,2021.0
KinomeScan assay: inhibition of CDK8,CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O,CHEMBL4507259,,,% Control,%,96.0,% Control,%,96.0,CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O,2021.0
KinomeScan assay: inhibition of CDK8,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1,CHEMBL4507295,,,% Control,%,100.0,% Control,%,100.0,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1,2021.0
KinomeScan assay: inhibition of CDK8,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1,CHEMBL4507295,,,% Control,%,100.0,% Control,%,100.0,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1,2021.0
KinomeScan assay: inhibition of CDK8,COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1,CHEMBL4507298,,,% Control,%,94.0,% Control,%,94.0,COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1,2021.0
KinomeScan assay: inhibition of CDK8,C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1,CHEMBL4507282,,,% Control,%,100.0,% Control,%,100.0,C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1,2021.0
KinomeScan assay: inhibition of CDK8,C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21,CHEMBL4507282,,,% Control,%,100.0,% Control,%,100.0,C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21,2021.0
KinomeScan assay: inhibition of CDK8,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1,CHEMBL4507299,,,% Control,%,50.0,% Control,%,50.0,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1,2021.0
KinomeScan assay: inhibition of CDK8,CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O,CHEMBL4507299,,,% Control,%,97.0,% Control,%,97.0,CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O,2021.0
KinomeScan assay: inhibition of CDK8,CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12,CHEMBL4507320,,,% Control,%,39.0,% Control,%,39.0,CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12,2021.0
KinomeScan assay: inhibition of CDK8,CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12,CHEMBL4507320,,,% Control,%,96.0,% Control,%,96.0,CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12,2021.0
Inhibition of CDK8 in human HEK293 cells measured by NanoBRET assay,NC(=O)c1sc2nccc(N3CCCCC3)c2c1N,CHEMBL5029178,=,=,IC50,nM,130.0,IC50,nM,130.0,NC(=O)c1sc2nccc(N3CCCCC3)c2c1N,2021.0
Inhibition of CDK8 in human HEK293 cells measured by NanoBRET assay,CC1CCN(c2ccnc3sc(C(N)=O)c(N)c23)CC1,CHEMBL5029178,=,=,IC50,nM,520.0,IC50,nM,520.0,CC1CCN(c2ccnc3sc(C(N)=O)c(N)c23)CC1,2021.0
Inhibition of CDK8 in human HEK293 cells measured by NanoBRET assay,CC1CCCN(c2ccnc3sc(C(N)=O)c(N)c23)C1,CHEMBL5029178,=,=,IC50,nM,31.0,IC50,nM,31.0,CC1CCCN(c2ccnc3sc(C(N)=O)c(N)c23)C1,2021.0
Inhibition of CDK8 in human HEK293 cells measured by NanoBRET assay,NC(=O)c1sc2nccc(N3CCCC(CO)C3)c2c1N,CHEMBL5029178,=,=,IC50,nM,93.0,IC50,nM,93.0,NC(=O)c1sc2nccc(N3CCCC(CO)C3)c2c1N,2021.0
Inhibition of CDK8 in human HEK293 cells measured by NanoBRET assay,CCCOCC1CCCN(c2ccnc3c2C(N)=C(C(N)=O)C3)C1,CHEMBL5029178,=,=,IC50,nM,33.0,IC50,nM,33.0,CCCOCC1CCCN(c2ccnc3c2C(N)=C(C(N)=O)C3)C1,2021.0
Inhibition of CDK8 in human HEK293 cells measured by NanoBRET assay,COC[C@H]1CCCN(c2ccnc3sc(C(N)=O)c(N)c23)C1,CHEMBL5029178,=,=,IC50,nM,34.0,IC50,nM,34.0,COC[C@H]1CCCN(c2ccnc3sc(C(N)=O)c(N)c23)C1,2021.0
Inhibition of CDK8 in human HEK293 cells measured by NanoBRET assay,COC[C@@H]1CCCN(c2ccnc3sc(C(N)=O)c(N)c23)C1,CHEMBL5029178,=,=,IC50,nM,410.0,IC50,nM,410.0,COC[C@@H]1CCCN(c2ccnc3sc(C(N)=O)c(N)c23)C1,2021.0
Inhibition of CDK8 in human HEK293 cells measured by NanoBRET assay,CCOCCOC[C@H]1CCCN(c2ccnc3sc(C(N)=O)c(N)c23)C1,CHEMBL5029178,=,=,IC50,nM,33.0,IC50,nM,33.0,CCOCCOC[C@H]1CCCN(c2ccnc3sc(C(N)=O)c(N)c23)C1,2021.0
Inhibition of CDK8 in human HEK293 cells measured by NanoBRET assay,NC(=O)c1sc2nccc(N3CCCN(c4ccccc4)CC3)c2c1N,CHEMBL5029178,=,=,IC50,nM,31.0,IC50,nM,31.0,NC(=O)c1sc2nccc(N3CCCN(c4ccccc4)CC3)c2c1N,2021.0
Inhibition of CDK8 in human HEK293 cells measured by NanoBRET assay,Cc1cc(Oc2ccc(CCCC(=O)N(C)C)cc2F)c2c(N)c(C(N)=O)sc2n1,CHEMBL5029178,=,=,IC50,nM,4.5,IC50,nM,4.5,Cc1cc(Oc2ccc(CCCC(=O)N(C)C)cc2F)c2c(N)c(C(N)=O)sc2n1,2021.0
Inhibition of CDK8 (unknown origin),Cc1c(Br)c(Br)c2c3c1nc(N1CCNCC1)n3CCC2,CHEMBL5230096,=,=,IC50,nM,4.4,IC50,nM,4.4,Cc1c(Br)c(Br)c2c3c1nc(N1CCNCC1)n3CCC2,2020.0
Inhibition of CDK8 (unknown origin),CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL5241055,=,=,Kd,nM,140.0,Kd,nM,140.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2021.0
Inhibition of CDK8 (unknown origin),CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL5241055,=,=,IC50,nM,30.0,IC50,nM,30.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2021.0
Inhibition of CDK8 (unknown origin),Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,CHEMBL5241055,=,=,IC50,nM,14.0,IC50,nM,14.0,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,2021.0
Inhibition of CDK8 (unknown origin),Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,CHEMBL5241055,=,=,IC50,nM,14.0,IC50,nM,14.0,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,2021.0
Inhibition of CDK8 (unknown origin),CNc1ncc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c(N)n1,CHEMBL5241055,=,=,IC50,nM,11.0,IC50,nM,11.0,CNc1ncc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c(N)n1,2021.0
Inhibition of CDK8 (unknown origin),O=C(Nc1cccc(C(F)(F)F)c1)NC1CCN(c2ccc3nncn3n2)C1,CHEMBL5241055,=,=,IC50,nM,14.0,IC50,nM,14.0,O=C(Nc1cccc(C(F)(F)F)c1)NC1CCN(c2ccc3nncn3n2)C1,2021.0
Inhibition of CDK8 (unknown origin),Cc1cccc(Cc2n[nH]c3cc(O)c(C(=O)N4Cc5ccccc5C4)cc23)c1,CHEMBL5241055,=,=,IC50,nM,15.0,IC50,nM,15.0,Cc1cccc(Cc2n[nH]c3cc(O)c(C(=O)N4Cc5ccccc5C4)cc23)c1,2021.0
Inhibition of CDK8 (unknown origin),CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,CHEMBL5241055,=,=,IC50,nM,10.0,IC50,nM,10.0,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,2021.0
Inhibition of CDK8 (unknown origin),CNC(=O)c1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,CHEMBL5241055,=,=,IC50,nM,5.0,IC50,nM,5.0,CNC(=O)c1ccc2[nH]nc(Cc3ccc(-c4cnn(C)c4)cc3)c2c1,2021.0
Inhibition of CDK8 (unknown origin),Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL5241055,=,=,IC50,nM,2.3,IC50,nM,2.3,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,2021.0
Binding affinity to CDK8 (unknown origin),Cc1ccc(-n2nc(C(C)(C)C)cc2NC(N)=O)cc1,CHEMBL5241055,=,=,Kd,nM,3240.0,Kd,uM,3.24,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(N)=O)cc1,2021.0
Binding affinity to CDK8 (unknown origin),Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCCCN2CCN(C(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)CC2)cc1,CHEMBL5241055,=,=,Kd,nM,30.0,Kd,uM,0.03,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCCCN2CCN(C(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)CC2)cc1,2021.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(CCO)c3)cc1)CC2,CHEMBL3797072,=,=,IC50,nM,4.6,IC50,nM,4.6,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(CCO)c3)cc1)CC2,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CC(C)(O)Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,13.1,IC50,nM,13.1,CC(C)(O)Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN(C)CCn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,23.9,IC50,nM,23.9,CN(C)CCn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(CCN4CCCC4)c3)cc1)CC2,CHEMBL3797072,=,=,IC50,nM,22.3,IC50,nM,22.3,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(CCN4CCCC4)c3)cc1)CC2,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cc1nc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1C,CHEMBL3797072,=,=,IC50,nM,19.5,IC50,nM,19.5,Cc1nc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1C,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3)CC2,CHEMBL3797072,=,=,IC50,nM,115.3,IC50,nM,115.3,O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3)CC2,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,1.0,IC50,nM,1.0,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,15.0,IC50,nM,15.0,CN1c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Nc1n[nH]c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,CHEMBL3797072,=,=,IC50,nM,13.6,IC50,nM,13.6,Nc1n[nH]c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)COC(=O)N4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,3433.0,IC50,nM,3433.0,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)COC(=O)N4)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,14.6,IC50,nM,14.6,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,1.4,IC50,nM,1.4,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)OC(=O)NC4(C)C)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,109.0,IC50,nM,109.0,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)OC(=O)NC4(C)C)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NCNC4=O)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,8.7,IC50,nM,8.7,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NCNC4=O)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,23.0,IC50,nM,23.0,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,35.5,IC50,nM,35.5,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CC1=NC2(CCN(c3c(Cl)cncc3-c3ccc4c(c3)CS(=O)(=O)N4C)CC2)C(=O)N1,CHEMBL3797072,=,=,IC50,nM,33.5,IC50,nM,33.5,CC1=NC2(CCN(c3c(Cl)cncc3-c3ccc4c(c3)CS(=O)(=O)N4C)CC2)C(=O)N1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)CNC4=O)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,34.3,IC50,nM,34.3,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)NC(=O)CNC4=O)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CC1=NNC(=O)C12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,CHEMBL3797072,=,=,IC50,nM,0.08,IC50,nM,0.08,CC1=NNC(=O)C12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)C(=O)NN=C4C(F)(F)F)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,3.7,IC50,nM,3.7,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)C(=O)NN=C4C(F)(F)F)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN(C)CCC1(C#N)CCN(c2c(Cl)cncc2-c2ccc3c(c2)CS(=O)(=O)N3C)CC1,CHEMBL3797072,=,=,IC50,nM,7.4,IC50,nM,7.4,CN(C)CCC1(C#N)CCN(c2c(Cl)cncc2-c2ccc3c(c2)CS(=O)(=O)N3C)CC1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,CHEMBL3797072,=,=,IC50,nM,342.0,IC50,nM,342.0,CN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,COCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,CHEMBL3797072,=,=,IC50,nM,621.0,IC50,nM,621.0,COCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,COCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,CHEMBL3797072,=,=,IC50,nM,73.5,IC50,nM,73.5,COCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,COCCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,CHEMBL3797072,=,=,IC50,nM,86.3,IC50,nM,86.3,COCCCN1CCCC12CCN(c1c(Cl)cncc1-c1ccc3c(c1)CS(=O)(=O)N3C)CC2,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CCCN4CCCS(C)(=O)=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,75.4,IC50,nM,75.4,CN1c2ccc(-c3cncc(Cl)c3N3CCC4(CCCN4CCCS(C)(=O)=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,186.0,IC50,nM,186.0,Cn1cc(-c2ccc(-c3cncc(F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cncc(F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,14.5,IC50,nM,14.5,CN1c2ccc(-c3cncc(F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,55.4,IC50,nM,55.4,Cn1cc(-c2ccc(-c3cncc(F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cncc(F)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,13.6,IC50,nM,13.6,CN1c2ccc(-c3cncc(F)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,3.5,IC50,nM,3.5,Cn1cc(-c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,0.6,IC50,nM,0.6,CN1c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,23.8,IC50,nM,23.8,Cn1cc(-c2ccc(-c3cncc(C(F)(F)F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,8.7,IC50,nM,8.7,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CC(C)(O)Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,8.6,IC50,nM,8.6,CC(C)(O)Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Nc1ncc(-c2ccc3c(N)n[nH]c3c2)c(N2CCC3(CCNC3=O)CC2)c1Cl,CHEMBL3797072,=,=,IC50,nM,42.5,IC50,nM,42.5,Nc1ncc(-c2ccc3c(N)n[nH]c3c2)c(N2CCC3(CCNC3=O)CC2)c1Cl,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,1.1,IC50,nM,1.1,CN1c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,12.8,IC50,nM,12.8,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,5.2,IC50,nM,5.2,CN1c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,5.3,IC50,nM,5.3,Cn1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)NC(=O)NC4=O)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cnc(N)c(F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,18.4,IC50,nM,18.4,CN1c2ccc(-c3cnc(N)c(F)c3N3CCC4(CCNC4=O)CC3)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1c2ccc(-c3cnc(N)c(F)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,CHEMBL3797072,=,=,IC50,nM,101.0,IC50,nM,101.0,CN1c2ccc(-c3cnc(N)c(F)c3N3CCC4(CC3)CNC(=O)O4)cc2CS1(=O)=O,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,2.1,IC50,nM,2.1,Cn1cc(-c2ccc(-c3cnc(N)c(C(F)(F)F)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cnc(N)c(C(F)(F)F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,12.7,IC50,nM,12.7,Cn1cc(-c2ccc(-c3cnc(N)c(C(F)(F)F)c3N3CCC4(CC3)CNC(=O)O4)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CNc1n[nH]c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,CHEMBL3797072,=,=,IC50,nM,2.9,IC50,nM,2.9,CNc1n[nH]c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1nc(N)c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc21,CHEMBL3797072,=,=,IC50,nM,1.8,IC50,nM,1.8,Cn1nc(N)c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc21,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN(C)c1nn(C)c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,CHEMBL3797072,=,=,IC50,nM,110.0,IC50,nM,110.0,CN(C)c1nn(C)c2cc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)ccc12,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1C(=O)NC(=O)C12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,CHEMBL3797072,=,=,IC50,nM,0.7,IC50,nM,0.7,CN1C(=O)NC(=O)C12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CN1CNC(=O)C12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,CHEMBL3797072,=,=,IC50,nM,2.4,IC50,nM,2.4,CN1CNC(=O)C12CCN(c1c(Cl)cncc1-c1ccc(-c3cnn(C)c3)cc1)CC2,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)C(=O)NCN4CC(F)(F)F)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,4.0,IC50,nM,4.0,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CC3)C(=O)NCN4CC(F)(F)F)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CC(C)n1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,22.5,IC50,nM,22.5,CC(C)n1cc(-c2ccc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL3797072,=,=,IC50,nM,11.8,IC50,nM,11.8,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)ccc21,CHEMBL3797072,=,=,IC50,nM,36.0,IC50,nM,36.0,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CC3)CNC(=O)O4)ccc21,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,CC(C)n1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,CHEMBL3797072,=,=,IC50,nM,58.3,IC50,nM,58.3,CC(C)n1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,2016.0
Binding affinity to CDK8/CDK19 in human 7dF3 cells preincubated for 2 hrs followed by addition 10 uM of beta-oestradiol measured after 24 hrs by luciferase reporter gene assay,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,CHEMBL3797072,=,=,IC50,nM,5.0,IC50,nM,5.0,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,2016.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of MYC expression as percent of control at 1 uM by QPCR assay relative to control,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,24.94,INH,%,24.94,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of MYC expression as percent of control at 1 uM by QPCR assay relative to control,CC(C)Nc1ccnc2ccc(C#N)cc12,CHEMBL4804282,=,=,Inhibition,%,65.64,INH,%,65.64,CC(C)Nc1ccnc2ccc(C#N)cc12,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of MYC expression as percent of control at 1 uM by QPCR assay relative to control,CCCNc1ccnc2ccc(C#N)cc12,CHEMBL4804282,=,=,Inhibition,%,57.22,INH,%,57.22,CCCNc1ccnc2ccc(C#N)cc12,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of MYC expression as percent of control at 1 uM by QPCR assay relative to control,N#Cc1ccc2nccc(NCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,38.3,INH,%,38.3,N#Cc1ccc2nccc(NCc3ccccc3)c2c1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of MYC expression as percent of control at 1 uM by QPCR assay relative to control,N#Cc1ccc2nccc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,24.15,INH,%,24.15,N#Cc1ccc2nccc(NCCc3ccccc3)c2c1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of CXCL1 expression as percent of control at 1 uM by QPCR assay relative to control,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,34.19,INH,%,34.19,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of CXCL1 expression as percent of control at 1 uM by QPCR assay relative to control,CC(C)Nc1ccnc2ccc(C#N)cc12,CHEMBL4804282,=,=,Inhibition,%,80.3,INH,%,80.3,CC(C)Nc1ccnc2ccc(C#N)cc12,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of CXCL1 expression as percent of control at 1 uM by QPCR assay relative to control,CCCNc1ccnc2ccc(C#N)cc12,CHEMBL4804282,=,=,Inhibition,%,72.16,INH,%,72.16,CCCNc1ccnc2ccc(C#N)cc12,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of CXCL1 expression as percent of control at 1 uM by QPCR assay relative to control,N#Cc1ccc2nccc(NCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,51.07,INH,%,51.07,N#Cc1ccc2nccc(NCc3ccccc3)c2c1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of CXCL1 expression as percent of control at 1 uM by QPCR assay relative to control,N#Cc1ccc2nccc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,33.36,INH,%,33.36,N#Cc1ccc2nccc(NCCc3ccccc3)c2c1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of IL-8 expression as percent of control at 1 uM by QPCR assay relative to control,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,29.53,INH,%,29.53,N#Cc1ccc2ncnc(NCCc3ccccc3)c2c1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of IL-8 expression as percent of control at 1 uM by QPCR assay relative to control,CC(C)Nc1ccnc2ccc(C#N)cc12,CHEMBL4804282,=,=,Inhibition,%,74.1,INH,%,74.1,CC(C)Nc1ccnc2ccc(C#N)cc12,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of IL-8 expression as percent of control at 1 uM by QPCR assay relative to control,CCCNc1ccnc2ccc(C#N)cc12,CHEMBL4804282,=,=,Inhibition,%,62.12,INH,%,62.12,CCCNc1ccnc2ccc(C#N)cc12,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of IL-8 expression as percent of control at 1 uM by QPCR assay relative to control,N#Cc1ccc2nccc(NCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,45.05,INH,%,45.05,N#Cc1ccc2nccc(NCc3ccccc3)c2c1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of IL-8 expression as percent of control at 1 uM by QPCR assay relative to control,N#Cc1ccc2nccc(NCCc3ccccc3)c2c1,CHEMBL4804282,=,=,Inhibition,%,29.25,INH,%,29.25,N#Cc1ccc2nccc(NCCc3ccccc3)c2c1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of MYC expression by QPCR assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,25.0,IC50,nM,25.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of MYC expression by QPCR assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,42.0,IC50,nM,42.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of CXCL1 expression by QPCR assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,36.0,IC50,nM,36.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of CXCL1 expression by QPCR assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,69.0,IC50,nM,69.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of IL-8 expression by QPCR assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,35.0,IC50,nM,35.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in TNF-alpha-induced HEK293 cells assessed as inhibition of IL-8 expression by QPCR assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,97.0,IC50,nM,97.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells assessed as reduction in JUN expression at 1 uM incubated for 2 hrs and measured after 24 hrs of compound wash-off,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,,,Inhibition,%,,INH,,,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells assessed as reduction in JUN expression at 1 uM incubated for 2 hrs and measured after 24 hrs of compound wash-off,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,,,Inhibition,%,,INH,,,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells assessed as reduction in MYC expression at 1 uM incubated for 2 hrs and measured after 24 hrs of compound wash-off,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,,,Inhibition,%,,INH,,,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells assessed as reduction in MYC expression at 1 uM incubated for 2 hrs and measured after 24 hrs of compound wash-off,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,,,Inhibition,%,,INH,,,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,105.0,IC50,nM,105.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,CN(C)C(=O)c1ccc2cc(CCNc3ccnc4ccc(C#N)cc34)ccc2c1,CHEMBL4804282,=,=,IC50,nM,140.0,IC50,nM,140.0,CN(C)C(=O)c1ccc2cc(CCNc3ccnc4ccc(C#N)cc34)ccc2c1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,N#Cc1ccc2nccc(NCCc3ccc4cc(C(=O)N5CCN(CCCO)CC5)ccc4c3)c2c1,CHEMBL4804282,=,=,IC50,nM,115.0,IC50,nM,115.0,N#Cc1ccc2nccc(NCCc3ccc4cc(C(=O)N5CCN(CCCO)CC5)ccc4c3)c2c1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,N#Cc1ccc2nccc(NCCc3ccc4cc(C(=O)N5CCNCC5)ccc4c3)c2c1,CHEMBL4804282,=,=,IC50,nM,388.0,IC50,nM,388.0,N#Cc1ccc2nccc(NCCc3ccc4cc(C(=O)N5CCNCC5)ccc4c3)c2c1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,IC50,nM,161.0,IC50,nM,161.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,NC(=O)c1sc2nccc(N3CCCN(c4ccccc4)CC3)c2c1N,CHEMBL4804286,=,=,IC50,nM,50.6,IC50,nM,50.6,NC(=O)c1sc2nccc(N3CCCN(c4ccccc4)CC3)c2c1N,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,IC50,nM,37.8,IC50,nM,37.8,Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,COc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,IC50,nM,43.1,IC50,nM,43.1,COc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,IC50,nM,10.0,IC50,nM,10.0,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,CNC(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,IC50,nM,23.1,IC50,nM,23.1,CNC(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in HEK293 cells by NF-kappaB reporter assay,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,IC50,nM,4.0,IC50,nM,4.0,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in CDK8 and CDK19-knockout HEK293 cells by NF-kappaB reporter assay,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,>,>,IC50,nM,5000.0,IC50,uM,5.0,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in CDK8 and CDK19-knockout HEK293 cells by NF-kappaB reporter assay,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,>,>,IC50,nM,5000.0,IC50,uM,5.0,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in ST2 cells by alkaline phosphatase activity assay,NC(=O)c1sc2nccc(N3CCCN(c4ccccc4)CC3)c2c1N,CHEMBL4804286,=,=,EC200,nM,138.8,EC200,nM,138.8,NC(=O)c1sc2nccc(N3CCCN(c4ccccc4)CC3)c2c1N,2020.0
Inhibition of CDK8/CDK19 in ST2 cells by alkaline phosphatase activity assay,Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,EC200,nM,88.1,EC200,nM,88.1,Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in ST2 cells by alkaline phosphatase activity assay,COc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,EC200,nM,115.4,EC200,nM,115.4,COc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in ST2 cells by alkaline phosphatase activity assay,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,EC200,nM,31.9,EC200,nM,31.9,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in ST2 cells by alkaline phosphatase activity assay,CNC(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,EC200,nM,54.2,EC200,nM,54.2,CNC(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of CDK8/CDK19 in ST2 cells by alkaline phosphatase activity assay,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,EC200,nM,6.6,EC200,nM,6.6,CN(C)C(=O)Cc1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
